No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4ltcO, 1.0000, 0.00, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2, 4ltcA, 0.9996, 0.11, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3, 5l6aO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4, 5l6aA, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
5, 5l5hO, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
6, 5l5hA, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
7, 4qv5O, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT
8, 4qv5A, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT
9, 4qv4O, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45T MUTANT
10, 4qv4A, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45T MUTANT
11, 4qv1O, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45A MUTANT
12, 4qv1A, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45A MUTANT
13, 5m2bO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
14, 5m2bA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
15, 5l6cO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
16, 5l6cA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
17, 5l6bO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
18, 5l6bA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
19, 5l67O, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
20, 5l67A, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
21, 5l66O, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
22, 5l65O, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
23, 5l63O, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
24, 5l63A, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
25, 5l61O, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
26, 5l5wO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
27, 5l5wA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
28, 5l5uO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
29, 5l5uA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
30, 5l5sO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
31, 5l5sA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
32, 5l5rO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
33, 5l5rA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
34, 5l5qO, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
35, 5l5qA, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
36, 5l5pO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
37, 5l5pA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
38, 5l5oO, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
39, 5l5dO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
40, 5l5dA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
41, 5l5bO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
42, 5l5bA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
43, 5l5aO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
44, 5l5aA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
45, 5czaO, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
46, 5cz6O, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
47, 5cz6A, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
48, 5bxnO, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
49, 5bxnA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
50, 5bxlA, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
51, 4qvlO, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
52, 4qvlA, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
53, 4qv8O, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-C52F MUTANT
54, 4qv8A, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-C52F MUTANT
55, 4qv7O, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A50V MUTANT
56, 4qv7A, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A50V MUTANT
57, 4qv0O, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
58, 4qv0A, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
59, 4quyO, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
60, 4quyA, 0.9990, 0.19, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
61, 3nzwO, 0.9990, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
62, 3nzjO, 0.9990, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
63, 6gopO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
64, 5lttO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
65, 5lttA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
66, 5l69O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
67, 5l69A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
68, 5l68O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
69, 5l68A, 0.9989, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
70, 5l66A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
71, 5l65A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
72, 5l64O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
73, 5l64A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
74, 5l62O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
75, 5l62A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
76, 5l61A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
77, 5l5tO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
78, 5l5tA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
79, 5l5oA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
80, 5l5jO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
81, 5l5jA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
82, 5l5iO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
83, 5l5iA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
84, 5l5fO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
85, 5l5fA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
86, 5fgaO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
87, 5fgaA, 0.9989, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
88, 5d0wO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
89, 5d0wA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
90, 5czaA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
91, 4ya4O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
92, 4ya4A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
93, 4ya1O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
94, 4ya1A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
95, 4y9yO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
96, 4y9yA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
97, 4y8tO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
98, 4y8tA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
99, 4qzzO, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
100, 4qzzA, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
101, 4qw1O, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
102, 4qw1A, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
103, 4qvyO, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
104, 4qvyA, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
105, 4qvwO, 0.9989, 0.20, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
106, 4qvwA, 0.9989, 0.20, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
107, 4qvnO, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
108, 4qvnA, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
109, 4qv3O, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT
110, 4qv3A, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT
111, 4jt0O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
112, 4jt0A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
113, 4jsuO, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
114, 4jsuA, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
115, 3un4O, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
116, 3un4A, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
117, 3nzxO, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
118, 3nzwA, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
119, 3nzjA, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
120, 6gopA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
121, 5l5zO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
122, 5l5zA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
123, 5l5yO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
124, 5l5yA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
125, 5l5xO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
126, 5l5xA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
127, 5l5vO, 0.9988, 0.20, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
128, 5l5vA, 0.9988, 0.20, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
129, 5fg9O, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
130, 5fg9A, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
131, 5fg7O, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
132, 5fg7A, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
133, 5bouO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
134, 4y8rO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
135, 4y8rA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
136, 4y8mO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
137, 4y8mA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
138, 4r18O, 0.9988, 0.20, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
139, 4r18A, 0.9988, 0.20, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
140, 4r02O, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
141, 4qvpO, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
142, 4qvpA, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
143, 4qv9O, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT
144, 4qv9A, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT
145, 4quxO, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
146, 4quxA, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
147, 4qltO, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
148, 4qltA, 0.9988, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
149, 4no8O, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
150, 4no8A, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
151, 4lqiO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
152, 4lqiA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
153, 4jsqO, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
154, 4jsqA, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
155, 3nzxA, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
156, 3mg0O, 0.9988, 0.20, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
157, 3hyeO, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
158, 3hyeA, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
159, 3gpwO, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
160, 3gpwA, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
161, 3gptO, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
162, 3gptA, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
163, 2fakO, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
164, 2fakA, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
165, 5l60O, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
166, 5l60A, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
167, 5l5eO, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
168, 5l5eA, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
169, 5l54O, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
170, 5l54A, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
171, 5cz7O, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
172, 5cz7A, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
173, 5cgfO, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
174, 5cgfA, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
175, 5bouA, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
176, 4y6vO, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
177, 4r00O, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
178, 4r00A, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
179, 4qwuO, 0.9987, 0.20, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
180, 4qwuA, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
181, 4qv6O, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49V MUTANT
182, 4qv6A, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49V MUTANT
183, 4qluO, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
184, 4qluA, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
185, 4no1O, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
186, 4no1A, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
187, 4intO, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
188, 4inrO, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
189, 4inrA, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
190, 3un8O, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
191, 3shjO, 0.9987, 0.21, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
192, 3shjA, 0.9987, 0.21, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
193, 5lajO, 0.9986, 0.21, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
194, 5lajA, 0.9986, 0.21, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
195, 5cghO, 0.9986, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
196, 4z1lO, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
197, 4z1lA, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
198, 4y75O, 0.9986, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
199, 4y6vA, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
200, 4rurO, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
201, 4rurA, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
202, 4qz7O, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
203, 4qz7A, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
204, 4qvqO, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
205, 4qvqA, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
206, 4qlsO, 0.9986, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
207, 4qlsA, 0.9986, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
208, 4inuO, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
209, 4intA, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
210, 3un8A, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
211, 3tddO, 0.9986, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
212, 3tddA, 0.9986, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
213, 2gplO, 0.9986, 0.22, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
214, 2gplA, 0.9986, 0.22, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
215, 5l55O, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
216, 5l55A, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
217, 5dkjO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
218, 5dkjA, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
219, 5cghA, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
220, 5cggO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
221, 5cggA, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
222, 5bxlO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
223, 4ya2O, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
224, 4ya2A, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
225, 4y8pO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
226, 4y8pA, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
227, 4y8nO, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
228, 4y8nA, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
229, 4y75A, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
230, 4qz4O, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
231, 4qz4A, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
232, 4qlqO, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
233, 4qlqA, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
234, 4j70O, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
235, 4j70A, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
236, 4inuA, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
237, 3okjO, 0.9985, 0.23, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
238, 3okjA, 0.9985, 0.23, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
239, 3mg0A, 0.9985, 0.22, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
240, 3e47O, 0.9985, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
241, 3e47A, 0.9985, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
242, 5jhrO, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
243, 5jhrA, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
244, 5d0tO, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
245, 5d0tA, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
246, 4ya9O, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
247, 4ya9A, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
248, 4ya7O, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
249, 4ya7A, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
250, 4y9zO, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
251, 4y9zA, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
252, 4y8sO, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
253, 4y8sA, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
254, 4y8gO, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
255, 4y8gA, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
256, 4y77O, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
257, 4y77A, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
258, 4y69O, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
259, 4y69A, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
260, 4qwxO, 0.9984, 0.24, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
261, 4qwxA, 0.9984, 0.24, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
262, 4qwlO, 0.9984, 0.24, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
263, 4qwlA, 0.9984, 0.24, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
264, 4qvmO, 0.9984, 0.23, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
265, 4qvmA, 0.9984, 0.23, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
266, 2f16O, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
267, 2f16A, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
268, 5laiO, 0.9983, 0.24, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
269, 5laiA, 0.9983, 0.24, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
270, 5l52O, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
271, 5l52A, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
272, 5fggO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
273, 5fggA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
274, 5d0xO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
275, 5d0xA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
276, 5d0vO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
277, 5d0vA, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
278, 5d0sO, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
279, 5d0sA, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
280, 5ahjO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
281, 5ahjA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
282, 4y8uO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
283, 4y8uA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
284, 4y8hO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
285, 4y8hA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
286, 4y84O, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
287, 4y84A, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
288, 4y6aO, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
289, 4y6aA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
290, 4qz6O, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
291, 4qz6A, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
292, 4qz5O, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
293, 4qz5A, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
294, 4qz3O, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
295, 4qz3A, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
296, 4qz0O, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
297, 4qz0A, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
298, 4qw6O, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
299, 4qw6A, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
300, 4qw0O, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
301, 4qw0A, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
302, 4q1sA, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
303, 4nnnO, 0.9983, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
304, 4nnnA, 0.9983, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
305, 3dy3O, 0.9983, 0.24, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
306, 3dy3A, 0.9983, 0.24, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
307, 3d29O, 0.9983, 0.24, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
308, 3d29A, 0.9983, 0.24, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
309, 5d0zO, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
310, 5d0zA, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
311, 4ya5O, 0.9982, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
312, 4ya5A, 0.9982, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
313, 4y8kO, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
314, 4y8kA, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
315, 4qwfO, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
316, 4qwfA, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
317, 4qw7O, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
318, 4qw7A, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
319, 4qw5O, 0.9982, 0.25, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
320, 4qw5A, 0.9982, 0.25, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
321, 4qlvO, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
322, 4qlvA, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
323, 4no6O, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
324, 4no6A, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
325, 5jhsO, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
326, 5jhsA, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
327, 5fghO, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
328, 5fghA, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
329, 5cz9O, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
330, 5cz9A, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
331, 5cgiO, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
332, 5cgiA, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
333, 4y8lO, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
334, 4y8lA, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
335, 4y8jO, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
336, 4y8jA, 0.9981, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
337, 4y82O, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
338, 4y82A, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
339, 4y74O, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
340, 4y74A, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
341, 4y70O, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
342, 4r02A, 0.9981, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
343, 4qzwO, 0.9981, 0.26, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
344, 4qzwA, 0.9981, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
345, 4q1sO, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
346, 4gk7O, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
347, 4gk7A, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
348, 4fzcO, 0.9981, 0.25, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
349, 4fzcA, 0.9981, 0.25, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
350, 3mg4A, 0.9981, 0.25, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
351, 3gpjO, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
352, 3gpjA, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
353, 3dy4A, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
354, 2zcyO, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
355, 2zcyA, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
356, 5fgfO, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
357, 5fgfA, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
358, 4y8qO, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
359, 4y8qA, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
360, 4y7wO, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
361, 4y7wA, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
362, 4y70A, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
363, 4qz2O, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
364, 4qz2A, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
365, 4qwrO, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
366, 4qwrA, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
367, 4qw4O, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
368, 4qw4A, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
369, 4no9O, 0.9980, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
370, 4no9A, 0.9980, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
371, 4nnwO, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
372, 4nnwA, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
373, 3dy4O, 0.9980, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
374, 5fgeO, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
375, 5fgeA, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
376, 5dkiO, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
377, 5dkiA, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
378, 5cz4O, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
379, 5cz4A, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
380, 4y8oO, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
381, 4y8oA, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
382, 4y8iO, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
383, 4y8iA, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
384, 4y81O, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
385, 4y81A, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
386, 4y7xO, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
387, 4y7xA, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
388, 4hnpO, 0.9979, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
389, 4fzgO, 0.9979, 0.27, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
390, 4fzgA, 0.9979, 0.27, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
391, 5fhsO, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
392, 5fhsA, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
393, 5cz8O, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
394, 5cz8A, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
395, 4y80O, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
396, 4y80A, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
397, 4y7yO, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
398, 4y7yA, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
399, 4qz1O, 0.9978, 0.28, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
400, 4qz1A, 0.9978, 0.28, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
401, 4qvvO, 0.9978, 0.27, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
402, 4qvvA, 0.9978, 0.27, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
403, 4hnpA, 0.9978, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
404, 5nifP, 0.9977, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
405, 4y6zO, 0.9977, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
406, 4y6zA, 0.9977, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
407, 4qzxO, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
408, 4qzxA, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
409, 4qwiO, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
410, 4qwiA, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
411, 3sdkO, 0.9977, 0.28, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
412, 5fgdO, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
413, 5fgdA, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
414, 5cz5O, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
415, 5cz5A, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
416, 4ya3O, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
417, 4ya3A, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
418, 4qxjO, 0.9976, 0.30, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
419, 4qxjA, 0.9976, 0.30, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
420, 4qw3O, 0.9976, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
421, 4qw3A, 0.9976, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
422, 3oeuO, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
423, 3mg8O, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
424, 3mg7O, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
425, 3bdmO, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
426, 3bdmA, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
427, 4zzgP, 0.9975, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
428, 4ya0O, 0.9975, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
429, 4ya0A, 0.9975, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
430, 4qwkO, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
431, 4qwkA, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
432, 4hrdO, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
433, 4hrdA, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
434, 4y78O, 0.9974, 0.31, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
435, 4y78A, 0.9974, 0.31, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
436, 4qbyO, 0.9974, 0.31, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
437, 4qbyA, 0.9973, 0.31, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
438, 3oevO, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
439, 3mg6O, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
440, 3mg6A, 0.9973, 0.30, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
441, 4qwjO, 0.9972, 0.32, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
442, 4qwjA, 0.9972, 0.32, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
443, 3oevA, 0.9972, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
444, 4qwsO, 0.9970, 0.34, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
445, 4qwsA, 0.9970, 0.34, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
446, 3sdkA, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
447, 3oeuA, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
448, 3mg8A, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
449, 3mg7A, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
450, 1rypP, 0.9969, 0.33, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
451, 3mg4O, 0.9968, 0.34, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
452, 1rypB, 0.9968, 0.34, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
453, 5nifB, 0.9966, 0.34, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
454, 4zzgB, 0.9966, 0.35, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
455, 4qwgO, 0.9966, 0.35, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
456, 4qwgA, 0.9966, 0.35, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
457, 1g65A, 0.9964, 0.36, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
458, 1g65O, 0.9963, 0.36, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
459, 1jd2A, 0.9951, 0.41, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
460, 4r17O, 0.9950, 0.18, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
461, 4r17A, 0.9950, 0.18, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
462, 1jd2V, 0.9948, 0.42, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
463, 5fgiO, 0.9946, 0.22, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
464, 5fgiA, 0.9945, 0.22, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
465, 3wxrB, 0.9940, 0.26, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
466, 4hrcO, 0.9937, 0.28, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
467, 4hrcA, 0.9933, 0.31, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
468, 4x6zP, 0.9931, 0.32, 1.000, 249, 249, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
469, 4eu2B, 0.9929, 0.33, 1.000, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
470, 3wxrP, 0.9925, 0.35, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
471, 4eu2P, 0.9916, 0.40, 0.996, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
472, 4x6zB, 0.9890, 0.33, 1.000, 248, 248, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
473, 3jcpKA, 0.9887, 0.63, 1.000, 250, 250, 
474, 3jcpK, 0.9887, 0.63, 1.000, 250, 250, 
475, 5mp9B, 0.9852, 0.63, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
476, 3sdiA, 0.9824, 0.72, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
477, 3sdiO, 0.9822, 0.24, 1.000, 246, 246, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
478, 3jcoKA, 0.9817, 0.25, 1.000, 246, 246, 
479, 3jcoK, 0.9817, 0.81, 1.000, 250, 250, 
480, 1g0uA, 0.9810, 0.81, 1.000, 250, 250, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
481, 1g0uO, 0.9807, 0.81, 1.000, 250, 250, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
482, 5mp9b, 0.9805, 0.32, 1.000, 246, 246, 26S PROTEASOME IN PRESENCE OF ATP (S1)
483, 4g4sB, 0.9798, 0.34, 1.000, 246, 246, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
484, 5mpab, 0.9753, 0.94, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S2)
485, 5mpaB, 0.9748, 0.39, 1.000, 246, 246, 26S PROTEASOME IN PRESENCE OF ATP (S2)
486, 5wvkW, 0.9720, 1.06, 1.000, 250, 250, 
487, 5wvkP, 0.9698, 0.96, 1.000, 250, 250, 
488, 4cr2B, 0.9591, 1.02, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
489, 5mpbB, 0.9551, 1.05, 1.000, 250, 250, 
490, 5wviOA, 0.9547, 1.30, 1.000, 250, 250, 
491, 5wviDA, 0.9530, 1.37, 1.000, 250, 250, 
492, 5mpbP, 0.9530, 1.32, 1.000, 250, 250, 
493, 1z7qP, 0.9524, 1.34, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
494, 1z7qB, 0.9523, 1.36, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
495, 1fntP, 0.9512, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
496, 1fntB, 0.9512, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
497, 4cr4B, 0.9464, 1.08, 1.000, 247, 243, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
498, 5a5bB, 0.9415, 1.08, 1.000, 247, 243, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
499, 4cr3B, 0.9415, 1.52, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
500, 5mpcB, 0.9342, 1.55, 1.000, 250, 250, 
501, 5mpcP, 0.9329, 1.55, 1.000, 250, 250, 
502, 4v7oB, 0.9171, 1.42, 1.000, 250, 244, 
503, 4v7oXA, 0.9170, 1.48, 1.000, 250, 244, 
504, 4v7oP, 0.9170, 0.53, 1.000, 231, 231, 
505, 4v7oJA, 0.9170, 1.74, 0.285, 234, 221, 
506, 4r3oB, 0.9048, 0.53, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
507, 4r3oP, 0.9047, 0.53, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
508, 4r67r, 0.9039, 0.53, 1.000, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
509, 4r67P, 0.9039, 1.02, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
510, 4r67d, 0.9039, 1.02, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
511, 4r67B, 0.9037, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
512, 5gjqC, 0.9025, 1.04, 0.608, 233, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
513, 5gjrHA, 0.9021, 1.04, 0.608, 233, 232, 
514, 5gjrT, 0.9020, 1.04, 0.608, 233, 232, 
515, 5l4gP, 0.9017, 1.08, 0.608, 233, 232, 
516, 5l4gB, 0.9015, 0.99, 0.606, 231, 231, 
517, 3uneO, 0.9014, 0.99, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
518, 5lezO, 0.9009, 1.08, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
519, 5lexO, 0.9007, 1.14, 0.608, 233, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
520, 1iruP, 0.9007, 1.10, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
521, 5leyO, 0.9004, 0.93, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
522, 3unec, 0.9004, 0.93, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
523, 5lf3O, 0.9003, 1.11, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
524, 5lf1O, 0.9003, 0.93, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
525, 5lezA, 0.9003, 1.14, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
526, 5lf7O, 0.9002, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
527, 5lexA, 0.9002, 0.94, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
528, 5lf6O, 0.9001, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
529, 5lf4O, 0.9001, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
530, 5le5O, 0.9001, 0.94, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
531, 3uneq, 0.9000, 0.94, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
532, 3unbq, 0.9000, 0.94, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
533, 3unbA, 0.8998, 0.94, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
534, 5lf0O, 0.8997, 1.13, 0.608, 233, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
535, 3unbO, 0.8997, 1.04, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
536, 3unbc, 0.8996, 1.04, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
537, 5leyA, 0.8995, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
538, 5lf6A, 0.8994, 1.05, 0.606, 231, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
539, 5gjqi, 0.8994, 1.05, 0.606, 231, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
540, 5lf3A, 0.8993, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
541, 5lf4A, 0.8992, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
542, 5lf1A, 0.8992, 1.05, 0.602, 231, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
543, 3uneA, 0.8990, 0.96, 0.613, 230, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
544, 5lf7A, 0.8989, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
545, 5lf0A, 0.8988, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
546, 5le5A, 0.8988, 1.17, 0.603, 233, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
547, 1iruB, 0.8988, 0.97, 0.613, 230, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
548, 6avoP, 0.8970, 0.98, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
549, 6avob, 0.8970, 0.97, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
550, 3unhO, 0.8944, 1.18, 0.608, 233, 232, MOUSE 20S IMMUNOPROTEASOME
551, 3unhA, 0.8944, 1.00, 0.613, 230, 230, MOUSE 20S IMMUNOPROTEASOME
552, 3unfO, 0.8937, 1.00, 0.613, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
553, 3unfA, 0.8937, 1.08, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
554, 5m32O, 0.8934, 1.08, 0.609, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
555, 5m32A, 0.8934, 1.10, 0.609, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
556, 5vfsAA, 0.8929, 1.10, 0.609, 230, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
557, 5vfsB, 0.8926, 1.06, 0.613, 230, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
558, 5vfoh, 0.8917, 1.06, 0.613, 230, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
559, 5vfqAA, 0.8914, 1.17, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
560, 5vfpZ, 0.8914, 1.18, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
561, 5vfrh, 0.8908, 2.23, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
562, 5vfuS, 0.8905, 1.19, 0.602, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
563, 5vftH, 0.8905, 1.20, 0.602, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
564, 5t0cZA, 0.8904, 1.20, 0.602, 232, 231, 
565, 5t0cT, 0.8904, 1.20, 0.602, 232, 231, 
566, 5vfuGA, 0.8870, 1.21, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
567, 5vfth, 0.8870, 1.21, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, 5t0gH, 0.8857, 1.22, 0.610, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
569, 5t0hH, 0.8749, 1.22, 0.610, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
570, 5ln3B, 0.8738, 1.27, 0.610, 232, 231, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
571, 4r02P, 0.8723, 1.27, 0.610, 232, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
572, 2gplP, 0.8711, 1.42, 0.608, 233, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
573, 1rypQ, 0.8711, 1.50, 0.606, 232, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
574, 4eu2Q, 0.8710, 1.57, 0.616, 234, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
575, 2gplB, 0.8710, 2.14, 0.357, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
576, 4q1sP, 0.8708, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
577, 3nzjP, 0.8708, 2.19, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
578, 3hyeP, 0.8708, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
579, 3wxrQ, 0.8707, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
580, 3nzjB, 0.8707, 2.24, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
581, 3unfP, 0.8706, 2.21, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
582, 3unfB, 0.8706, 2.20, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
583, 3hyeB, 0.8706, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
584, 2fakP, 0.8706, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
585, 5lajP, 0.8705, 1.98, 0.356, 248, 233, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
586, 5fgaP, 0.8705, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
587, 5cgfP, 0.8705, 2.20, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
588, 5bouP, 0.8705, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
589, 5bouB, 0.8705, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
590, 4rurP, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
591, 4r18P, 0.8705, 2.16, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
592, 4r17P, 0.8705, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
593, 4r17B, 0.8705, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
594, 4qluP, 0.8705, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
595, 4qluB, 0.8705, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
596, 3nzwP, 0.8705, 2.16, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
597, 5lajB, 0.8704, 2.16, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
598, 5fgaB, 0.8704, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
599, 5cgfB, 0.8704, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
600, 4z1lP, 0.8704, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
601, 4y6vP, 0.8704, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
602, 4rurB, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
603, 4qlqP, 0.8704, 2.16, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
604, 4lqiP, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
605, 3nzwB, 0.8704, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
606, 2fakB, 0.8704, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
607, 5bxlP, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
608, 4z1lB, 0.8703, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
609, 4y9yP, 0.8703, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
610, 4y8sP, 0.8703, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
611, 4y6vB, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
612, 4y69P, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
613, 4r18B, 0.8703, 2.17, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
614, 4qlqB, 0.8703, 2.17, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
615, 4lqiB, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
616, 3tddP, 0.8703, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
617, 5laiP, 0.8702, 2.18, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
618, 5laiB, 0.8702, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
619, 5fg7P, 0.8702, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
620, 5fg7B, 0.8702, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
621, 5cz4P, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
622, 5bxlB, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
623, 4ya5P, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
624, 4ya4P, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
625, 4ya4B, 0.8702, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
626, 4ya1P, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
627, 4ya0P, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
628, 4ya0B, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
629, 4y9yB, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
630, 4y8sB, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
631, 4y8rP, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
632, 4y8nP, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
633, 4y69B, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
634, 4qwfP, 0.8702, 2.17, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
635, 4qw6P, 0.8702, 2.16, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
636, 4qw1P, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
637, 4qvyP, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
638, 4qvwP, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
639, 4qvlP, 0.8702, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
640, 4qltP, 0.8702, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
641, 3gpwP, 0.8702, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
642, 3e47P, 0.8702, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
643, 1g65P, 0.8702, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
644, 5l54P, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
645, 5fg9P, 0.8701, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
646, 5dkiP, 0.8701, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
647, 5d0tP, 0.8701, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
648, 5czaP, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
649, 5cz6P, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
650, 5cz6B, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
651, 5cz4B, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
652, 4ya5B, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
653, 4ya1B, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
654, 4y8uP, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
655, 4y8rB, 0.8701, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
656, 4y8nB, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
657, 4y8mP, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
658, 4qz2P, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
659, 4qz2B, 0.8701, 2.16, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
660, 4qwfB, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
661, 4qw6B, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
662, 4qw1B, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
663, 4qvyB, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
664, 4qvwB, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
665, 4qvmP, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
666, 4qvlB, 0.8701, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
667, 4qltB, 0.8701, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
668, 4intP, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
669, 3tddB, 0.8701, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
670, 3gpwB, 0.8701, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
671, 3e47B, 0.8701, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
672, 5lf4B, 0.8700, 2.23, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
673, 5l54B, 0.8700, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
674, 5fg9B, 0.8700, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
675, 5dkjP, 0.8700, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
676, 5dkjB, 0.8700, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
677, 5dkiB, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
678, 5d0xP, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
679, 5d0wP, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
680, 5d0wB, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
681, 5d0tB, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
682, 5czaB, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
683, 5cz8P, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
684, 4ya3P, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
685, 4y8uB, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
686, 4y8mB, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
687, 4y8iP, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
688, 4qz1P, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
689, 4qz1B, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
690, 4qwuP, 0.8700, 2.17, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
691, 4qw0P, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
692, 4qw0B, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
693, 4qvvP, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
694, 4qvpP, 0.8700, 2.18, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
695, 4qvmB, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
696, 4qlsP, 0.8700, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
697, 4qlsB, 0.8700, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
698, 4nnwP, 0.8700, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
699, 3unhP, 0.8700, 2.18, 0.353, 244, 235, MOUSE 20S IMMUNOPROTEASOME
700, 3unhB, 0.8700, 2.19, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME
701, 5l65P, 0.8699, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
702, 5l65B, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
703, 5l5sP, 0.8699, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
704, 5l5iP, 0.8699, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
705, 5l5iB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
706, 5gjqD, 0.8699, 2.18, 0.357, 244, 235, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
707, 5fghP, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
708, 5d0xB, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
709, 5cz8B, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
710, 5cz7P, 0.8699, 1.98, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
711, 4ya3B, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
712, 4y8iB, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
713, 4y84P, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
714, 4qz4P, 0.8699, 2.17, 0.357, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
715, 4qz0P, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
716, 4qxjP, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
717, 4qxjB, 0.8699, 2.19, 0.357, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
718, 4qwuB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
719, 4qw7P, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
720, 4qw4P, 0.8699, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
721, 4qvvB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
722, 4qvqP, 0.8699, 2.18, 0.357, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
723, 4qvpB, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
724, 4qvnP, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
725, 4quxP, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-A49T-MUTANT
726, 4nnwB, 0.8699, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
727, 3nzxP, 0.8699, 2.17, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
728, 5le5B, 0.8698, 2.17, 0.357, 244, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
729, 5l69P, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
730, 5l60P, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
731, 5l5zP, 0.8698, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
732, 5l5sB, 0.8698, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
733, 5l5eP, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
734, 5l5eB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
735, 5fgiP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
736, 5fghB, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
737, 5cz7B, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
738, 5bxnP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
739, 4ya9P, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
740, 4ya2P, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
741, 4y8lP, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
742, 4y8gP, 0.8698, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
743, 4y8gB, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
744, 4y84B, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
745, 4y6aP, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
746, 4y6aB, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
747, 4qz7P, 0.8698, 2.19, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
748, 4qz6P, 0.8698, 2.19, 0.357, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
749, 4qz5P, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
750, 4qz5B, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
751, 4qz4B, 0.8698, 2.17, 0.353, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
752, 4qz0B, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
753, 4qwiP, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
754, 4qw7B, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
755, 4qw5P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
756, 4qw4B, 0.8698, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
757, 4qvqB, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
758, 4qvnB, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
759, 4qv6P, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT
760, 4quxB, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT
761, 4ltcP, 0.8698, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
762, 3d29B, 0.8698, 2.18, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
763, 6gopP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
764, 5m2bP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
765, 5lttP, 0.8697, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
766, 5lttB, 0.8697, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
767, 5lf3B, 0.8697, 2.18, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
768, 5lezB, 0.8697, 2.18, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
769, 5l6bP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
770, 5l69B, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
771, 5l68P, 0.8697, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
772, 5l60B, 0.8697, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
773, 5l5zB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
774, 5l5xP, 0.8697, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
775, 5l5tP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
776, 5l5tB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
777, 5l5jP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
778, 5l5hP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
779, 5l5fP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
780, 5l5fB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
781, 5l5dP, 0.8697, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
782, 5l5aP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
783, 5jhsP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
784, 5fgiB, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
785, 5d0vP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
786, 5cgiP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
787, 5bxnB, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
788, 4ya9B, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
789, 4ya2B, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
790, 4y9zP, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
791, 4y8lB, 0.8697, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
792, 4y8hP, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
793, 4y7xP, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
794, 4y7xB, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
795, 4qzzP, 0.8697, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH OMURALIDE
796, 4qz7B, 0.8697, 2.19, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
797, 4qz6B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
798, 4qwlP, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
799, 4qwiB, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
800, 4qw5B, 0.8697, 2.17, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
801, 4qw3P, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
802, 4qw3B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
803, 4qv6B, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT
804, 4quyP, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT
805, 4quyB, 0.8697, 2.18, 0.353, 244, 235, YCP BETA5-A49S-MUTANT
806, 4hrdP, 0.8697, 2.18, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
807, 3nzxB, 0.8697, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
808, 3mg4P, 0.8697, 2.18, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
809, 3dy4P, 0.8697, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
810, 3dy4B, 0.8697, 2.20, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
811, 3d29P, 0.8697, 2.22, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
812, 2f16P, 0.8697, 2.25, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
813, 6gopB, 0.8696, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
814, 5m2bB, 0.8696, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
815, 5lf7B, 0.8696, 2.24, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
816, 5l6cP, 0.8696, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
817, 5l6bB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
818, 5l68B, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
819, 5l67P, 0.8696, 1.98, 0.356, 248, 233, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
820, 5l66P, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
821, 5l66B, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
822, 5l64P, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
823, 5l63P, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
824, 5l63B, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
825, 5l5yP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
826, 5l5xB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
827, 5l5uP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
828, 5l5uB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
829, 5l5pP, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
830, 5l5jB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
831, 5l5hB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
832, 5l5dB, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
833, 5l5aB, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
834, 5jhsB, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
835, 5fgfP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
836, 5fgdP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
837, 5d0zP, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
838, 5d0vB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
839, 5cgiB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
840, 5cghP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
841, 4y9zB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
842, 4y8pP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
843, 4y8pB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
844, 4y8oP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
845, 4y8jP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
846, 4y8jB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
847, 4y8hB, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
848, 4y7yP, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
849, 4qzzB, 0.8696, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH OMURALIDE
850, 4qzxP, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
851, 4qzxB, 0.8696, 2.19, 0.357, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
852, 4qzwP, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
853, 4qz3P, 0.8696, 2.18, 0.357, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
854, 4qwxP, 0.8696, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
855, 4qwxB, 0.8696, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
856, 4qwrP, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
857, 4qwlB, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
858, 4qwkP, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
859, 4qwjP, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
860, 4gk7P, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
861, 3mg0P, 0.8696, 2.19, 0.353, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
862, 3gptP, 0.8696, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
863, 3dy3P, 0.8696, 2.20, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
864, 3dy3B, 0.8696, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
865, 5t0iH, 0.8695, 2.26, 0.357, 244, 235, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
866, 5lf0B, 0.8695, 2.22, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
867, 5l6cB, 0.8695, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
868, 5l67B, 0.8695, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
869, 5l64B, 0.8695, 1.56, 0.613, 233, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
870, 5l5yB, 0.8695, 1.99, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
871, 5l5wP, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
872, 5l5qP, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
873, 5l5qB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
874, 5l5pB, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
875, 5l5oP, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
876, 5l5oB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
877, 5l52P, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
878, 5jhrP, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
879, 5fgfB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
880, 5fgdB, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
881, 5d0zB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
882, 5cz9P, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
883, 5cghB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
884, 4y8oB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
885, 4y80P, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
886, 4y7yB, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
887, 4y78P, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
888, 4y78B, 0.8695, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
889, 4y77P, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
890, 4y77B, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
891, 4qzwB, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
892, 4qz3B, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
893, 4qwrB, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
894, 4qwkB, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
895, 4qwjB, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
896, 4qv9P, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT
897, 4qv8P, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT
898, 4qv7P, 0.8695, 2.20, 0.353, 244, 235, YCP BETA5-A50V MUTANT
899, 4intB, 0.8695, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
900, 4inrP, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
901, 4hnpP, 0.8695, 2.18, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
902, 4gk7B, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
903, 3gptB, 0.8695, 2.24, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
904, 2f16B, 0.8695, 2.24, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
905, 6epfB, 0.8694, 2.23, 0.362, 244, 235, GROUND STATE 26S PROTEASOME (GS1)
906, 5leyB, 0.8694, 2.23, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
907, 5l62P, 0.8694, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
908, 5l62B, 0.8694, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
909, 5l5wB, 0.8694, 1.65, 0.608, 234, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
910, 5l5vP, 0.8694, 1.99, 0.356, 248, 233,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
911, 5l52B, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
912, 5jhrB, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
913, 5gjrIA, 0.8694, 2.19, 0.357, 244, 235, 
914, 5fhsP, 0.8694, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
915, 5fgeP, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
916, 5d0sP, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
917, 5cz9B, 0.8694, 1.98, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
918, 5cz5P, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
919, 5cz5B, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
920, 5cggP, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
921, 4ya7P, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
922, 4ya7B, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
923, 4y8tP, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
924, 4y8tB, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
925, 4y8qP, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
926, 4y8qB, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
927, 4y8kP, 0.8694, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
928, 4y82P, 0.8694, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
929, 4y81P, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
930, 4y81B, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
931, 4y80B, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
932, 4y70P, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
933, 4r00P, 0.8694, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
934, 4r00B, 0.8694, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
935, 4qv9B, 0.8694, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT
936, 4qv8B, 0.8694, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT
937, 4qv7B, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT
938, 4qv1P, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-M45A MUTANT
939, 4qv0P, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
940, 4qv0B, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
941, 4jsuP, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
942, 4jsuB, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
943, 5lf1B, 0.8693, 2.18, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
944, 5l6aP, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
945, 5l61P, 0.8693, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
946, 5l61B, 0.8693, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
947, 5l5vB, 0.8693, 1.99, 0.356, 248, 233,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
948, 5l5rP, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
949, 5l5bP, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
950, 5l55P, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
951, 5l55B, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
952, 5fhsB, 0.8693, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
953, 5fggP, 0.8693, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
954, 5fggB, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
955, 5fgeB, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
956, 5d0sB, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
957, 5cggB, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
958, 4y8kB, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
959, 4y82B, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
960, 4y7wP, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
961, 4y75P, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
962, 4y74P, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
963, 4y70B, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
964, 4qwsP, 0.8693, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
965, 4qv1B, 0.8693, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT
966, 3okjP, 0.8693, 2.20, 0.353, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
967, 3gpjP, 0.8693, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
968, 3gpjB, 0.8693, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
969, 5l6aB, 0.8692, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
970, 5l5rB, 0.8692, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
971, 5l5bB, 0.8692, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
972, 4y7wB, 0.8692, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
973, 4y75B, 0.8692, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
974, 4y74B, 0.8692, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
975, 4qwsB, 0.8692, 2.18, 0.357, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
976, 4qv4P, 0.8692, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT
977, 4qlvP, 0.8692, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
978, 4no9P, 0.8692, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
979, 4inrB, 0.8692, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
980, 4fzcP, 0.8692, 2.19, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
981, 3okjB, 0.8692, 2.18, 0.357, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
982, 5lezP, 0.8691, 2.21, 0.353, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
983, 5lexB, 0.8691, 2.25, 0.362, 244, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
984, 5gjrU, 0.8691, 2.25, 0.357, 244, 235, 
985, 4y6zP, 0.8691, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
986, 4y6zB, 0.8691, 2.01, 0.356, 247, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
987, 4qv4B, 0.8691, 2.00, 0.356, 248, 233, YCP BETA5-M45T MUTANT
988, 4qv3P, 0.8691, 1.99, 0.356, 250, 233, YCP BETA5-M45V MUTANT
989, 4qlvB, 0.8691, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
990, 4qbyP, 0.8691, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
991, 4no9B, 0.8691, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
992, 4j70P, 0.8691, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
993, 4fzcB, 0.8691, 2.18, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
994, 3bdmP, 0.8691, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
995, 4qv5P, 0.8690, 2.21, 0.353, 244, 235, YCP BETA5-M45I MUTANT
996, 4qv5B, 0.8690, 2.26, 0.353, 244, 235, YCP BETA5-M45I MUTANT
997, 4qv3B, 0.8690, 2.25, 0.357, 244, 235, YCP BETA5-M45V MUTANT
998, 4qbyB, 0.8690, 2.27, 0.357, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
999, 4nnnP, 0.8690, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
1000, 4nnnB, 0.8690, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH MG132
1001, 3bdmB, 0.8690, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1002, 1g65B, 0.8690, 2.17, 0.353, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1003, 5lf6B, 0.8689, 2.20, 0.353, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1004, 5ahjP, 0.8689, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1005, 5ahjB, 0.8689, 2.27, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1006, 4r02B, 0.8689, 2.22, 0.362, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1007, 4inuP, 0.8689, 2.00, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1008, 1rypC, 0.8689, 2.19, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1009, 4jsqP, 0.8688, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1010, 3unfQ, 0.8688, 2.20, 0.357, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1011, 3unfC, 0.8688, 2.25, 0.362, 244, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1012, 3shjP, 0.8688, 2.22, 0.362, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1013, 2zcyP, 0.8688, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1014, 2zcyB, 0.8688, 1.52, 0.336, 238, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1015, 4qwgP, 0.8687, 1.52, 0.336, 238, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1016, 4no6P, 0.8687, 2.25, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1017, 4no6B, 0.8687, 2.25, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1018, 4no1P, 0.8687, 2.25, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1019, 4jsqB, 0.8687, 2.21, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1020, 3un4P, 0.8687, 2.21, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1021, 3dy3R, 0.8687, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1022, 3dy3D, 0.8687, 2.20, 0.353, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1023, 4qwgB, 0.8686, 2.25, 0.362, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1024, 4no1B, 0.8686, 2.24, 0.362, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1025, 4hrcP, 0.8686, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1026, 3unhQ, 0.8686, 1.60, 0.329, 242, 228, MOUSE 20S IMMUNOPROTEASOME
1027, 3unhC, 0.8686, 2.21, 0.353, 244, 235, MOUSE 20S IMMUNOPROTEASOME
1028, 3unbB, 0.8686, 2.20, 0.353, 244, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1029, 3un4B, 0.8686, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1030, 3shjB, 0.8686, 1.52, 0.336, 238, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1031, 5lf4P, 0.8685, 1.52, 0.336, 238, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1032, 4jt0P, 0.8685, 2.03, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1033, 4jt0B, 0.8685, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1034, 4j70D, 0.8685, 2.25, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1035, 3un8P, 0.8685, 2.01, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1036, 5lf1P, 0.8684, 2.23, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1037, 5le5P, 0.8684, 2.23, 0.357, 244, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1038, 4x6zQ, 0.8684, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1039, 4q1sB, 0.8684, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1040, 4no8P, 0.8684, 2.01, 0.356, 248, 233, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1041, 4j70R, 0.8684, 2.01, 0.356, 247, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1042, 4j70B, 0.8684, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1043, 4inuB, 0.8684, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1044, 4fzgP, 0.8684, 2.20, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1045, 3unbP, 0.8684, 1.61, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1046, 4no8B, 0.8683, 2.26, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1047, 4fzgB, 0.8683, 2.25, 0.362, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1048, 4eu2S, 0.8683, 2.26, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1049, 3mg0R, 0.8683, 2.03, 0.356, 248, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1050, 4hnpB, 0.8682, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1051, 3mg0D, 0.8682, 2.26, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1052, 5nifS, 0.8681, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1053, 5lezC, 0.8681, 1.60, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1054, 4zzgS, 0.8681, 2.24, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1055, 3unbd, 0.8681, 1.61, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1056, 3dy4D, 0.8681, 1.46, 0.330, 236, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1057, 2gplD, 0.8681, 1.45, 0.338, 236, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1058, 2fakR, 0.8681, 1.46, 0.330, 236, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1059, 2fakD, 0.8681, 2.03, 0.356, 248, 233, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1060, 5lf7P, 0.8680, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1061, 4ltcB, 0.8680, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1062, 3nzjR, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1063, 3nzjD, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1064, 3mg0B, 0.8680, 2.02, 0.356, 247, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1065, 3dy4R, 0.8680, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1066, 2zcyD, 0.8680, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1067, 2gplR, 0.8680, 1.62, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1068, 5lf6P, 0.8679, 2.28, 0.357, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1069, 5lf3P, 0.8679, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1070, 4lqiR, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1071, 4lqiD, 0.8679, 1.60, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1072, 3tddR, 0.8679, 2.02, 0.356, 248, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1073, 3tddD, 0.8679, 2.02, 0.356, 248, 233, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1074, 2zcyR, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1075, 5mp9c, 0.8678, 1.61, 0.329, 242, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1076, 5lf0P, 0.8678, 1.61, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1077, 4intD, 0.8678, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1078, 4eu2E, 0.8678, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1079, 3unbr, 0.8678, 2.16, 0.353, 244, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1080, 5lexP, 0.8677, 2.03, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1081, 4fzgD, 0.8677, 1.62, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1082, 4q1sD, 0.8676, 1.67, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1083, 4gk7D, 0.8676, 2.04, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1084, 4fzgR, 0.8676, 2.03, 0.356, 247, 233, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1085, 3gpwD, 0.8676, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1086, 3d29R, 0.8676, 1.66, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1087, 3d29D, 0.8676, 1.61, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1088, 5nifQ, 0.8675, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1089, 4zzgQ, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1090, 4gk7R, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1091, 3un4D, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1092, 3gpwR, 0.8675, 2.01, 0.361, 242, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1093, 3gptD, 0.8675, 2.02, 0.361, 242, 233, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1094, 3gpjR, 0.8675, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1095, 3gpjD, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1096, 2f16R, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1097, 2f16D, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1098, 5leyP, 0.8674, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1099, 4q1sR, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1100, 4jt0D, 0.8674, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1101, 4intR, 0.8674, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1102, 4hrdB, 0.8674, 2.03, 0.356, 247, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1103, 3un8B, 0.8674, 1.64, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1104, 3un4R, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1105, 3nzwD, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1106, 3hyeR, 0.8674, 2.24, 0.362, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1107, 3hyeD, 0.8674, 2.26, 0.362, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1108, 3gptR, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1109, 3e47D, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1110, 1jd2W, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1111, 5lf7C, 0.8673, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1112, 4jt0R, 0.8673, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1113, 4inrD, 0.8673, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1114, 3okjR, 0.8673, 2.25, 0.353, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1115, 3okjD, 0.8673, 1.46, 0.338, 236, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1116, 3nzwR, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1117, 3e47R, 0.8673, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1118, 5l4gQ, 0.8672, 1.62, 0.329, 242, 228, 
1119, 5gjqj, 0.8672, 1.62, 0.329, 242, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1120, 4jsuR, 0.8672, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1121, 4jsuD, 0.8672, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1122, 4inuD, 0.8672, 2.01, 0.356, 250, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1123, 3unbe, 0.8672, 2.01, 0.356, 250, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1124, 5le5C, 0.8671, 1.62, 0.329, 242, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1125, 4inrR, 0.8671, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1126, 4hrdD, 0.8671, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1127, 4fzcD, 0.8671, 1.53, 0.332, 239, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1128, 3nzxD, 0.8671, 1.47, 0.338, 236, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1129, 4jsqD, 0.8670, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1130, 4hrcB, 0.8670, 1.66, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1131, 4fzcR, 0.8670, 1.62, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1132, 3wxrS, 0.8670, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1133, 3shjR, 0.8670, 1.63, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1134, 3shjD, 0.8670, 2.29, 0.357, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1135, 3nzxR, 0.8670, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1136, 5lf4C, 0.8669, 1.47, 0.330, 238, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1137, 5leyC, 0.8669, 1.62, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1138, 5lexC, 0.8669, 1.62, 0.329, 242, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1139, 4ltcD, 0.8669, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1140, 4jsqR, 0.8669, 1.47, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1141, 4eu2C, 0.8669, 1.47, 0.338, 236, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1142, 5lf3C, 0.8668, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1143, 5lf1C, 0.8668, 1.64, 0.329, 242, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1144, 4ltcR, 0.8668, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1145, 4inuR, 0.8668, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1146, 3un8D, 0.8668, 1.47, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1147, 4q1sC, 0.8667, 1.47, 0.338, 236, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1148, 4hrcD, 0.8667, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1149, 3mg8R, 0.8667, 1.63, 0.329, 242, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1150, 1g65D, 0.8667, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1151, 5lf6C, 0.8666, 1.54, 0.367, 241, 229, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1152, 3mg7R, 0.8666, 1.65, 0.329, 242, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1153, 5lf0C, 0.8665, 1.47, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1154, 3uneP, 0.8665, 1.64, 0.329, 242, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
1155, 3dy4C, 0.8665, 1.48, 0.338, 236, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1156, 5l60R, 0.8664, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1157, 5l60D, 0.8664, 1.48, 0.338, 236, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1158, 3un8R, 0.8664, 2.05, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1159, 3mg8D, 0.8664, 1.53, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1160, 3dy4Q, 0.8664, 1.57, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1161, 3bdmD, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1162, 2zcyC, 0.8664, 1.64, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1163, 5nifD, 0.8663, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1164, 5lttR, 0.8663, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1165, 5lttD, 0.8663, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1166, 5l62R, 0.8663, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1167, 5l62D, 0.8663, 1.54, 0.362, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1168, 5l5yD, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1169, 4zzgD, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1170, 4hrcR, 0.8663, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1171, 3oeuD, 0.8663, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1172, 3mg6R, 0.8663, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1173, 3bdmR, 0.8663, 1.54, 0.362, 241, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1174, 2zcyQ, 0.8663, 1.68, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1175, 5l5zR, 0.8662, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1176, 5l5zD, 0.8662, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1177, 5l5yR, 0.8662, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1178, 5l5xR, 0.8662, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1179, 5l5xD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1180, 5l5wR, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1181, 5l5wD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1182, 5l5sD, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1183, 4ya0R, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1184, 4ya0D, 0.8662, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1185, 3unbQ, 0.8662, 1.57, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1186, 3oevR, 0.8662, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1187, 1rypE, 0.8662, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1188, 1jd2B, 0.8662, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1189, 5l63R, 0.8661, 1.54, 0.336, 239, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1190, 5l63D, 0.8661, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1191, 5l61R, 0.8661, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1192, 5l61D, 0.8661, 2.27, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1193, 5l5vR, 0.8661, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1194, 5l5vD, 0.8661, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1195, 5l5tR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1196, 5l5tD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1197, 5l5sR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1198, 5l5iR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1199, 5l5iD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1200, 5l5eR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1201, 5l5eD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1202, 5l4gC, 0.8661, 1.58, 0.330, 235, 227, 
1203, 5cz4R, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1204, 5cz4D, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1205, 4ya5D, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1206, 4ya3R, 0.8661, 2.04, 0.356, 250, 233, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1207, 4ya3D, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1208, 4y8uR, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1209, 4y8uD, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1210, 4y69R, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1211, 4y69D, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1212, 4r67s, 0.8661, 1.59, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1213, 4r67Q, 0.8661, 1.59, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1214, 4r67e, 0.8661, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1215, 4r67C, 0.8661, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1216, 4qw3R, 0.8661, 2.04, 0.356, 250, 233, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1217, 4qw3D, 0.8661, 2.04, 0.356, 250, 233, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1218, 4qvvR, 0.8661, 2.04, 0.356, 250, 233, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1219, 4qvvD, 0.8661, 2.04, 0.356, 250, 233, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1220, 4hnpR, 0.8661, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1221, 4hnpD, 0.8661, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1222, 3unbC, 0.8661, 1.58, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1223, 3dy3C, 0.8661, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1224, 5l6cR, 0.8660, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1225, 5l6cD, 0.8660, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1226, 5l68R, 0.8660, 1.56, 0.332, 239, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1227, 5l68D, 0.8660, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1228, 5l65R, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1229, 5l65D, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1230, 5l64R, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1231, 5l64D, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1232, 5l5qR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1233, 5l5qD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1234, 5l5pR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1235, 5l5pD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1236, 5l5jR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1237, 5l5jD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1238, 5l5aR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1239, 5l5aD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1240, 5fghR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1241, 5fghD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1242, 5dkiR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1243, 5dkiD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1244, 4ya5R, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1245, 4y8nR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1246, 4y8nD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1247, 4y6vR, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1248, 4y6vD, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1249, 4r3oQ, 0.8660, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
1250, 4r3oC, 0.8660, 1.58, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
1251, 3unbs, 0.8660, 1.58, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1252, 3mg4R, 0.8660, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1253, 3mg4B, 0.8660, 2.05, 0.356, 250, 233, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1254, 3dy3Q, 0.8660, 2.05, 0.356, 250, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1255, 5l69R, 0.8659, 1.55, 0.336, 239, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1256, 5l69D, 0.8659, 1.47, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1257, 5l67R, 0.8659, 2.33, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1258, 5l67D, 0.8659, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1259, 5l5oR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1260, 5l5oD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1261, 5l5hD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1262, 5l5fR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1263, 5l5fD, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1264, 5d0xR, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1265, 5d0xD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1266, 5bouR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1267, 5bouD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1268, 4zzgR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1269, 4y6aR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1270, 4y6aD, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1271, 4rurR, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1272, 4rurD, 0.8659, 1.55, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1273, 4hrdR, 0.8659, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1274, 3oevD, 0.8659, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1275, 3mg6D, 0.8659, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1276, 5nifR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1277, 5m2bR, 0.8658, 1.49, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1278, 5m2bD, 0.8658, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1279, 5lajR, 0.8658, 1.48, 0.330, 242, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1280, 5lajD, 0.8658, 1.56, 0.362, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1281, 5l6bR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1282, 5l6bD, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1283, 5l66R, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1284, 5l66D, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1285, 5l5hR, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1286, 5dkjD, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1287, 5cz7R, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1288, 5cz7D, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1289, 4qwjR, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1290, 4qwjD, 0.8658, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1291, 4qw0R, 0.8658, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1292, 4qw0D, 0.8658, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1293, 4qvmR, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1294, 4qvmD, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1295, 4q1sQ, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1296, 3oeuR, 0.8658, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1297, 3mg4D, 0.8658, 1.58, 0.330, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1298, 3jcpLA, 0.8658, 1.58, 0.330, 235, 227, 
1299, 3jcpL, 0.8658, 1.53, 0.367, 241, 229, 
1300, 1g65R, 0.8658, 1.53, 0.330, 236, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1301, 5laiR, 0.8657, 1.50, 0.330, 242, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1302, 5laiD, 0.8657, 2.21, 0.362, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1303, 5l5uR, 0.8657, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1304, 5l5uD, 0.8657, 2.21, 0.362, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1305, 5fg9R, 0.8657, 1.65, 0.329, 242, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1306, 5fg9D, 0.8657, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1307, 5dkjR, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1308, 5d0tR, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1309, 5d0tD, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1310, 4y9yD, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1311, 4quxR, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1312, 4quxD, 0.8657, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1313, 3mg7D, 0.8657, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1314, 5l6aD, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1315, 5l5rR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1316, 5l5rD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1317, 5l5dR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1318, 5l5dD, 0.8656, 1.48, 0.330, 242, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1319, 5fgaR, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1320, 5fgaD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1321, 5cz6R, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1322, 5cz6D, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1323, 4z1lD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1324, 4y9yR, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1325, 4y8oR, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1326, 4y8oD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1327, 4y8mR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1328, 4y8mD, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1329, 4y8iR, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1330, 4y8iD, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1331, 4y78D, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1332, 4r18R, 0.8656, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1333, 4r18D, 0.8656, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1334, 4qwiR, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1335, 4qwiD, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1336, 4qvyR, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1337, 4qvyD, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1338, 4qvwR, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1339, 4qvwD, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1340, 1rypS, 0.8656, 1.58, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1341, 5l6aR, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1342, 5l5bR, 0.8655, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1343, 5l5bD, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1344, 5cgfR, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1345, 5cgfD, 0.8655, 1.46, 0.330, 242, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1346, 4z1lR, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1347, 4ya1D, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1348, 4y8tD, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1349, 4y78R, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1350, 4x6zR, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1351, 4x6zC, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1352, 4qz1D, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1353, 4eu2D, 0.8655, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1354, 3wxrE, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1355, 5fg7R, 0.8654, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1356, 5fg7D, 0.8654, 2.30, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1357, 5bxlR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1358, 5bxlD, 0.8654, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1359, 4ya1R, 0.8654, 1.68, 0.329, 239, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1360, 4y8tR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1361, 4y80R, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1362, 4y80D, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1363, 4y7yR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1364, 4y7yD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1365, 4y7xR, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1366, 4y7xD, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1367, 4y7wR, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1368, 4y7wD, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1369, 4r00R, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1370, 4r00D, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1371, 4qz5R, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1372, 4qz5D, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1373, 4qz1R, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1374, 4qw4R, 0.8654, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1375, 4qw4D, 0.8654, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1376, 4qvqR, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1377, 4qvqD, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1378, 4qvlR, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1379, 4qvlD, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1380, 3uner, 0.8654, 1.59, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
1381, 6avoZ, 0.8653, 1.59, 0.330, 235, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1382, 6avoO, 0.8653, 1.59, 0.330, 235, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1383, 5czaR, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1384, 5czaD, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1385, 4y8lR, 0.8653, 2.08, 0.356, 248, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1386, 4y8lD, 0.8653, 2.05, 0.356, 240, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1387, 4y8jR, 0.8653, 2.05, 0.356, 240, 233, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1388, 4y8jD, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1389, 4y81R, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1390, 4y81D, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1391, 4y70R, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1392, 4y70D, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1393, 4x6zD, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1394, 4r02C, 0.8653, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1395, 4qzzR, 0.8653, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1396, 4qzzD, 0.8653, 1.58, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1397, 4qz3D, 0.8653, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1398, 4qxjR, 0.8653, 1.55, 0.367, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1399, 4qwgR, 0.8653, 1.57, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1400, 4qwgD, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1401, 4qw1R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1402, 4qw1D, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1403, 4qvpR, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1404, 4qvpD, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1405, 4qv8R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1406, 4qv8D, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1407, 4qv7R, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1408, 4qv7D, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1409, 3d29C, 0.8653, 1.59, 0.330, 235, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1410, 6gopQ, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1411, 6gopC, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1412, 5lajC, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1413, 5fhsR, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1414, 5fhsD, 0.8652, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1415, 4y9zR, 0.8652, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1416, 4y9zD, 0.8652, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1417, 4y8sR, 0.8652, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1418, 4y8sD, 0.8652, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1419, 4y8rR, 0.8652, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1420, 4y8rD, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1421, 4y82D, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1422, 4y74R, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1423, 4y74D, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1424, 4y6zR, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1425, 4y6zD, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1426, 4r17R, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1427, 4r17D, 0.8652, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1428, 4qz3R, 0.8652, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1429, 4qxjD, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1430, 4qvvQ, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1431, 4qvvC, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1432, 4qv4R, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1433, 4qv4D, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1434, 4qv0R, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1435, 4qv0D, 0.8652, 1.55, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1436, 4quyD, 0.8652, 1.55, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1437, 4hrcC, 0.8652, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1438, 3wxrC, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1439, 3mg6C, 0.8652, 1.59, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1440, 3d29Q, 0.8652, 1.59, 0.330, 235, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1441, 5lajQ, 0.8651, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1442, 5jhsR, 0.8651, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1443, 5jhsD, 0.8651, 2.11, 0.361, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1444, 5d0wR, 0.8651, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1445, 5d0wD, 0.8651, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1446, 5cz9R, 0.8651, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1447, 5cz9D, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1448, 5cgiR, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1449, 5cgiD, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1450, 4ya4R, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1451, 4ya4D, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1452, 4y82R, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1453, 4qz6R, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1454, 4qz6D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1455, 4qwuR, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1456, 4qwuD, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1457, 4qw7R, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1458, 4qw7D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1459, 4qv5R, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1460, 4qv5D, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1461, 4qv3D, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1462, 4qv1R, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1463, 4qv1D, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1464, 4quyR, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1465, 3sdkC, 0.8651, 1.60, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1466, 6gopD, 0.8650, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1467, 5mp9C, 0.8650, 1.59, 0.330, 235, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1468, 5dkjC, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1469, 5dkiC, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1470, 5d0tQ, 0.8650, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1471, 5d0tC, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1472, 5bxnR, 0.8650, 2.24, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1473, 5bxnD, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1474, 4ya9R, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1475, 4ya9D, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1476, 4y8pR, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1477, 4y8pD, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1478, 4y77R, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1479, 4y77D, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1480, 4qz4R, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1481, 4qz4D, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1482, 4qwxR, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1483, 4qwxD, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1484, 4qv6Q, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1485, 4qv6C, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1486, 4qv3R, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1487, 3uned, 0.8650, 1.59, 0.330, 235, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
1488, 3gpjC, 0.8650, 1.59, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1489, 6gopR, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1490, 5dkjQ, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1491, 5dkiQ, 0.8649, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1492, 4ya7R, 0.8649, 2.08, 0.356, 248, 233, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1493, 4ya7D, 0.8649, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1494, 4y75R, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1495, 4y75D, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1496, 4x6zE, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1497, 4r67t, 0.8649, 1.59, 0.330, 235, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1498, 4r00C, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1499, 4qwjQ, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1500, 4qwjC, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1501, 4qw1C, 0.8649, 1.54, 0.330, 242, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1502, 4qw0C, 0.8649, 1.57, 0.336, 243, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1503, 4qvpQ, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1504, 4qvpC, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1505, 4qv6R, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1506, 4qv6D, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1507, 4qv0Q, 0.8649, 1.55, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1508, 4qv0C, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1509, 4qlsR, 0.8649, 1.55, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1510, 4qlsD, 0.8649, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1511, 4fzcQ, 0.8649, 1.59, 0.330, 235, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1512, 4fzcC, 0.8649, 1.56, 0.367, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1513, 3mg0C, 0.8649, 1.56, 0.367, 240, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1514, 3gpjQ, 0.8649, 1.60, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1515, 1iruQ, 0.8649, 1.60, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1516, 5fgdR, 0.8648, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1517, 5fgdD, 0.8648, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1518, 5d0xQ, 0.8648, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1519, 5d0xC, 0.8648, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1520, 5cz8Q, 0.8648, 2.04, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1521, 5cz8C, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1522, 4zzgC, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1523, 4r67f, 0.8648, 1.56, 0.367, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1524, 4r67D, 0.8648, 1.55, 0.367, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1525, 4r3oR, 0.8648, 1.56, 0.362, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1526, 4r3oD, 0.8648, 1.56, 0.362, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1527, 4r00Q, 0.8648, 2.04, 0.362, 241, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1528, 4qzzQ, 0.8648, 1.57, 0.336, 243, 229, YCP IN COMPLEX WITH OMURALIDE
1529, 4qzzC, 0.8648, 1.57, 0.336, 243, 229, YCP IN COMPLEX WITH OMURALIDE
1530, 4qz6Q, 0.8648, 1.57, 0.341, 243, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1531, 4qz6C, 0.8648, 1.57, 0.341, 243, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1532, 4qz5Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1533, 4qz5C, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1534, 4qwuQ, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1535, 4qwuC, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1536, 4qw1Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1537, 4qw0Q, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1538, 4qv9R, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1539, 4qv9D, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1540, 4qv7C, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1541, 3bdmC, 0.8648, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1542, 1iruC, 0.8648, 1.55, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1543, 5l52R, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1544, 5l52D, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1545, 5jhrR, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1546, 5jhrD, 0.8647, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1547, 5fgaQ, 0.8647, 2.04, 0.356, 250, 233, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1548, 5fgaC, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1549, 5cgfQ, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1550, 5cgfC, 0.8647, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1551, 4r18C, 0.8647, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1552, 4qzwQ, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1553, 4qzwC, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1554, 4qz3C, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1555, 4qwlD, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1556, 4qwkR, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1557, 4qwkD, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1558, 4qwkC, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1559, 4qvnR, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1560, 4qvnD, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1561, 4qvmC, 0.8647, 1.40, 0.332, 235, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1562, 4qvlC, 0.8647, 1.40, 0.332, 235, 226, YCP IN COMPLEX WITH BORTEZOMIB
1563, 4qv8Q, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1564, 4qv8C, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1565, 4qv7Q, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1566, 4nnnR, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1567, 4nnnD, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1568, 4hnpC, 0.8647, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1569, 3oeuC, 0.8647, 1.56, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1570, 3bdmQ, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1571, 5nifC, 0.8646, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1572, 5fghQ, 0.8646, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1573, 5fghC, 0.8646, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1574, 5fggR, 0.8646, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1575, 5fggD, 0.8646, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1576, 5fgfR, 0.8646, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1577, 5fgfD, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1578, 5cz7Q, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1579, 5cz7C, 0.8646, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1580, 4z1lQ, 0.8646, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1581, 4z1lC, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1582, 4y9yC, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1583, 4y8uQ, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1584, 4y8uC, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1585, 4r67R, 0.8646, 1.56, 0.367, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1586, 4r18Q, 0.8646, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1587, 4r02R, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1588, 4qz7R, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1589, 4qz7D, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1590, 4qz3Q, 0.8646, 1.57, 0.336, 243, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1591, 4qxjC, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1592, 4qwsR, 0.8646, 1.60, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1593, 4qwsD, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1594, 4qwlR, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1595, 4qwlQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1596, 4qwlC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1597, 4qwkQ, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1598, 4qw7Q, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1599, 4qw7C, 0.8646, 1.60, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1600, 4qw6C, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1601, 4qw5C, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1602, 4qvyQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1603, 4qvyC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1604, 4qvwQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1605, 4qvwC, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1606, 4qvqQ, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1607, 4qvqC, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1608, 4qvmQ, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1609, 4qvlQ, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1610, 4qv9Q, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1611, 4qv9C, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1612, 4quyQ, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1613, 4quyC, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1614, 4qlvR, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1615, 4qlvD, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1616, 4no8D, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1617, 4eu2R, 0.8646, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1618, 1g65C, 0.8646, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1619, 5jhsQ, 0.8645, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1620, 5jhsC, 0.8645, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1621, 5fgeR, 0.8645, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1622, 5fgeD, 0.8645, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1623, 5fg9Q, 0.8645, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1624, 5fg9C, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1625, 5fg7Q, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1626, 5fg7C, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1627, 5cgiC, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1628, 4ya0C, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1629, 4y9yQ, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1630, 4y8rQ, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1631, 4y8rC, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1632, 4y8qR, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1633, 4y8qD, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1634, 4r02D, 0.8645, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1635, 4qzxC, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1636, 4qz4Q, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1637, 4qz4C, 0.8645, 1.41, 0.332, 235, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1638, 4qz2C, 0.8645, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1639, 4qxjQ, 0.8645, 1.61, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1640, 4qwiQ, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1641, 4qwiC, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1642, 4qw6Q, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1643, 4qw5Q, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1644, 4qv3Q, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1645, 4qv3C, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1646, 4no8R, 0.8645, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1647, 4nnwR, 0.8645, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1648, 4nnwD, 0.8645, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1649, 4j70C, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1650, 3shjQ, 0.8645, 1.56, 0.367, 240, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1651, 3shjC, 0.8645, 1.60, 0.330, 235, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1652, 3hyeC, 0.8645, 1.60, 0.330, 235, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1653, 5l5sC, 0.8644, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1654, 5l55R, 0.8644, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1655, 5l52Q, 0.8644, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1656, 5l52C, 0.8644, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1657, 5fhsQ, 0.8644, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1658, 5fhsC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1659, 5d0zC, 0.8644, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1660, 5d0vQ, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1661, 5d0vC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1662, 5d0sC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1663, 5czaQ, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1664, 5czaC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1665, 5cz5R, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1666, 5cz5Q, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1667, 5cz5D, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1668, 5cz5C, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1669, 5cgiQ, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1670, 5cghR, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1671, 5cghD, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1672, 5bxlQ, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1673, 5bxlC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1674, 4ya2R, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1675, 4ya2D, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1676, 4ya0Q, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1677, 4y8sQ, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1678, 4y8sC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1679, 4y8lC, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1680, 4y8iQ, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1681, 4y8iC, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1682, 4y84R, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1683, 4y84D, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1684, 4y7yQ, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1685, 4y7yC, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1686, 4qzxR, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1687, 4qzxQ, 0.8644, 1.61, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1688, 4qzxD, 0.8644, 1.61, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1689, 4qzwR, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1690, 4qzwD, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1691, 4qz2Q, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1692, 4qwrR, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1693, 4qwrD, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1694, 4qwrC, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1695, 4qwfC, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1696, 4qw4Q, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1697, 4qw4C, 0.8644, 1.41, 0.332, 235, 226, YCP IN COMPLEX WITH CARFILZOMIB
1698, 4qw3Q, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1699, 4qw3C, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1700, 4qv1Q, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1701, 4qv1C, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1702, 4qltR, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1703, 4qltD, 0.8644, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1704, 3hyeQ, 0.8644, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1705, 1rypD, 0.8644, 1.56, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1706, 5lttQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1707, 5lttC, 0.8643, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1708, 5l60C, 0.8643, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1709, 5l5sQ, 0.8643, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1710, 5fgiR, 0.8643, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1711, 5fgiQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1712, 5fgiD, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1713, 5fgiC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1714, 5fggQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1715, 5fggC, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1716, 5fgfQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1717, 5fgfC, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1718, 5d0zQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1719, 5d0wQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1720, 5d0wC, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1721, 5d0sQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1722, 5cz9Q, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1723, 5cz9C, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1724, 5cz8R, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1725, 5cz8D, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1726, 5cz6Q, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1727, 5cz6C, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1728, 5bxnQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1729, 5bxnC, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1730, 4ya4Q, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1731, 4ya4C, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1732, 4ya3C, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1733, 4y9zQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1734, 4y9zC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1735, 4y8lQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1736, 4y8jQ, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1737, 4y8jC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1738, 4y69Q, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1739, 4qz7Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1740, 4qz7C, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1741, 4qz0C, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1742, 4qwrQ, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1743, 4qwfR, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1744, 4qwfQ, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1745, 4qwfD, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1746, 4qvnC, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1747, 4qv4Q, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1748, 4qv4C, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-M45T MUTANT
1749, 4quxQ, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1750, 4quxC, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-A49T-MUTANT
1751, 4no6D, 0.8643, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1752, 4lqiQ, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1753, 4lqiC, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1754, 4fzgC, 0.8643, 1.56, 0.367, 240, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1755, 3uneB, 0.8643, 1.56, 0.367, 240, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1756, 3nzwC, 0.8643, 1.60, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1757, 3gptQ, 0.8643, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1758, 3gptC, 0.8643, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1759, 3e47C, 0.8643, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1760, 5l60Q, 0.8642, 2.09, 0.356, 248, 233, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1761, 5l5xQ, 0.8642, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1762, 5l5xC, 0.8642, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1763, 5l5vC, 0.8642, 1.56, 0.367, 241, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1764, 5l5uQ, 0.8642, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1765, 5l5uC, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1766, 5l5eQ, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1767, 5l5eC, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1768, 5l55Q, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1769, 5l55C, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1770, 5fgdQ, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1771, 5fgdC, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1772, 5cz4Q, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1773, 5cz4C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1774, 4ya3Q, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1775, 4y78C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1776, 4y69C, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1777, 4qz0Q, 0.8642, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1778, 4qw6R, 0.8642, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1779, 4qw6D, 0.8642, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1780, 4qvnQ, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1781, 4qv5Q, 0.8642, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1782, 4qv5C, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1783, 4no6R, 0.8642, 1.41, 0.332, 235, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1784, 4fzgQ, 0.8642, 1.41, 0.332, 235, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1785, 3gpwQ, 0.8642, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1786, 3gpwC, 0.8642, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1787, 3e47Q, 0.8642, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1788, 5l67Q, 0.8641, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1789, 5l67C, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1790, 5l65Q, 0.8641, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1791, 5l65C, 0.8641, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1792, 5l5zQ, 0.8641, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1793, 5l5zC, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1794, 5l5vQ, 0.8641, 1.57, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1795, 5l5qQ, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1796, 5l5qC, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1797, 5jhrQ, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1798, 5jhrC, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1799, 5fgeQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1800, 5fgeC, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1801, 5d0vR, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1802, 5d0vD, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1803, 5cggQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1804, 5cggC, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1805, 4ya5Q, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1806, 4ya5C, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1807, 4ya2C, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1808, 4ya1Q, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1809, 4ya1C, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1810, 4y8qC, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1811, 4y8nC, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1812, 4y8mQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1813, 4y8mC, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1814, 4y8gR, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1815, 4y8gD, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1816, 4y80C, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1817, 4y78Q, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1818, 4y6vQ, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1819, 4y6vC, 0.8641, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1820, 4rurQ, 0.8641, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1821, 4rurC, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1822, 4qz2R, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1823, 4qz2D, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1824, 4qz1Q, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1825, 4qz1C, 0.8641, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1826, 4qwxQ, 0.8641, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1827, 4qwxC, 0.8641, 1.41, 0.332, 235, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1828, 4qw5R, 0.8641, 1.41, 0.332, 235, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1829, 4qw5D, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1830, 4no1R, 0.8641, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1831, 4no1D, 0.8641, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1832, 3uneQ, 0.8641, 1.57, 0.367, 240, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1833, 3tddC, 0.8641, 1.41, 0.332, 235, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1834, 3nzwQ, 0.8641, 1.41, 0.332, 235, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1835, 3nzjQ, 0.8641, 1.61, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1836, 3nzjC, 0.8641, 1.61, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1837, 3mg0Q, 0.8641, 1.57, 0.341, 239, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1838, 5nifE, 0.8640, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1839, 5mpaC, 0.8640, 1.57, 0.367, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1840, 5l6cQ, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1841, 5l6cC, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1842, 5l64Q, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1843, 5l64C, 0.8640, 1.42, 0.332, 236, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1844, 5l62Q, 0.8640, 2.27, 0.353, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1845, 5l62C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1846, 5l61Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1847, 5l61C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1848, 5l5yQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1849, 5l5yC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1850, 5l5wQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1851, 5l5wC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1852, 5l5iQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1853, 5l5iC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1854, 5l5hQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1855, 5l5hC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1856, 5l5fQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1857, 5l5fC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1858, 5gjrJA, 0.8640, 1.57, 0.367, 240, 229, 
1859, 5d0zR, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1860, 5d0zD, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1861, 5bouQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1862, 5bouC, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1863, 4ya9Q, 0.8640, 1.58, 0.341, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1864, 4ya9C, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1865, 4ya7Q, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1866, 4ya7C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1867, 4ya2Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1868, 4y8qQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1869, 4y8pQ, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1870, 4y8pC, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1871, 4y8nQ, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1872, 4y8kR, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1873, 4y8kD, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1874, 4y8hR, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1875, 4y8hD, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1876, 4y80Q, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1877, 4y7xC, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1878, 4y7wQ, 0.8640, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1879, 4y7wC, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1880, 4y70Q, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1881, 4y70C, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1882, 4x6zS, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1883, 4qluR, 0.8640, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1884, 4qluD, 0.8640, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1885, 4j70Q, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1886, 4inrQ, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1887, 4inrC, 0.8640, 1.56, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1888, 4hrdC, 0.8640, 1.62, 0.330, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1889, 3un8Q, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1890, 3un8C, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1891, 3tddQ, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1892, 3oevC, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1893, 3mg8C, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1894, 1z7qQ, 0.8640, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1895, 1z7qC, 0.8640, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1896, 1rypR, 0.8640, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1897, 5l6bQ, 0.8639, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1898, 5l6bC, 0.8639, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1899, 5l69C, 0.8639, 1.87, 0.355, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1900, 5l66Q, 0.8639, 1.87, 0.355, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1901, 5l66C, 0.8639, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1902, 5l63Q, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1903, 5l63C, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1904, 5l5tQ, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1905, 5l5tC, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1906, 5l54R, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1907, 5l54D, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1908, 5gjrV, 0.8639, 1.57, 0.367, 240, 229, 
1909, 5cggR, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1910, 5cggD, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1911, 4y7xQ, 0.8639, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1912, 4y6aQ, 0.8639, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1913, 4y6aC, 0.8639, 1.58, 0.341, 243, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1914, 4qwsQ, 0.8639, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1915, 4qwsC, 0.8639, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1916, 4ltcQ, 0.8639, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1917, 4ltcC, 0.8639, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1918, 4gk7Q, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1919, 4gk7C, 0.8639, 1.58, 0.362, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1920, 3oeuP, 0.8639, 1.58, 0.362, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1921, 3nzxQ, 0.8639, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1922, 3nzxC, 0.8639, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1923, 2fakC, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1924, 5l69Q, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1925, 5l68C, 0.8638, 1.81, 0.357, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1926, 5l5pQ, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1927, 5l5pC, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1928, 5l5jQ, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1929, 5l5jC, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1930, 5l54C, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1931, 5d0sR, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1932, 5d0sD, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1933, 5cghQ, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1934, 5cghC, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1935, 4zzgE, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1936, 4y8oQ, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1937, 4y8oC, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1938, 4y77Q, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1939, 4y77C, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1940, 4qz0R, 0.8638, 1.43, 0.332, 236, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1941, 4qz0D, 0.8638, 1.58, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1942, 4no9R, 0.8638, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1943, 4no9D, 0.8638, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1944, 4nnnQ, 0.8638, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1945, 3wxrD, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1946, 3un4Q, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1947, 3un4C, 0.8638, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1948, 3mg8Q, 0.8638, 1.62, 0.330, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1949, 2fakQ, 0.8638, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1950, 2f16C, 0.8638, 1.59, 0.362, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1951, 5l6aQ, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1952, 5l6aC, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1953, 5l68Q, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1954, 5l5oQ, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1955, 5l5oC, 0.8637, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1956, 5l54Q, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1957, 5gjqE, 0.8637, 1.57, 0.367, 240, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1958, 5ahjQ, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1959, 5ahjC, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1960, 4y8tC, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1961, 4y82Q, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1962, 4y82C, 0.8637, 1.59, 0.341, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1963, 4qlqR, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1964, 4qlqD, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1965, 4qbyR, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1966, 4qbyD, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1967, 4nnnC, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1968, 4jsuQ, 0.8637, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1969, 4jsuC, 0.8637, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1970, 4intC, 0.8637, 1.63, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1971, 2f16Q, 0.8637, 1.63, 0.330, 235, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1972, 5laiQ, 0.8636, 1.58, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1973, 5laiC, 0.8636, 1.58, 0.367, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1974, 5l5aQ, 0.8636, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1975, 5l5aC, 0.8636, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1976, 5l55D, 0.8636, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1977, 4y8tQ, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1978, 4y81Q, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1979, 4y81C, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1980, 4y75C, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1981, 4r17Q, 0.8636, 1.42, 0.332, 235, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1982, 4r17C, 0.8636, 1.58, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1983, 4qltC, 0.8636, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1984, 4no6Q, 0.8636, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1985, 4no6C, 0.8636, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1986, 1g65Q, 0.8636, 1.57, 0.367, 240, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1987, 5m2bQ, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1988, 5m2bC, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1989, 5l5dQ, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1990, 5l5dC, 0.8635, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1991, 4y75Q, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1992, 4y74Q, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1993, 4y74C, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1994, 4qltQ, 0.8635, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1995, 4jt0Q, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1996, 4jt0C, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1997, 4inuC, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1998, 4intQ, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1999, 4hrcQ, 0.8635, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2000, 3mg7C, 0.8635, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2001, 1fntC, 0.8635, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2002, 5l5rQ, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2003, 5l5rC, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2004, 5l5bQ, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2005, 5l5bC, 0.8634, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2006, 4y8kQ, 0.8634, 2.00, 0.358, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2007, 4y8kC, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2008, 4qlsC, 0.8634, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2009, 4no9C, 0.8634, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2010, 4inuQ, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2011, 4hnpQ, 0.8634, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2012, 3uneC, 0.8634, 1.58, 0.367, 240, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2013, 3okjQ, 0.8634, 1.59, 0.367, 240, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2014, 3okjC, 0.8634, 1.59, 0.362, 240, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2015, 1fntQ, 0.8634, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2016, 4qlsQ, 0.8633, 1.59, 0.367, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2017, 4qbyQ, 0.8633, 1.58, 0.336, 239, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2018, 4qbyC, 0.8633, 1.58, 0.367, 241, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2019, 4no9Q, 0.8633, 1.58, 0.367, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2020, 4jsqQ, 0.8633, 2.00, 0.358, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2021, 4jsqC, 0.8633, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2022, 4hrdQ, 0.8633, 1.58, 0.367, 240, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2023, 3oevQ, 0.8633, 1.58, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2024, 3oevP, 0.8633, 1.59, 0.362, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2025, 3mg6Q, 0.8633, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2026, 2gplC, 0.8633, 1.59, 0.367, 241, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2027, 5ahjR, 0.8632, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2028, 5ahjD, 0.8632, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2029, 4y8hQ, 0.8632, 1.83, 0.357, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2030, 4y8hC, 0.8632, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2031, 4y84Q, 0.8632, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2032, 4y6zQ, 0.8632, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2033, 4y6zC, 0.8632, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2034, 4qlqQ, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2035, 4qlqC, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2036, 4no1Q, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2037, 4no1C, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2038, 3oeuB, 0.8632, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2039, 2gplQ, 0.8632, 1.59, 0.367, 240, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2040, 4y8gC, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2041, 4y84C, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2042, 4qwgC, 0.8631, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2043, 3sdkQ, 0.8631, 1.76, 0.365, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2044, 3mg7P, 0.8631, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2045, 3mg4Q, 0.8631, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2046, 5mpad, 0.8630, 1.59, 0.367, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2047, 4y8gQ, 0.8630, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2048, 4r02Q, 0.8630, 1.58, 0.367, 241, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2049, 4qwgQ, 0.8630, 1.84, 0.357, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2050, 3mg6P, 0.8630, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2051, 1jd2D, 0.8630, 1.58, 0.362, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2052, 5vfqB, 0.8629, 1.59, 0.367, 240, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2053, 4qluQ, 0.8629, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2054, 4qluC, 0.8629, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2055, 3unee, 0.8629, 1.85, 0.357, 235, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2056, 3oeuQ, 0.8628, 1.52, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2057, 3mg4C, 0.8628, 1.35, 0.609, 230, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2058, 4qlvC, 0.8627, 2.21, 0.352, 250, 233, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2059, 3sdiP, 0.8627, 1.59, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2060, 4qlvQ, 0.8626, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2061, 4no8Q, 0.8626, 1.58, 0.341, 239, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2062, 4no8C, 0.8626, 1.59, 0.367, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2063, 4r3oS, 0.8624, 1.60, 0.367, 241, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
2064, 4r3oE, 0.8624, 1.60, 0.367, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
2065, 4nnwQ, 0.8624, 1.85, 0.357, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2066, 4nnwC, 0.8624, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2067, 1jd2Y, 0.8624, 1.60, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2068, 1fntS, 0.8624, 1.60, 0.367, 240, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2069, 1z7qS, 0.8623, 1.74, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2070, 1z7qE, 0.8623, 1.74, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2071, 3mg8P, 0.8622, 1.60, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2072, 3mg8B, 0.8622, 1.60, 0.367, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2073, 1fntE, 0.8622, 1.52, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2074, 4g4sC, 0.8621, 1.58, 0.330, 244, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2075, 3mg7Q, 0.8621, 1.55, 0.330, 245, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2076, 1jd2X, 0.8621, 1.55, 0.330, 245, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2077, 1jd2C, 0.8621, 1.87, 0.357, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2078, 1g0uP, 0.8621, 1.80, 0.361, 235, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2079, 3sdkP, 0.8620, 1.59, 0.330, 244, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2080, 3mg7B, 0.8619, 1.88, 0.357, 237, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2081, 5l4gD, 0.8618, 1.60, 0.367, 241, 229, 
2082, 5m32P, 0.8617, 1.59, 0.367, 241, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2083, 5l4gR, 0.8617, 1.59, 0.367, 241, 229, 
2084, 5vfoH, 0.8616, 1.85, 0.357, 235, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2085, 3unes, 0.8616, 1.88, 0.357, 235, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2086, 3oevB, 0.8616, 1.80, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2087, 5mp9d, 0.8615, 1.61, 0.336, 243, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2088, 3sdkB, 0.8615, 2.07, 0.356, 244, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2089, 3mg6B, 0.8615, 1.62, 0.341, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2090, 5mp9D, 0.8613, 1.38, 0.609, 230, 225, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2091, 4r67u, 0.8613, 1.60, 0.341, 239, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2092, 4r67g, 0.8613, 1.80, 0.361, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2093, 4r67S, 0.8612, 1.61, 0.362, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2094, 4r67E, 0.8612, 1.81, 0.361, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2095, 5gjrW, 0.8611, 1.83, 0.361, 235, 230, 
2096, 5gjrKA, 0.8610, 1.62, 0.367, 240, 229, 
2097, 5mpac, 0.8609, 1.77, 0.326, 234, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2098, 1iruR, 0.8609, 1.77, 0.326, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2099, 1iruD, 0.8609, 1.77, 0.326, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2100, 5vfpB, 0.8608, 1.77, 0.326, 234, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2101, 3jcpMA, 0.8608, 1.76, 0.322, 234, 227, 
2102, 3jcpM, 0.8608, 1.78, 0.322, 234, 227, 
2103, 1iruS, 0.8608, 2.21, 0.355, 244, 234, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2104, 1iruE, 0.8608, 1.61, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2105, 1g0uB, 0.8608, 1.61, 0.336, 243, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2106, 5vfrH, 0.8607, 1.40, 0.609, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2107, 3wxrR, 0.8606, 1.93, 0.336, 239, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2108, 6avoN, 0.8605, 1.61, 0.367, 241, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2109, 5lexR, 0.8604, 1.61, 0.367, 241, 229, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2110, 5wvkY, 0.8603, 1.61, 0.367, 241, 229, 
2111, 3jcoLA, 0.8603, 1.77, 0.322, 234, 227, 
2112, 3jcoL, 0.8603, 1.77, 0.322, 234, 227, 
2113, 5mp9E, 0.8599, 1.87, 0.357, 235, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2114, 5le5R, 0.8599, 1.39, 0.609, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2115, 5gjql, 0.8599, 1.66, 0.367, 241, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2116, 5gjqk, 0.8599, 1.62, 0.336, 232, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2117, 3uneD, 0.8599, 1.75, 0.326, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2118, 5lexD, 0.8598, 1.59, 0.362, 241, 229, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2119, 5gjqF, 0.8598, 2.28, 0.362, 244, 235, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2120, 5lf6Q, 0.8597, 2.28, 0.362, 244, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2121, 4g4sE, 0.8596, 2.28, 0.362, 244, 235, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2122, 3unbD, 0.8596, 1.64, 0.330, 242, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2123, 6avoI, 0.8595, 1.59, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2124, 5lf1Q, 0.8594, 1.60, 0.323, 234, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2125, 3sdiB, 0.8593, 1.64, 0.336, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2126, 5mp9e, 0.8592, 1.62, 0.327, 233, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2127, 5lf4Q, 0.8592, 1.77, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2128, 3uneR, 0.8592, 1.60, 0.323, 234, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2129, 5lf6R, 0.8591, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2130, 5lf0Q, 0.8591, 1.57, 0.330, 249, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2131, 3sdkD, 0.8591, 1.61, 0.323, 233, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2132, 5mpaE, 0.8590, 1.64, 0.336, 232, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2133, 3unbf, 0.8590, 1.60, 0.338, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2134, 5lf1R, 0.8589, 1.96, 0.357, 235, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2135, 5lezR, 0.8589, 1.61, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2136, 5lezD, 0.8589, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2137, 5l4gS, 0.8588, 1.61, 0.327, 233, 226, 
2138, 5lf7Q, 0.8587, 1.60, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2139, 5leyQ, 0.8587, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2140, 5le5D, 0.8587, 1.36, 0.335, 233, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2141, 3unef, 0.8587, 1.59, 0.330, 242, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2142, 5lf3R, 0.8586, 1.62, 0.323, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2143, 5l4gE, 0.8586, 1.60, 0.327, 233, 226, 
2144, 3unhR, 0.8586, 1.77, 0.326, 233, 227, MOUSE 20S IMMUNOPROTEASOME
2145, 3unhD, 0.8586, 1.77, 0.326, 233, 227, MOUSE 20S IMMUNOPROTEASOME
2146, 3jcpNA, 0.8586, 1.62, 0.327, 234, 226, 
2147, 3jcpN, 0.8586, 1.61, 0.338, 238, 228, 
2148, 5lf3Q, 0.8585, 1.61, 0.338, 239, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2149, 3unfR, 0.8585, 1.62, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2150, 3unfD, 0.8585, 1.62, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2151, 5lf6D, 0.8584, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2152, 5lf7R, 0.8583, 1.81, 0.326, 234, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2153, 3unet, 0.8583, 1.60, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2154, 5lf3D, 0.8582, 1.60, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2155, 5lf1D, 0.8582, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2156, 5lf0R, 0.8582, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2157, 5lf7D, 0.8581, 1.57, 0.330, 242, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2158, 5lf4R, 0.8581, 1.62, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2159, 5leyR, 0.8579, 1.60, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2160, 6avoM, 0.8578, 1.60, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2161, 3unbR, 0.8578, 1.61, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2162, 5lf0D, 0.8577, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2163, 5leyD, 0.8577, 1.63, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2164, 6avoH, 0.8576, 1.62, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2165, 3sdkR, 0.8575, 1.62, 0.327, 233, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2166, 5lf4D, 0.8574, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2167, 1g0uD, 0.8574, 1.62, 0.327, 233, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2168, 3unbt, 0.8570, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2169, 1j2qB, 0.8567, 1.62, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2170, 5mpcC, 0.8566, 1.60, 0.327, 233, 226, 
2171, 3jcoMA, 0.8566, 1.63, 0.327, 233, 226, 
2172, 3jcoM, 0.8566, 1.62, 0.327, 233, 226, 
2173, 1g0uR, 0.8566, 1.62, 0.327, 233, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2174, 5mpae, 0.8563, 1.60, 0.327, 233, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2175, 1j2qD, 0.8563, 1.29, 0.336, 232, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2176, 1j2qF, 0.8562, 1.63, 0.327, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2177, 1j2qC, 0.8562, 1.24, 0.341, 230, 223, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2178, 1j2qG, 0.8561, 1.65, 0.323, 233, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2179, 1j2qE, 0.8561, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2180, 1j2qA, 0.8561, 2.13, 0.352, 244, 233, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2181, 5mpaD, 0.8558, 1.67, 0.367, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2182, 4cr2C, 0.8558, 1.67, 0.367, 241, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2183, 3sdiR, 0.8556, 1.67, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2184, 5m32C, 0.8555, 1.26, 0.341, 230, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2185, 3sdiC, 0.8554, 1.74, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2186, 5mpbQ, 0.8552, 1.71, 0.388, 237, 227, 
2187, 5wvkZ, 0.8547, 1.71, 0.388, 237, 227, 
2188, 5wvkR, 0.8547, 1.71, 0.388, 237, 227, 
2189, 1g0uC, 0.8545, 1.72, 0.388, 237, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2190, 1g0uQ, 0.8537, 1.72, 0.388, 237, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2191, 5gjqB, 0.8531, 1.71, 0.388, 237, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2192, 3sdiQ, 0.8531, 1.72, 0.362, 240, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2193, 5l4gA, 0.8530, 2.24, 0.362, 245, 235, 
2194, 3jcoN, 0.8530, 1.20, 0.338, 229, 222, 
2195, 5gjrS, 0.8529, 1.77, 0.341, 234, 229, 
2196, 3jcoNA, 0.8529, 1.53, 0.367, 238, 226, 
2197, 5gjrGA, 0.8528, 2.09, 0.352, 244, 233, 
2198, 3sdiD, 0.8525, 1.69, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2199, 5gjqh, 0.8524, 1.74, 0.358, 241, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2200, 5mpbS, 0.8522, 1.54, 0.367, 238, 226, 
2201, 5m32Q, 0.8521, 1.55, 0.367, 238, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2202, 5l4gO, 0.8520, 1.82, 0.360, 244, 228, 
2203, 4cr2E, 0.8520, 1.56, 0.367, 238, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2204, 3unbG, 0.8520, 1.80, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2205, 5vfoi, 0.8518, 1.65, 0.330, 242, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2206, 5vfpAA, 0.8517, 1.65, 0.330, 242, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2207, 6epcB, 0.8515, 1.81, 0.360, 244, 228, GROUND STATE 26S PROTEASOME (GS2)
2208, 5a0qQ, 0.8514, 1.65, 0.330, 242, 227, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2209, 5a0qC, 0.8514, 1.81, 0.360, 244, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2210, 4cr4C, 0.8514, 1.18, 0.339, 228, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2211, 4v7oQ, 0.8513, 1.79, 0.360, 244, 228, 
2212, 4v7oYA, 0.8512, 1.93, 0.325, 242, 228, 
2213, 4v7oKA, 0.8512, 1.80, 0.341, 235, 229, 
2214, 4v7oC, 0.8512, 1.79, 0.360, 244, 228, 
2215, 3unbw, 0.8511, 1.91, 0.329, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2216, 3unbU, 0.8511, 1.82, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2217, 3unbi, 0.8509, 2.19, 0.352, 250, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2218, 5vfqBA, 0.8507, 2.20, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2219, 3unhU, 0.8507, 1.93, 0.608, 234, 232, MOUSE 20S IMMUNOPROTEASOME
2220, 3unhG, 0.8507, 1.96, 0.368, 237, 228, MOUSE 20S IMMUNOPROTEASOME
2221, 5wvkS, 0.8506, 1.96, 0.368, 237, 228, 
2222, 3unfU, 0.8505, 2.39, 0.357, 245, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2223, 3unfG, 0.8505, 1.87, 0.357, 232, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2224, 5vfsC, 0.8503, 1.87, 0.357, 232, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2225, 5a5bC, 0.8503, 1.87, 0.357, 232, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2226, 4cr3C, 0.8503, 1.87, 0.357, 232, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2227, 5vfoI, 0.8502, 1.92, 0.341, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2228, 5vfsD, 0.8501, 1.83, 0.360, 243, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2229, 5vfqC, 0.8501, 1.83, 0.360, 243, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2230, 5a5bD, 0.8501, 1.84, 0.360, 243, 228, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2231, 4cr3D, 0.8501, 2.21, 0.352, 250, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2232, 3uneG, 0.8501, 1.83, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2233, 5vfri, 0.8499, 1.83, 0.360, 243, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2234, 5ln3E, 0.8499, 1.72, 0.330, 242, 227, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2235, 4r3oO, 0.8496, 1.83, 0.360, 243, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2236, 1iruO, 0.8495, 1.83, 0.360, 243, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2237, 4r3oA, 0.8494, 2.22, 0.352, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
2238, 4cr2D, 0.8494, 1.82, 0.336, 239, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2239, 1iruA, 0.8494, 2.34, 0.362, 245, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2240, 5vfrI, 0.8493, 2.34, 0.362, 245, 235, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2241, 5vfsBA, 0.8492, 1.86, 0.352, 248, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2242, 5gjqn, 0.8492, 1.78, 0.341, 239, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2243, 4r67q, 0.8491, 1.56, 0.326, 228, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2244, 4r67O, 0.8491, 1.86, 0.352, 248, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2245, 4r67c, 0.8491, 1.93, 0.336, 239, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2246, 4r67A, 0.8491, 1.79, 0.358, 242, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2247, 5vfpC, 0.8488, 1.79, 0.358, 242, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2248, 3uneU, 0.8488, 1.83, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2249, 4v7oE, 0.8487, 2.22, 0.352, 250, 233, 
2250, 4v7oAB, 0.8487, 1.66, 0.327, 232, 226, 
2251, 4v7oMA, 0.8486, 1.86, 0.360, 244, 228, 
2252, 4v7oS, 0.8485, 1.87, 0.360, 244, 228, 
2253, 3unew, 0.8484, 1.87, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2254, 3unei, 0.8483, 1.77, 0.362, 242, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2255, 5vfuU, 0.8479, 1.87, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2256, 5vftJ, 0.8479, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2257, 5vfrK, 0.8478, 2.23, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2258, 6avoQ, 0.8477, 1.85, 0.295, 243, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2259, 6avoJ, 0.8477, 1.86, 0.360, 244, 228, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2260, 5vfok, 0.8477, 1.86, 0.360, 244, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2261, 5vfuT, 0.8475, 1.86, 0.360, 244, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2262, 5vftI, 0.8475, 1.86, 0.360, 244, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2263, 5mpbC, 0.8475, 1.87, 0.352, 248, 230, 
2264, 5gjqX, 0.8474, 1.58, 0.321, 228, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2265, 5mpcQ, 0.8473, 1.85, 0.360, 244, 228, 
2266, 5vfqDA, 0.8472, 1.85, 0.330, 250, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2267, 5vfrk, 0.8471, 1.85, 0.330, 250, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2268, 5vfsDA, 0.8469, 1.85, 0.330, 250, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2269, 5vfsCA, 0.8469, 1.85, 0.330, 250, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2270, 5l4gU, 0.8469, 1.86, 0.360, 244, 228, 
2271, 5l4gG, 0.8469, 1.87, 0.360, 244, 228, 
2272, 3uneF, 0.8469, 1.81, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2273, 5vfsE, 0.8468, 1.81, 0.336, 239, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2274, 5vfqE, 0.8467, 1.54, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2275, 3unbT, 0.8467, 1.71, 0.296, 239, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2276, 5vfpE, 0.8466, 1.71, 0.296, 239, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2277, 3unbv, 0.8466, 1.57, 0.321, 228, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2278, 5vfpCA, 0.8465, 2.26, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2279, 5vfoK, 0.8465, 2.26, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2280, 1j2pF, 0.8463, 2.28, 0.361, 244, 233, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2281, 5t0cU, 0.8461, 2.12, 0.285, 243, 228, 
2282, 5t0cAB, 0.8461, 2.26, 0.356, 244, 233, 
2283, 5gjrMA, 0.8461, 1.57, 0.321, 228, 224, 
2284, 1j2pG, 0.8461, 1.57, 0.321, 228, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2285, 1j2pE, 0.8461, 1.56, 0.326, 228, 224, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2286, 1j2pD, 0.8461, 1.82, 0.336, 239, 229, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2287, 1j2pC, 0.8461, 1.97, 0.285, 241, 228, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2288, 1j2pA, 0.8461, 2.14, 0.284, 242, 229, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2289, 1j2pB, 0.8460, 1.74, 0.296, 244, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2290, 5gjrY, 0.8459, 1.69, 0.324, 228, 225, 
2291, 2ku2A, 0.8459, 1.72, 0.317, 238, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2292, 5lf3F, 0.8457, 1.69, 0.320, 228, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2293, 5lexT, 0.8456, 1.73, 0.317, 238, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2294, 5lexF, 0.8456, 1.74, 0.296, 244, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2295, 5t0cV, 0.8454, 1.56, 0.321, 228, 224, 
2296, 5t0cBB, 0.8454, 2.00, 0.286, 240, 227, 
2297, 5lf7F, 0.8454, 1.74, 0.296, 244, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2298, 5lf1F, 0.8454, 1.58, 0.321, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2299, 5lezF, 0.8454, 1.69, 0.320, 228, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2300, 5lf4F, 0.8453, 1.73, 0.381, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2301, 5lf0F, 0.8453, 2.26, 0.352, 250, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2302, 5lezT, 0.8453, 2.26, 0.352, 250, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2303, 5leyF, 0.8452, 2.00, 0.286, 243, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2304, 5vfuHA, 0.8451, 1.73, 0.381, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2305, 5vfti, 0.8451, 1.73, 0.381, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2306, 5lf1T, 0.8451, 1.73, 0.381, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2307, 5le5T, 0.8450, 1.73, 0.381, 243, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2308, 5lf6T, 0.8449, 1.73, 0.381, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2309, 4r3oG, 0.8449, 1.73, 0.381, 243, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2310, 2ku1A, 0.8449, 2.00, 0.286, 243, 227, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2311, 5mpcS, 0.8448, 1.84, 0.390, 237, 228, 
2312, 5lf3T, 0.8448, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2313, 4r3oU, 0.8448, 1.74, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2314, 5lf7T, 0.8447, 1.74, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2315, 5le5F, 0.8447, 1.84, 0.336, 239, 229, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2316, 5lf4T, 0.8446, 1.84, 0.336, 239, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2317, 5lf0T, 0.8446, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2318, 5leyT, 0.8445, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2319, 5mpbE, 0.8443, 1.74, 0.296, 239, 226, 
2320, 5lf6F, 0.8443, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2321, 4cr4E, 0.8441, 1.75, 0.296, 239, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2322, 5wvkQ, 0.8438, 1.74, 0.296, 240, 226, 
2323, 5vftK, 0.8438, 1.76, 0.296, 239, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2324, 4r67w, 0.8438, 2.29, 0.352, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2325, 4r67U, 0.8438, 2.29, 0.352, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2326, 4r67i, 0.8438, 1.75, 0.296, 240, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2327, 1iruU, 0.8437, 1.75, 0.296, 240, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2328, 1iruG, 0.8437, 1.76, 0.296, 240, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2329, 4r67G, 0.8436, 1.87, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2330, 3unev, 0.8436, 1.94, 0.395, 237, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2331, 3uneh, 0.8436, 1.89, 0.335, 242, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2332, 5lezQ, 0.8435, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2333, 3unbF, 0.8435, 1.88, 0.288, 245, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2334, 5m32R, 0.8434, 1.76, 0.296, 240, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2335, 5m32D, 0.8434, 1.77, 0.296, 239, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2336, 5vfuV, 0.8433, 1.76, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2337, 5lexQ, 0.8433, 1.76, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2338, 3uneT, 0.8433, 1.76, 0.296, 240, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2339, 3h4pH, 0.8433, 1.85, 0.330, 242, 227, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2340, 3h4pD, 0.8433, 1.78, 0.296, 239, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2341, 3unbh, 0.8431, 1.86, 0.313, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2342, 5vftk, 0.8430, 2.52, 0.357, 244, 235, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2343, 5le5Q, 0.8430, 1.76, 0.329, 228, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2344, 3unhT, 0.8430, 1.89, 0.288, 245, 226, MOUSE 20S IMMUNOPROTEASOME
2345, 3unhF, 0.8430, 1.89, 0.288, 245, 226, MOUSE 20S IMMUNOPROTEASOME
2346, 3h4pJ, 0.8429, 1.89, 0.288, 245, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2347, 3h4pF, 0.8428, 1.78, 0.296, 245, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2348, 3h4pA, 0.8428, 1.78, 0.296, 245, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2349, 5vfsZ, 0.8427, 1.89, 0.288, 245, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2350, 5vfsA, 0.8427, 1.90, 0.288, 244, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2351, 3h4pI, 0.8426, 1.92, 0.288, 244, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2352, 5m32U, 0.8424, 1.55, 0.345, 234, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2353, 3unfT, 0.8424, 2.06, 0.286, 244, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2354, 3unfF, 0.8424, 1.77, 0.311, 233, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2355, 3h4pE, 0.8424, 1.77, 0.311, 233, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2356, 5wvkX, 0.8423, 1.76, 0.329, 228, 225, 
2357, 5vfrG, 0.8423, 1.55, 0.345, 233, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2358, 5mpcE, 0.8423, 1.92, 0.292, 244, 226, 
2359, 3h4pN, 0.8423, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2360, 3h4pC, 0.8423, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2361, 3sdiF, 0.8422, 1.91, 0.288, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2362, 3h4pL, 0.8422, 1.77, 0.324, 228, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2363, 1z7qD, 0.8422, 1.56, 0.345, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2364, 5m2bF, 0.8421, 1.91, 0.288, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2365, 5l63T, 0.8421, 1.91, 0.288, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2366, 5l63F, 0.8421, 1.68, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2367, 1z7qR, 0.8421, 1.69, 0.364, 232, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2368, 5t0cW, 0.8420, 1.69, 0.364, 232, 225, 
2369, 5t0cCB, 0.8420, 1.95, 0.360, 240, 228, 
2370, 5m2bT, 0.8420, 1.17, 0.610, 232, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2371, 5l6aT, 0.8420, 1.94, 0.360, 240, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2372, 5l6aF, 0.8420, 1.69, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2373, 5l64T, 0.8420, 1.85, 0.361, 241, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2374, 5l64F, 0.8420, 1.92, 0.288, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2375, 5l61T, 0.8420, 1.92, 0.288, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2376, 5l61F, 0.8420, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2377, 5l5rT, 0.8420, 2.31, 0.358, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2378, 5l5dT, 0.8420, 1.93, 0.360, 239, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2379, 5l5dF, 0.8420, 2.00, 0.329, 242, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2380, 3h4pK, 0.8420, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2381, 3h4pB, 0.8420, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2382, 5l69T, 0.8419, 2.02, 0.330, 242, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2383, 5l69F, 0.8419, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2384, 5l66T, 0.8419, 1.80, 0.360, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2385, 5l66F, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2386, 5l65F, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2387, 5l5wT, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2388, 5l5wF, 0.8419, 1.81, 0.360, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2389, 5l5rF, 0.8419, 1.76, 0.329, 228, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2390, 3h4pM, 0.8419, 1.76, 0.329, 228, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2391, 5vfoG, 0.8418, 1.87, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2392, 5t0cYA, 0.8418, 1.87, 0.336, 243, 226, 
2393, 5t0cS, 0.8418, 1.87, 0.336, 243, 226, 
2394, 5l65T, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2395, 5l62T, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2396, 5l62F, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2397, 5l5hT, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2398, 5l5hF, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2399, 4r18T, 0.8418, 1.87, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2400, 4r18F, 0.8418, 1.87, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2401, 4qv6F, 0.8418, 1.70, 0.364, 232, 225, YCP BETA5-A49V MUTANT
2402, 5l6cT, 0.8417, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2403, 5l6cF, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2404, 5l5zT, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2405, 5l5zF, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2406, 5l5yT, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2407, 5l5yF, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2408, 5l5uT, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2409, 5l5uF, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2410, 5l5sT, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2411, 5l5sF, 0.8417, 1.71, 0.364, 232, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2412, 5l5pT, 0.8417, 1.94, 0.360, 239, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2413, 5l5pF, 0.8417, 1.95, 0.360, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2414, 5bxnT, 0.8417, 1.95, 0.360, 240, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2415, 5bxnF, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2416, 4r02T, 0.8417, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2417, 4qvnT, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2418, 4qvnF, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2419, 4qv6T, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2420, 3h4pG, 0.8417, 1.88, 0.336, 243, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2421, 5l6bT, 0.8416, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2422, 5l6bF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2423, 5l60T, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2424, 5l60F, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2425, 5l5xT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2426, 5l5xF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2427, 5l5tT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2428, 5l5tF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2429, 5l5qT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2430, 5l5qF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2431, 5l5oT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2432, 5l5oF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2433, 5l5jT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2434, 5l5jF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2435, 5l5iT, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2436, 5l5iF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2437, 5l5bT, 0.8416, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2438, 5l5bF, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2439, 4r02F, 0.8416, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2440, 5vfog, 0.8415, 1.87, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2441, 5l68T, 0.8415, 1.70, 0.364, 232, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2442, 5l68F, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2443, 5l67T, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2444, 5l67F, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2445, 5l5fT, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2446, 5l5fF, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2447, 5cz6F, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2448, 4y8tT, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2449, 4y8tF, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2450, 4qvyT, 0.8415, 1.87, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2451, 4qvyF, 0.8415, 1.87, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2452, 4qvlT, 0.8415, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2453, 6avoR, 0.8414, 1.87, 0.336, 243, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2454, 5vfuJA, 0.8414, 1.87, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2455, 5l5vT, 0.8414, 1.87, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2456, 5l5vF, 0.8414, 1.87, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2457, 5l5aT, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2458, 5l5aF, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2459, 5cz6T, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2460, 5bxlT, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2461, 5bxlF, 0.8414, 1.94, 0.360, 240, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2462, 4ya4T, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2463, 4ya4F, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2464, 4qvwT, 0.8414, 1.87, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2465, 4qvwF, 0.8414, 1.87, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2466, 4qvlF, 0.8414, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2467, 4nnwT, 0.8414, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2468, 4nnwF, 0.8414, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2469, 5lajT, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2470, 5lajF, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2471, 5l5eT, 0.8413, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2472, 5l5eF, 0.8413, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2473, 5dsvL, 0.8413, 1.87, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2474, 5dsvF, 0.8413, 1.95, 0.363, 240, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2475, 5bouT, 0.8413, 1.80, 0.324, 228, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2476, 5bouF, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2477, 4ya9F, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2478, 4hnpF, 0.8413, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2479, 5vfoj, 0.8412, 1.88, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2480, 5t0gI, 0.8412, 1.88, 0.336, 243, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2481, 5d0wF, 0.8412, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2482, 5cz7F, 0.8412, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2483, 4ya9T, 0.8412, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2484, 4r17T, 0.8412, 1.87, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2485, 4r17F, 0.8412, 1.88, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2486, 4qzzT, 0.8412, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2487, 4qzzF, 0.8412, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2488, 4qw1T, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2489, 4qw1F, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2490, 4qvpT, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2491, 4qvpF, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2492, 6gopT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2493, 6gopF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2494, 5mp9g, 0.8411, 1.81, 0.296, 245, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2495, 5lttT, 0.8411, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2496, 5lttF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2497, 5fggT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2498, 5fggF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2499, 5d0wT, 0.8411, 1.88, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2500, 5czaT, 0.8411, 1.90, 0.336, 239, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2501, 5czaF, 0.8411, 2.31, 0.352, 250, 233, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2502, 5cz7T, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2503, 5cghT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2504, 5cghF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2505, 4ya2T, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2506, 4ya2F, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2507, 4y8rF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2508, 4y8gT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2509, 4y8gF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2510, 4y6vF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2511, 4rurT, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2512, 4rurF, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2513, 4qz7T, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2514, 4qz7F, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2515, 4qvqT, 0.8411, 1.87, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2516, 4qvqF, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2517, 4qvmT, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2518, 4qvmF, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2519, 4qv1T, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2520, 4qv1F, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2521, 4quxT, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2522, 4quxF, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2523, 1fntD, 0.8411, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2524, 5vfqA, 0.8410, 1.89, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2525, 5dsvB, 0.8410, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2526, 5dsvA, 0.8410, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2527, 4y9yT, 0.8410, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2528, 4y9yF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2529, 4y8rT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2530, 4y8mT, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2531, 4y8mF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2532, 4y75T, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2533, 4y75F, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2534, 4y6vT, 0.8410, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2535, 4qwuT, 0.8410, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2536, 4qwuF, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2537, 4qv0T, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2538, 4qv0F, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2539, 4quyT, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2540, 4quyF, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2541, 4q1sF, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2542, 1fntR, 0.8410, 1.88, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2543, 5vfqZ, 0.8409, 1.88, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2544, 5fgaT, 0.8409, 1.78, 0.364, 239, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2545, 5fgaF, 0.8409, 1.20, 0.602, 232, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2546, 5fg9T, 0.8409, 1.94, 0.360, 239, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2547, 5fg9F, 0.8409, 1.81, 0.296, 245, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2548, 5ahjT, 0.8409, 1.81, 0.296, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2549, 5ahjF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2550, 4ya1T, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2551, 4ya1F, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2552, 4y8sT, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2553, 4y8sF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2554, 4y8pT, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2555, 4y8pF, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2556, 4y8nF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2557, 4y6aT, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2558, 4y6aF, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2559, 4qz4T, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2560, 4qz4F, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2561, 4qw0T, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2562, 4qw0F, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2563, 4qv5F, 0.8409, 1.88, 0.332, 244, 226, YCP BETA5-M45I MUTANT
2564, 4qv4T, 0.8409, 1.78, 0.364, 239, 225, YCP BETA5-M45T MUTANT
2565, 4qv4F, 0.8409, 1.95, 0.360, 240, 228, YCP BETA5-M45T MUTANT
2566, 4qlsT, 0.8409, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2567, 4qlsF, 0.8409, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2568, 4no1T, 0.8409, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2569, 4no1F, 0.8409, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2570, 5laiT, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2571, 5laiF, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2572, 5fg7T, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2573, 5fg7F, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2574, 5dsvN, 0.8408, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2575, 5dsvI, 0.8408, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2576, 4y8uT, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2577, 4y8uF, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2578, 4y8nT, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2579, 4y77T, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2580, 4y77F, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2581, 4y69F, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2582, 4qz6T, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2583, 4qz6F, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2584, 4qwfT, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2585, 4qwfF, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2586, 4qw6T, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2587, 4qw6F, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2588, 4qv8T, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2589, 4qv8F, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2590, 4qv5T, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2591, 4qltT, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2592, 4qltF, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2593, 4qbyT, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2594, 4qbyF, 0.8408, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2595, 5jhrT, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2596, 5jhrF, 0.8407, 1.82, 0.296, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2597, 5fghT, 0.8407, 1.82, 0.296, 244, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2598, 5fghF, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2599, 5dkjT, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2600, 5dkjF, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2601, 5d0vT, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2602, 5d0vF, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2603, 5cz9F, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2604, 5cggT, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2605, 5cggF, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2606, 4ya7T, 0.8407, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2607, 4ya7F, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2608, 4ya5T, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2609, 4ya5F, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2610, 4y69T, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2611, 4qwxT, 0.8407, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2612, 4qwxF, 0.8407, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2613, 4qv7T, 0.8407, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2614, 4qv7F, 0.8407, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2615, 4hrdF, 0.8407, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2616, 3sdiT, 0.8407, 1.89, 0.336, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2617, 1rypU, 0.8407, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2618, 1rypG, 0.8407, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2619, 5l54T, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2620, 5l54F, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2621, 5d0xT, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2622, 5d0xF, 0.8406, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2623, 5d0tT, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2624, 5d0tF, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2625, 5cz9T, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2626, 4y84T, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2627, 4y84F, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2628, 4y74T, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2629, 4y74F, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2630, 4x6zU, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2631, 4qz0T, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2632, 4qz0F, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2633, 4qwlT, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2634, 4qwlF, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2635, 4qw7T, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2636, 4qw7F, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2637, 4qw5T, 0.8406, 1.89, 0.332, 244, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2638, 4qw5F, 0.8406, 1.89, 0.332, 242, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2639, 4qw4T, 0.8406, 1.88, 0.336, 244, 226, YCP IN COMPLEX WITH CARFILZOMIB
2640, 4qw4F, 0.8406, 1.88, 0.336, 244, 226, YCP IN COMPLEX WITH CARFILZOMIB
2641, 4qv9T, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2642, 4qv9F, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2643, 4qlqT, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2644, 4qlqF, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2645, 4nnnT, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2646, 3nzjT, 0.8406, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2647, 3nzjF, 0.8406, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2648, 5l55T, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2649, 5l55F, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2650, 5fgeT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2651, 5fgeF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2652, 5dsvK, 0.8405, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2653, 5d0sT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2654, 5d0sF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2655, 5cgfT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2656, 5cgfF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2657, 4y9zT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2658, 4y9zF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2659, 4y8hT, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2660, 4y8hF, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2661, 4y81T, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2662, 4y81F, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2663, 4y7xT, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2664, 4y7xF, 0.8405, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2665, 4qz3F, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2666, 4qz1F, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2667, 4qw3T, 0.8405, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2668, 4qw3F, 0.8405, 1.89, 0.332, 244, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2669, 4qluT, 0.8405, 1.89, 0.332, 244, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2670, 4qluF, 0.8405, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2671, 4no9T, 0.8405, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2672, 4no9F, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2673, 4nnnF, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2674, 6avoK, 0.8404, 1.82, 0.296, 244, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2675, 5jhsT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2676, 5jhsF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2677, 5fgiT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2678, 5fgiF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2679, 5dsvE, 0.8404, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2680, 5d0zT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2681, 5d0zF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2682, 4y8oT, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2683, 4y8oF, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2684, 4y8kT, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2685, 4y8kF, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2686, 4y6zT, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2687, 4y6zF, 0.8404, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2688, 4x6zG, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2689, 4qz5T, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2690, 4qz5F, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2691, 4qz3T, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2692, 4qz1T, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2693, 4qwkT, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2694, 4qwkF, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2695, 4fzgF, 0.8404, 1.90, 0.336, 243, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2696, 5vfpA, 0.8403, 1.95, 0.363, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2697, 5t0gK, 0.8403, 1.90, 0.336, 243, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2698, 5fgfT, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2699, 5fgfF, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2700, 4y82T, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2701, 4y82F, 0.8403, 1.82, 0.296, 245, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2702, 4r00T, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2703, 4r00F, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2704, 4qzwT, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2705, 4qzwF, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2706, 4qz2T, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2707, 4qz2F, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2708, 4ltcF, 0.8403, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2709, 4j70F, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2710, 4fzgT, 0.8403, 1.90, 0.336, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2711, 3un8F, 0.8403, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2712, 5vfuR, 0.8402, 1.89, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2713, 5vfrg, 0.8402, 1.89, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2714, 5fgdT, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2715, 5fgdF, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2716, 5dkiT, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2717, 5dkiF, 0.8402, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2718, 5cz4T, 0.8402, 2.20, 0.352, 250, 233, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2719, 5cz4F, 0.8402, 1.96, 0.360, 239, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2720, 4zzgG, 0.8402, 1.93, 0.327, 228, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2721, 4z1lT, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2722, 4z1lF, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2723, 4y8iT, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2724, 4y8iF, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2725, 4qwrT, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2726, 4qwrF, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2727, 4qwiT, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2728, 4qwiF, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2729, 4qv3T, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2730, 4qv3F, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2731, 4no8F, 0.8402, 1.89, 0.332, 244, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2732, 4no6T, 0.8402, 1.90, 0.332, 244, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2733, 4no6F, 0.8402, 1.89, 0.332, 244, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2734, 4intF, 0.8402, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2735, 4hrcF, 0.8402, 1.98, 0.360, 240, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2736, 3mg0F, 0.8402, 1.96, 0.360, 240, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2737, 3hyeT, 0.8402, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2738, 3hyeF, 0.8402, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2739, 5vftG, 0.8401, 1.89, 0.336, 243, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2740, 5l52T, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2741, 5l52F, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2742, 5dsvD, 0.8401, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2743, 4y8lT, 0.8401, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2744, 4y8lF, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2745, 4y70T, 0.8401, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2746, 4y70F, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2747, 4qvvT, 0.8401, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2748, 4qvvF, 0.8401, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2749, 4no8T, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2750, 4j70T, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2751, 4hrdT, 0.8401, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2752, 4hnpT, 0.8401, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2753, 4eu2G, 0.8401, 1.89, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2754, 4cr4D, 0.8401, 1.90, 0.336, 243, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2755, 3mg0T, 0.8401, 1.90, 0.336, 243, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2756, 3gptT, 0.8401, 1.90, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2757, 3gptF, 0.8401, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2758, 5nifG, 0.8400, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2759, 5cgiT, 0.8400, 1.89, 0.336, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2760, 5cgiF, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2761, 4ya3T, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2762, 4ya3F, 0.8400, 1.98, 0.360, 240, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2763, 4ya0T, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2764, 4ya0F, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2765, 4y8qT, 0.8400, 1.82, 0.296, 244, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2766, 4y8qF, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2767, 4y8jT, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2768, 4y8jF, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2769, 4y80T, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2770, 4y80F, 0.8400, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2771, 4y7wT, 0.8400, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2772, 4y7wF, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2773, 4inrF, 0.8400, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2774, 3un8T, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2775, 5gjqm, 0.8399, 1.90, 0.332, 244, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2776, 5dsvG, 0.8399, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2777, 4qwgF, 0.8399, 1.90, 0.358, 242, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2778, 4q1sT, 0.8399, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2779, 4ltcT, 0.8399, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2780, 3nzwT, 0.8399, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2781, 3nzwF, 0.8399, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2782, 3mg4F, 0.8399, 1.90, 0.336, 243, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2783, 5fhsT, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2784, 5fhsF, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2785, 5cz8T, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2786, 5cz8F, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2787, 5cz5T, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2788, 5cz5F, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2789, 4qxjT, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2790, 4qxjF, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2791, 4qwsT, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2792, 4qwsF, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2793, 4qwgT, 0.8398, 1.90, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2794, 4intT, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2795, 4inrT, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2796, 3tddT, 0.8398, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2797, 3tddF, 0.8398, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2798, 3d29T, 0.8398, 1.63, 0.317, 238, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2799, 3d29F, 0.8398, 1.83, 0.296, 242, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2800, 2ku2B, 0.8398, 1.91, 0.336, 243, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2801, 5vfuIA, 0.8397, 1.91, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2802, 5vftj, 0.8397, 1.90, 0.332, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2803, 5mpbR, 0.8397, 1.90, 0.332, 244, 226, 
2804, 4zzgU, 0.8397, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2805, 4qwjT, 0.8397, 1.89, 0.332, 244, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2806, 4qwjF, 0.8397, 1.90, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2807, 4lqiF, 0.8397, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2808, 5t0hI, 0.8396, 1.90, 0.336, 243, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2809, 5nifU, 0.8396, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2810, 5mp9G, 0.8396, 1.91, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2811, 4y7yT, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2812, 4y7yF, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2813, 4y78T, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2814, 4y78F, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2815, 4qzxT, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2816, 4qzxF, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2817, 4qlvT, 0.8396, 1.89, 0.332, 244, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2818, 4qlvF, 0.8396, 1.90, 0.332, 244, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2819, 4lqiT, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2820, 4jsqT, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2821, 4jsqF, 0.8396, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2822, 4inuF, 0.8396, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2823, 1g0uF, 0.8396, 1.81, 0.394, 237, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2824, 3nzxT, 0.8395, 1.93, 0.332, 239, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2825, 3nzxF, 0.8395, 1.93, 0.332, 239, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2826, 3gpwT, 0.8395, 1.94, 0.362, 240, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2827, 3gpwF, 0.8395, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2828, 3dy3T, 0.8395, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2829, 3dy3F, 0.8395, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2830, 4jt0T, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2831, 4jt0F, 0.8394, 2.32, 0.352, 250, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2832, 4jsuF, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2833, 4inuT, 0.8394, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2834, 4g4sG, 0.8394, 1.91, 0.336, 243, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2835, 3e47T, 0.8394, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2836, 3e47F, 0.8394, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2837, 4jsuT, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2838, 4hrcT, 0.8393, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2839, 4gk7F, 0.8393, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2840, 3gpjT, 0.8393, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2841, 2fakT, 0.8393, 1.91, 0.336, 243, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2842, 2fakF, 0.8393, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2843, 1g65F, 0.8393, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2844, 1g0uT, 0.8393, 1.89, 0.332, 244, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2845, 4v7oG, 0.8392, 1.90, 0.332, 244, 226, 
2846, 4gk7T, 0.8392, 1.89, 0.336, 242, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2847, 4fzcF, 0.8392, 1.90, 0.336, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2848, 3gpjF, 0.8392, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2849, 2zcyT, 0.8392, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2850, 2gplF, 0.8392, 1.90, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2851, 1jd2F, 0.8392, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2852, 1g65T, 0.8392, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2853, 5vfqCA, 0.8391, 1.90, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2854, 5vfpY, 0.8391, 1.90, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2855, 4v7oU, 0.8391, 1.90, 0.336, 244, 226, 
2856, 4fzcT, 0.8391, 1.90, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2857, 3okjF, 0.8391, 1.90, 0.336, 246, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2858, 3dy4T, 0.8391, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2859, 3dy4F, 0.8391, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2860, 3bdmT, 0.8391, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2861, 3bdmF, 0.8391, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2862, 2zcyF, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2863, 2gplT, 0.8391, 1.91, 0.336, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2864, 4v7oCB, 0.8390, 1.90, 0.341, 244, 226, 
2865, 3un4T, 0.8390, 1.90, 0.341, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2866, 3un4F, 0.8390, 1.89, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2867, 3shjT, 0.8390, 1.90, 0.336, 242, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2868, 3shjF, 0.8390, 1.92, 0.341, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2869, 3okjT, 0.8390, 1.91, 0.332, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2870, 3mg4T, 0.8390, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2871, 4v7oOA, 0.8389, 1.91, 0.336, 244, 226, 
2872, 4eu2U, 0.8389, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2873, 5m32T, 0.8388, 1.91, 0.332, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2874, 1jd21, 0.8388, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2875, 5vfoM, 0.8387, 1.89, 0.336, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2876, 5vfpBA, 0.8386, 1.93, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2877, 3mg8F, 0.8385, 1.98, 0.360, 240, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2878, 1z7qU, 0.8385, 1.92, 0.341, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2879, 1z7qG, 0.8385, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2880, 5wviNA, 0.8384, 1.90, 0.332, 244, 226, 
2881, 2f16T, 0.8383, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2882, 2f16F, 0.8383, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2883, 5t0gG, 0.8382, 1.91, 0.332, 244, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2884, 5vfrj, 0.8381, 1.91, 0.332, 244, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2885, 3oevF, 0.8381, 1.91, 0.336, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2886, 3oeuF, 0.8381, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2887, 3mg8T, 0.8381, 1.92, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2888, 3mg7F, 0.8381, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2889, 2ku2C, 0.8381, 1.91, 0.332, 244, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2890, 3oevT, 0.8379, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2891, 3mg6T, 0.8379, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2892, 5vfqG, 0.8378, 1.91, 0.332, 244, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2893, 3mg7T, 0.8378, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2894, 3oeuT, 0.8377, 1.92, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2895, 3mg6F, 0.8377, 1.92, 0.341, 244, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2896, 5wviH, 0.8376, 2.31, 0.288, 240, 229, 
2897, 5m32F, 0.8376, 1.91, 0.336, 244, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2898, 5m32B, 0.8376, 1.96, 0.286, 240, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2899, 6epfC, 0.8373, 1.93, 0.336, 239, 229, GROUND STATE 26S PROTEASOME (GS1)
2900, 5wviCA, 0.8372, 1.85, 0.329, 237, 225, 
2901, 4eu2O, 0.8372, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2902, 5vfpG, 0.8371, 1.92, 0.336, 243, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2903, 5t0jI, 0.8368, 2.29, 0.361, 245, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2904, 5t0hK, 0.8368, 1.92, 0.336, 244, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2905, 5a5bE, 0.8367, 1.92, 0.341, 244, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2906, 4cr3E, 0.8367, 1.97, 0.360, 240, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2907, 3wxrG, 0.8367, 1.94, 0.336, 239, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2908, 5wviBA, 0.8366, 1.87, 0.329, 237, 225, 
2909, 5nifA, 0.8365, 1.86, 0.333, 237, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2910, 5mpag, 0.8365, 1.86, 0.329, 237, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2911, 4zzgA, 0.8365, 1.86, 0.329, 237, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2912, 3sdkU, 0.8365, 1.81, 0.396, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2913, 6epcA, 0.8364, 1.86, 0.329, 237, 225, GROUND STATE 26S PROTEASOME (GS2)
2914, 3jcpPA, 0.8364, 1.86, 0.329, 237, 225, 
2915, 3mg4U, 0.8363, 1.97, 0.286, 240, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2916, 3mg7U, 0.8362, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2917, 5vfuX, 0.8360, 1.86, 0.329, 237, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2918, 5vfuFA, 0.8360, 1.87, 0.329, 237, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2919, 5vftM, 0.8360, 1.94, 0.308, 243, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2920, 5vftg, 0.8360, 1.87, 0.292, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2921, 5vfom, 0.8360, 2.07, 0.354, 234, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2922, 5d0wU, 0.8360, 2.47, 0.361, 249, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2923, 5d0wG, 0.8360, 2.30, 0.356, 245, 233, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2924, 3jcpP, 0.8360, 1.83, 0.311, 241, 225, 
2925, 5vfsG, 0.8359, 1.98, 0.286, 240, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2926, 5vfrM, 0.8359, 2.04, 0.352, 250, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2927, 4ya4U, 0.8359, 1.79, 0.329, 228, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2928, 4qv9U, 0.8359, 2.22, 0.328, 243, 229, YCP BETA5-C63F MUTANT
2929, 4qv9G, 0.8359, 2.22, 0.328, 243, 229, YCP BETA5-C63F MUTANT
2930, 3sdkF, 0.8359, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2931, 5l5bU, 0.8358, 1.90, 0.326, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2932, 5l5bG, 0.8358, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2933, 5czaU, 0.8358, 1.94, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2934, 4ya4G, 0.8358, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2935, 5fggU, 0.8357, 1.84, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2936, 5fggG, 0.8357, 2.03, 0.360, 246, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2937, 5dsvH, 0.8357, 1.93, 0.341, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2938, 5czaG, 0.8357, 1.84, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2939, 4y8rU, 0.8357, 1.85, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2940, 4y8rG, 0.8357, 1.90, 0.296, 240, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2941, 4qv3U, 0.8357, 2.05, 0.360, 240, 228, YCP BETA5-M45V MUTANT
2942, 4qv3G, 0.8357, 1.90, 0.296, 240, 226, YCP BETA5-M45V MUTANT
2943, 4no9U, 0.8357, 2.05, 0.360, 240, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2944, 4no9G, 0.8357, 1.88, 0.296, 240, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2945, 3sdiU, 0.8357, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2946, 3mg6U, 0.8357, 1.86, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2947, 5l55U, 0.8356, 1.93, 0.341, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2948, 5l55G, 0.8356, 1.94, 0.341, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2949, 5fg7U, 0.8356, 1.90, 0.296, 240, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2950, 5fg7G, 0.8356, 1.99, 0.286, 240, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2951, 5ahjU, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2952, 4ya1U, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2953, 4nnnU, 0.8356, 1.86, 0.307, 241, 225, YCP IN COMPLEX WITH MG132
2954, 4eu2A, 0.8356, 1.83, 0.335, 236, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2955, 3wxrU, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2956, 3wxrO, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2957, 6epdC, 0.8355, 1.86, 0.307, 241, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2958, 5gjqG, 0.8355, 1.86, 0.307, 241, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2959, 5cggU, 0.8355, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2960, 5cgfU, 0.8355, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2961, 5cgfG, 0.8355, 1.94, 0.289, 239, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2962, 5ahjG, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2963, 4ya1G, 0.8355, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2964, 4quyU, 0.8355, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2965, 4quyG, 0.8355, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2966, 4nnnG, 0.8355, 1.86, 0.307, 241, 225, YCP IN COMPLEX WITH MG132
2967, 4hnpU, 0.8355, 1.86, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2968, 3un8U, 0.8355, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2969, 3mg8U, 0.8355, 1.85, 0.311, 240, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2970, 1fntU, 0.8355, 1.96, 0.310, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2971, 1fntG, 0.8355, 1.86, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2972, 5vfoL, 0.8354, 1.86, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2973, 5fgaU, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2974, 5cggG, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2975, 5bxlU, 0.8354, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2976, 4no8U, 0.8354, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2977, 4no8G, 0.8354, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2978, 4g4sA, 0.8354, 1.86, 0.307, 241, 225, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2979, 3sdkT, 0.8354, 1.88, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2980, 1g0uU, 0.8354, 1.86, 0.311, 243, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2981, 5l5rU, 0.8353, 2.07, 0.361, 249, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2982, 5l5rG, 0.8353, 1.69, 0.317, 238, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2983, 5jhrU, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2984, 5jhrG, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2985, 5fgaG, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2986, 5d0sU, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2987, 5bxlG, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2988, 4qwlU, 0.8353, 1.86, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2989, 4qwlG, 0.8353, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2990, 4qv7U, 0.8353, 1.86, 0.311, 241, 225, YCP BETA5-A50V MUTANT
2991, 4qv7G, 0.8353, 1.86, 0.311, 243, 225, YCP BETA5-A50V MUTANT
2992, 4ltcU, 0.8353, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2993, 4j70U, 0.8353, 1.97, 0.310, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2994, 3oevG, 0.8353, 1.97, 0.336, 240, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2995, 5vfqFA, 0.8352, 1.97, 0.336, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2996, 5t0cY, 0.8352, 1.70, 0.317, 238, 224, 
2997, 5t0cEB, 0.8352, 1.87, 0.307, 241, 225, 
2998, 5l5uU, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2999, 5l52U, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3000, 5l52G, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3001, 5d0sG, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3002, 5bxnU, 0.8352, 2.12, 0.308, 241, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3003, 4y8hU, 0.8352, 1.84, 0.330, 236, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3004, 4y8hG, 0.8352, 1.86, 0.307, 240, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3005, 4qz6U, 0.8352, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3006, 4no1U, 0.8352, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3007, 4no1G, 0.8352, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3008, 4hrcU, 0.8352, 1.86, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3009, 3oeuU, 0.8352, 1.87, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3010, 6gopU, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3011, 5t0gJ, 0.8351, 1.87, 0.307, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3012, 5nifO, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3013, 5l5uG, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3014, 5bxnG, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3015, 4ya7U, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3016, 4qz6G, 0.8351, 1.86, 0.311, 243, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3017, 4qwuU, 0.8351, 1.87, 0.307, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3018, 4qwuG, 0.8351, 1.86, 0.307, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3019, 4qv6U, 0.8351, 2.00, 0.286, 240, 227, YCP BETA5-A49V MUTANT
3020, 4qv5U, 0.8351, 1.95, 0.360, 240, 228, YCP BETA5-M45I MUTANT
3021, 4qv1U, 0.8351, 2.04, 0.295, 240, 227, YCP BETA5-M45A MUTANT
3022, 4qv1G, 0.8351, 2.04, 0.295, 240, 227, YCP BETA5-M45A MUTANT
3023, 4qv0U, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3024, 4qv0G, 0.8351, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3025, 4q1sU, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3026, 4hrdU, 0.8351, 1.86, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3027, 1rypO, 0.8351, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3028, 5vfpEA, 0.8350, 1.87, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3029, 4zzgO, 0.8350, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3030, 4z1lU, 0.8350, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3031, 4ya7G, 0.8350, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3032, 4y9yU, 0.8350, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3033, 4y9yG, 0.8350, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3034, 4y8pU, 0.8350, 1.97, 0.310, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3035, 4y8pG, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3036, 4y8mU, 0.8350, 1.99, 0.332, 239, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3037, 4y8mG, 0.8350, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3038, 4r17U, 0.8350, 1.87, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3039, 4r17G, 0.8350, 1.87, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3040, 4qzzU, 0.8350, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3041, 4qzzG, 0.8350, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3042, 4qz0U, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3043, 4qvnU, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3044, 4qv6G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
3045, 4qv5G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45I MUTANT
3046, 4qv4U, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3047, 4qv4G, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3048, 3gpjU, 0.8350, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3049, 3gpjG, 0.8350, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3050, 6gopG, 0.8349, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3051, 5l6aU, 0.8349, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3052, 5l6aG, 0.8349, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3053, 5fg9U, 0.8349, 2.00, 0.286, 240, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3054, 5d0zU, 0.8349, 1.88, 0.307, 242, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3055, 5d0zG, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3056, 4z1lG, 0.8349, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3057, 4qz0G, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3058, 4qvnG, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3059, 4qv8U, 0.8349, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT
3060, 4qv8G, 0.8349, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT
3061, 4j70G, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3062, 3un4U, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3063, 3oevU, 0.8349, 1.87, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3064, 3jcpJA, 0.8349, 1.88, 0.307, 241, 225, 
3065, 3jcpJ, 0.8349, 1.87, 0.307, 241, 225, 
3066, 2ku1B, 0.8349, 1.87, 0.307, 241, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3067, 1g65U, 0.8349, 1.86, 0.311, 241, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3068, 5vfsFA, 0.8348, 1.87, 0.307, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3069, 5fgfU, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3070, 5fgfG, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3071, 5fg9G, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3072, 5cz9U, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3073, 5cz9G, 0.8348, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3074, 4y9zU, 0.8348, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3075, 4y9zG, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3076, 4x6zO, 0.8348, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3077, 4r00U, 0.8348, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3078, 4r00G, 0.8348, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3079, 4fzgU, 0.8348, 1.87, 0.311, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3080, 3un4G, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3081, 3tddU, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3082, 3tddG, 0.8348, 1.86, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3083, 3nzjU, 0.8348, 1.87, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3084, 5mpaG, 0.8347, 1.87, 0.307, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3085, 5fhsU, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3086, 4y8sU, 0.8347, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3087, 4y8sG, 0.8347, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3088, 4y8gU, 0.8347, 1.98, 0.310, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3089, 4y75U, 0.8347, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3090, 4qz5U, 0.8347, 1.87, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3091, 4qz5G, 0.8347, 1.87, 0.307, 243, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3092, 4qz3U, 0.8347, 1.89, 0.400, 237, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3093, 4qw1U, 0.8347, 1.88, 0.307, 243, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3094, 4qvlU, 0.8347, 1.92, 0.296, 240, 226, YCP IN COMPLEX WITH BORTEZOMIB
3095, 4no6U, 0.8347, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3096, 4jsuU, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3097, 4jsuG, 0.8347, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3098, 3nzjG, 0.8347, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3099, 3mg0U, 0.8347, 1.87, 0.311, 241, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3100, 3gpwU, 0.8347, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3101, 3gptU, 0.8347, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3102, 1jd22, 0.8347, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3103, 1g0uG, 0.8347, 1.87, 0.307, 241, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3104, 5l6bU, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3105, 5l6bG, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3106, 5jhsU, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3107, 5jhsG, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3108, 5fhsG, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3109, 5d0vU, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3110, 5cz8U, 0.8346, 1.96, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3111, 4ya2U, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3112, 4ya2G, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3113, 4y8tU, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3114, 4y8tG, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3115, 4y8kU, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3116, 4y8gG, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3117, 4y75G, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3118, 4qz3G, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3119, 4qw7U, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3120, 4qw5U, 0.8346, 1.88, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3121, 4qw5G, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3122, 4qw1G, 0.8346, 1.87, 0.311, 243, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3123, 4qvlG, 0.8346, 1.87, 0.311, 243, 225, YCP IN COMPLEX WITH BORTEZOMIB
3124, 4qltU, 0.8346, 1.87, 0.311, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3125, 4no6G, 0.8346, 1.87, 0.311, 243, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3126, 4lqiU, 0.8346, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3127, 4jt0U, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3128, 4jt0G, 0.8346, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3129, 4jsqU, 0.8346, 1.87, 0.307, 240, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3130, 4intU, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3131, 4fzgG, 0.8346, 1.88, 0.307, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3132, 3shjU, 0.8346, 1.87, 0.311, 241, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3133, 3nzxU, 0.8346, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3134, 3mg4G, 0.8346, 1.87, 0.307, 241, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3135, 3gptG, 0.8346, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3136, 1rypA, 0.8346, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3137, 5vfrl, 0.8345, 1.88, 0.311, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3138, 5lttU, 0.8345, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3139, 5lttG, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3140, 5l63U, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3141, 5l61U, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3142, 5l5aU, 0.8345, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3143, 5l5aG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3144, 5d0vG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3145, 5cz8G, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3146, 5cz7U, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3147, 5cz6U, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3148, 5cz6G, 0.8345, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3149, 4ya9U, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3150, 4y8lU, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3151, 4y8lG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3152, 4y8kG, 0.8345, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3153, 4y77U, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3154, 4y77G, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3155, 4y70U, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3156, 4y70G, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3157, 4v7oO, 0.8345, 1.87, 0.311, 243, 225, 
3158, 4v7oIA, 0.8345, 1.88, 0.311, 243, 225, 
3159, 4v7oA, 0.8345, 1.88, 0.307, 243, 225, 
3160, 4qz4U, 0.8345, 1.87, 0.307, 243, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3161, 4qw7G, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3162, 4qw6U, 0.8345, 1.88, 0.307, 243, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3163, 4qvyU, 0.8345, 1.72, 0.317, 238, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3164, 4qvyG, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3165, 4qvpU, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3166, 4quxU, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3167, 4quxG, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3168, 4qltG, 0.8345, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3169, 4nnwU, 0.8345, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3170, 4nnwG, 0.8345, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3171, 4jsqG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3172, 4inrU, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3173, 3un8G, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3174, 3shjG, 0.8345, 1.88, 0.307, 241, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3175, 3sdkG, 0.8345, 1.87, 0.311, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3176, 3nzxG, 0.8345, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3177, 3mg7G, 0.8345, 1.87, 0.311, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3178, 3gpwG, 0.8345, 1.87, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3179, 3bdmU, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3180, 3bdmG, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3181, 5t0jG, 0.8344, 1.87, 0.311, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3182, 5l63G, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3183, 5l61G, 0.8344, 1.92, 0.341, 244, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3184, 5l5oU, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3185, 5l5oG, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3186, 5l5hU, 0.8344, 1.85, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3187, 5l5hG, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3188, 5l5dU, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3189, 5l5dG, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3190, 5cz7G, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3191, 5cgiU, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3192, 4ya9G, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3193, 4y7wU, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3194, 4y7wG, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3195, 4v7oWA, 0.8344, 1.88, 0.307, 241, 225, 
3196, 4qz4G, 0.8344, 1.87, 0.311, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3197, 4qw6G, 0.8344, 1.88, 0.311, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3198, 4qvpG, 0.8344, 1.88, 0.311, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3199, 4lqiG, 0.8344, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3200, 3nzwU, 0.8344, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3201, 3mg6G, 0.8344, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3202, 3hyeU, 0.8344, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3203, 5l67U, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3204, 5l67G, 0.8343, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3205, 5l66U, 0.8343, 1.99, 0.305, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3206, 5l65U, 0.8343, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3207, 5l65G, 0.8343, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3208, 5l64U, 0.8343, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3209, 5l62U, 0.8343, 1.97, 0.355, 240, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3210, 5l62G, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3211, 5l5pU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3212, 5l5fU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3213, 5l5fG, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3214, 5l54U, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3215, 5fgeU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3216, 5fgeG, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3217, 5cgiG, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3218, 4y8uU, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3219, 4y8uG, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3220, 4y8jU, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3221, 4y7yU, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3222, 4qzwU, 0.8343, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3223, 4qwrU, 0.8343, 1.88, 0.307, 243, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3224, 4qwrG, 0.8343, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3225, 4qwjU, 0.8343, 1.87, 0.311, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3226, 4qluU, 0.8343, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3227, 4qluG, 0.8343, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3228, 4qlsU, 0.8343, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3229, 4qlsG, 0.8343, 1.88, 0.307, 243, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3230, 3nzwG, 0.8343, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3231, 3hyeG, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3232, 3e47U, 0.8343, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3233, 5l6cU, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3234, 5l6cG, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3235, 5l66G, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3236, 5l64G, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3237, 5l5wU, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3238, 5l5pG, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3239, 5l54G, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3240, 5cghU, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3241, 5cghG, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3242, 4y8jG, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3243, 4y82U, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3244, 4y7yG, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3245, 4y74U, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3246, 4qzwG, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3247, 4qz7U, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3248, 4qwjG, 0.8342, 1.87, 0.311, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3249, 4qvwU, 0.8342, 1.87, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3250, 4qvwG, 0.8342, 1.87, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3251, 3wxrA, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3252, 3okjU, 0.8342, 1.88, 0.311, 241, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3253, 3oeuG, 0.8342, 1.87, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3254, 3e47G, 0.8342, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3255, 5vfrL, 0.8341, 1.88, 0.311, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3256, 5l5xU, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3257, 5l5xG, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3258, 5l5wG, 0.8341, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3259, 5l5eU, 0.8341, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3260, 5l5eG, 0.8341, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3261, 4y8qU, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3262, 4y8qG, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3263, 4y82G, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3264, 4y74G, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3265, 4r02U, 0.8341, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3266, 4qzxU, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3267, 4qzxG, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3268, 4qz7G, 0.8341, 1.87, 0.311, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3269, 4qwxU, 0.8341, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3270, 4qwxG, 0.8341, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3271, 4qwiU, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3272, 4qbyU, 0.8341, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3273, 4inrG, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3274, 4fzcU, 0.8341, 1.87, 0.311, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3275, 3okjG, 0.8341, 1.88, 0.307, 241, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3276, 3d29U, 0.8341, 1.87, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3277, 3d29G, 0.8341, 1.88, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3278, 2fakU, 0.8341, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3279, 5t0gM, 0.8340, 1.88, 0.307, 243, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3280, 5m32G, 0.8340, 1.89, 0.307, 243, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3281, 5m2bU, 0.8340, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3282, 5m2bG, 0.8340, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3283, 5lajU, 0.8340, 1.72, 0.317, 238, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3284, 5l5tU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3285, 5l5tG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3286, 5fgiU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3287, 5fgiG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3288, 5d0tU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3289, 5d0tG, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3290, 5cz5U, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3291, 5cz5G, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3292, 4y80U, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3293, 4y80G, 0.8340, 1.99, 0.310, 241, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3294, 4y6vU, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3295, 4y6vG, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3296, 4y6aU, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3297, 4qz2U, 0.8340, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3298, 4qwiG, 0.8340, 1.88, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3299, 4qbyG, 0.8340, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3300, 2fakG, 0.8340, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3301, 5lajG, 0.8339, 1.88, 0.311, 243, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3302, 5l5sU, 0.8339, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3303, 5l5sG, 0.8339, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3304, 5l5qU, 0.8339, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3305, 5l5qG, 0.8339, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3306, 4y84U, 0.8339, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3307, 4y84G, 0.8339, 2.04, 0.295, 240, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3308, 4y7xU, 0.8339, 2.00, 0.358, 233, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3309, 4y7xG, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3310, 4y6aG, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3311, 4y69U, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3312, 4y69G, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3313, 4r18U, 0.8339, 1.88, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3314, 4qz2G, 0.8339, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3315, 4qlqU, 0.8339, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3316, 4qlqG, 0.8339, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3317, 4ltcG, 0.8339, 1.88, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3318, 4inuU, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3319, 4intG, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3320, 4fzcG, 0.8339, 1.88, 0.311, 241, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3321, 3sdiG, 0.8339, 1.88, 0.311, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3322, 2gplU, 0.8339, 1.89, 0.307, 241, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3323, 2f16U, 0.8339, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3324, 1g65G, 0.8339, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3325, 5vfqF, 0.8338, 1.88, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3326, 5l5zU, 0.8338, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3327, 5l5vU, 0.8338, 1.88, 0.307, 241, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3328, 5l5vG, 0.8338, 1.89, 0.307, 243, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3329, 5l5jU, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3330, 5l5jG, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3331, 5fgdU, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3332, 5fgdG, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3333, 5dkjU, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3334, 4r18G, 0.8338, 1.89, 0.311, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3335, 4qwkU, 0.8338, 1.89, 0.311, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3336, 4qwfU, 0.8338, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3337, 4qvqU, 0.8338, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3338, 4qvqG, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3339, 4qlvU, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3340, 4qlvG, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3341, 2gplG, 0.8338, 1.89, 0.307, 241, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3342, 5vfqEA, 0.8337, 1.88, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3343, 5mpbD, 0.8337, 1.89, 0.311, 241, 225, 
3344, 5l68U, 0.8337, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3345, 5l5zG, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3346, 5l5iU, 0.8337, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3347, 5l5iG, 0.8337, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3348, 5dkjG, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3349, 5bouU, 0.8337, 1.89, 0.307, 240, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3350, 5bouG, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3351, 4y8nU, 0.8337, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3352, 4y8nG, 0.8337, 1.89, 0.307, 243, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3353, 4y6zU, 0.8337, 2.00, 0.286, 240, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3354, 4y6zG, 0.8337, 1.72, 0.317, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3355, 4rurU, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3356, 4rurG, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3357, 4qwkG, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3358, 4qwfG, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3359, 4qw0U, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3360, 4q1sG, 0.8337, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3361, 4inuG, 0.8337, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3362, 3mg8G, 0.8337, 1.89, 0.307, 241, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3363, 3dy3U, 0.8337, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3364, 3dy3G, 0.8337, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3365, 2f16G, 0.8337, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3366, 5l68G, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3367, 4y8iU, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3368, 4y8iG, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3369, 4qw0G, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3370, 4gk7U, 0.8336, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3371, 5d0xU, 0.8335, 1.73, 0.317, 238, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3372, 4ya5U, 0.8335, 2.00, 0.358, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3373, 4ya5G, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3374, 4y78U, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3375, 4y78G, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3376, 4qxjU, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3377, 4qxjG, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3378, 4qw4U, 0.8335, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3379, 4qw4G, 0.8335, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3380, 4qvvU, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3381, 4qvvG, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3382, 4gk7G, 0.8335, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3383, 5laiU, 0.8334, 1.88, 0.311, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3384, 5laiG, 0.8334, 1.89, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3385, 5l60U, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3386, 5l5yU, 0.8334, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3387, 5l5yG, 0.8334, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3388, 5d0xG, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3389, 4qz1U, 0.8334, 1.90, 0.307, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3390, 4qz1G, 0.8334, 1.89, 0.311, 243, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3391, 3dy4U, 0.8334, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3392, 3dy4G, 0.8334, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3393, 6avoG, 0.8333, 1.91, 0.307, 243, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3394, 5vfuLA, 0.8333, 1.89, 0.311, 243, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3395, 5vftm, 0.8333, 1.89, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3396, 5vfsEA, 0.8333, 1.88, 0.311, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3397, 5l60G, 0.8333, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3398, 4qvmU, 0.8333, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3399, 6avoL, 0.8332, 1.88, 0.311, 243, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3400, 5l69U, 0.8332, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3401, 4x6zA, 0.8332, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3402, 4qvmG, 0.8332, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3403, 4hnpG, 0.8332, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3404, 3unfS, 0.8332, 1.88, 0.311, 241, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3405, 2zcyU, 0.8332, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3406, 2zcyG, 0.8332, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3407, 5vfsF, 0.8331, 1.88, 0.311, 241, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3408, 5vfol, 0.8331, 1.88, 0.311, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3409, 5t0iI, 0.8331, 1.89, 0.307, 241, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3410, 5l69G, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3411, 5cz4U, 0.8331, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3412, 4ya3U, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3413, 4ya3G, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3414, 4y81U, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3415, 4y81G, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3416, 4cr2G, 0.8331, 1.89, 0.307, 241, 225, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3417, 3unfE, 0.8331, 1.89, 0.307, 241, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3418, 3unbS, 0.8331, 1.88, 0.311, 241, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3419, 1iruT, 0.8331, 1.88, 0.311, 241, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3420, 1iruF, 0.8331, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3421, 5cz4G, 0.8330, 1.91, 0.307, 243, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3422, 4y8oU, 0.8330, 1.73, 0.317, 234, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3423, 4qwsU, 0.8330, 1.94, 0.296, 240, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3424, 4hrdG, 0.8330, 1.94, 0.296, 240, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3425, 3unbu, 0.8330, 1.72, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3426, 5vfrm, 0.8329, 1.89, 0.307, 241, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3427, 4y8oG, 0.8329, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3428, 4qwsG, 0.8329, 1.73, 0.317, 234, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3429, 1jd2G, 0.8329, 1.89, 0.307, 241, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3430, 6epdB, 0.8328, 1.90, 0.307, 242, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3431, 5vfpDA, 0.8328, 1.89, 0.307, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3432, 5fghU, 0.8328, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3433, 5fghG, 0.8328, 1.72, 0.312, 238, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3434, 4ya0U, 0.8328, 1.91, 0.307, 243, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3435, 3unhS, 0.8328, 1.92, 0.307, 243, 225, MOUSE 20S IMMUNOPROTEASOME
3436, 3unhE, 0.8328, 1.92, 0.296, 240, 226, MOUSE 20S IMMUNOPROTEASOME
3437, 5vfpF, 0.8327, 1.72, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3438, 4ya0G, 0.8327, 1.74, 0.317, 238, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3439, 4hrcG, 0.8327, 2.38, 0.352, 250, 233, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3440, 4r02G, 0.8326, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3441, 6epeA, 0.8325, 1.90, 0.307, 241, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3442, 4qw3U, 0.8325, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3443, 4qw3G, 0.8324, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3444, 3j9iU, 0.8324, 1.89, 0.311, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3445, 3j9iT, 0.8324, 1.89, 0.311, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3446, 3j9iS, 0.8324, 2.14, 0.335, 245, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3447, 3j9iR, 0.8324, 1.72, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3448, 3j9iQ, 0.8324, 1.73, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3449, 3j9iP, 0.8324, 1.74, 0.317, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3450, 3j9iO, 0.8324, 1.74, 0.317, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3451, 3j9iG, 0.8324, 1.90, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3452, 3j9iF, 0.8324, 1.89, 0.311, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3453, 3j9iE, 0.8324, 1.89, 0.307, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3454, 3j9iD, 0.8324, 1.90, 0.311, 243, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3455, 3j9iC, 0.8324, 1.73, 0.312, 238, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3456, 3j9iB, 0.8324, 2.03, 0.286, 240, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3457, 3j9iA, 0.8324, 1.89, 0.311, 241, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3458, 5mp9a, 0.8323, 1.89, 0.307, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3459, 4r3oF, 0.8323, 1.90, 0.311, 243, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3460, 5dkiU, 0.8322, 2.20, 0.603, 234, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3461, 5dkiG, 0.8322, 1.74, 0.317, 238, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3462, 4r67v, 0.8322, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3463, 4r67F, 0.8322, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3464, 4r67T, 0.8321, 1.90, 0.307, 241, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3465, 4r67h, 0.8321, 1.73, 0.312, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3466, 4r3oT, 0.8321, 1.73, 0.312, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3467, 5mp9A, 0.8320, 1.74, 0.317, 238, 224, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3468, 4qwgU, 0.8320, 1.90, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3469, 4qwgG, 0.8320, 1.90, 0.311, 243, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3470, 5dsvJ, 0.8317, 1.91, 0.307, 241, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3471, 5lf4E, 0.8316, 2.10, 0.354, 246, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3472, 5lf0E, 0.8316, 1.90, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3473, 3mg0G, 0.8316, 1.90, 0.307, 241, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3474, 5vftL, 0.8315, 1.67, 0.403, 224, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3475, 5t0jM, 0.8315, 1.67, 0.403, 224, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3476, 5vfuW, 0.8314, 1.67, 0.403, 224, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3477, 5lf4S, 0.8314, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3478, 5lf0S, 0.8314, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3479, 5lf6E, 0.8313, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3480, 5lexS, 0.8313, 1.67, 0.403, 224, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3481, 3uneu, 0.8313, 1.67, 0.403, 224, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
3482, 5leyE, 0.8312, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3483, 5lf7S, 0.8311, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3484, 5lf7E, 0.8311, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3485, 3uneE, 0.8311, 1.67, 0.403, 224, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
3486, 5lf6S, 0.8310, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3487, 5lf1E, 0.8310, 1.67, 0.403, 224, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3488, 5lexE, 0.8310, 1.98, 0.305, 241, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3489, 5wvkBA, 0.8309, 1.74, 0.317, 238, 224, 
3490, 5lf3E, 0.8309, 1.90, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3491, 5lf1S, 0.8309, 1.90, 0.307, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3492, 5le5S, 0.8309, 1.75, 0.317, 238, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3493, 3uneS, 0.8309, 1.75, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3494, 3unbg, 0.8309, 1.75, 0.317, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3495, 5lf3S, 0.8308, 1.75, 0.317, 238, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3496, 5mpbU, 0.8307, 1.74, 0.317, 238, 224, 
3497, 5leyS, 0.8307, 1.96, 0.305, 241, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3498, 5le5E, 0.8307, 1.91, 0.311, 241, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3499, 5vfuKA, 0.8306, 1.91, 0.311, 241, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3500, 5lezS, 0.8306, 1.94, 0.290, 239, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3501, 5vftl, 0.8305, 1.69, 0.318, 233, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3502, 3uneg, 0.8305, 1.69, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME
3503, 5lezE, 0.8304, 1.92, 0.307, 243, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3504, 3jcoPA, 0.8304, 1.74, 0.317, 238, 224, 
3505, 5a5bG, 0.8303, 1.91, 0.296, 240, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3506, 4cr3G, 0.8303, 1.74, 0.317, 238, 224, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3507, 3unbE, 0.8303, 1.70, 0.318, 237, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3508, 3jcoP, 0.8303, 1.70, 0.318, 237, 223, 
3509, 1ya7F, 0.8303, 1.70, 0.318, 233, 223, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3510, 5wvkU, 0.8300, 1.70, 0.318, 235, 223, 
3511, 5mpcD, 0.8300, 1.76, 0.312, 238, 224, 
3512, 5a0qP, 0.8299, 1.70, 0.318, 233, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3513, 5a0qB, 0.8299, 1.70, 0.318, 237, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3514, 3jcoJA, 0.8298, 1.70, 0.318, 233, 223, 
3515, 1yauF, 0.8298, 1.76, 0.312, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3516, 5t0hJ, 0.8296, 1.70, 0.318, 237, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3517, 5mpaa, 0.8296, 1.70, 0.318, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3518, 3jcoJ, 0.8296, 1.70, 0.318, 233, 223, 
3519, 1ya7G, 0.8296, 1.99, 0.332, 244, 226, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3520, 5mpcG, 0.8295, 1.71, 0.318, 233, 223, 
3521, 5ln3C, 0.8295, 1.70, 0.318, 237, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3522, 5mpcU, 0.8294, 1.70, 0.318, 237, 223, 
3523, 1yauG, 0.8294, 1.76, 0.312, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3524, 1yauA, 0.8293, 1.76, 0.312, 238, 224, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3525, 1yauC, 0.8292, 1.71, 0.318, 237, 223, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3526, 1ya7C, 0.8292, 2.01, 0.332, 243, 226, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3527, 3jseG, 0.8289, 1.71, 0.318, 235, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3528, 3jseF, 0.8288, 1.71, 0.318, 233, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3529, 3jseB, 0.8287, 1.77, 0.317, 238, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3530, 2ku2G, 0.8287, 1.71, 0.318, 237, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3531, 5t0hM, 0.8286, 1.77, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3532, 3jseA, 0.8286, 1.76, 0.312, 238, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3533, 2ku1D, 0.8286, 1.71, 0.318, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3534, 1yauB, 0.8286, 2.02, 0.341, 244, 226, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3535, 3jseD, 0.8285, 2.07, 0.336, 245, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3536, 3jseC, 0.8285, 2.07, 0.336, 245, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3537, 5ln3G, 0.8284, 1.77, 0.312, 238, 224, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3538, 3jseE, 0.8284, 2.02, 0.341, 244, 226, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3539, 2ku2F, 0.8282, 2.02, 0.341, 244, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3540, 2ku2D, 0.8282, 1.64, 0.412, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3541, 2ku1F, 0.8282, 2.14, 0.330, 244, 227, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3542, 1ya7B, 0.8282, 2.19, 0.363, 240, 226, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3543, 5mpcR, 0.8280, 1.10, 0.631, 214, 214, 
3544, 2ku1C, 0.8280, 1.10, 0.631, 214, 214, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3545, 6epcC, 0.8278, 1.95, 0.307, 243, 225, GROUND STATE 26S PROTEASOME (GS2)
3546, 1ya7D, 0.8278, 1.54, 0.414, 222, 220, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3547, 1ya7A, 0.8278, 2.03, 0.336, 239, 229, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3548, 5mpaf, 0.8277, 1.93, 0.311, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3549, 5lezG, 0.8277, 1.95, 0.307, 243, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3550, 5lexG, 0.8277, 1.95, 0.307, 243, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3551, 1yauD, 0.8277, 1.65, 0.412, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3552, 5wviI, 0.8275, 2.43, 0.336, 243, 229, 
3553, 1yarG, 0.8275, 2.27, 0.359, 261, 231, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3554, 1yarC, 0.8275, 2.30, 0.342, 243, 228, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3555, 6epfA, 0.8274, 1.57, 0.414, 222, 220, GROUND STATE 26S PROTEASOME (GS1)
3556, 1yarF, 0.8272, 1.55, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3557, 4g4sF, 0.8271, 1.56, 0.414, 222, 220, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3558, 2ku2E, 0.8271, 1.65, 0.412, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3559, 6epfD, 0.8269, 1.65, 0.412, 227, 221, GROUND STATE 26S PROTEASOME (GS1)
3560, 5lf0G, 0.8269, 1.66, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3561, 5leyG, 0.8269, 1.66, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3562, 1yarD, 0.8269, 1.77, 0.401, 237, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3563, 5wvkV, 0.8268, 2.39, 0.288, 240, 229, 
3564, 4cr2A, 0.8268, 1.66, 0.412, 227, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3565, 2ku1E, 0.8268, 1.91, 0.404, 237, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3566, 5lf3G, 0.8267, 1.57, 0.414, 222, 220, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3567, 5dsvM, 0.8267, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3568, 5t0jK, 0.8266, 1.66, 0.412, 227, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3569, 5m32S, 0.8266, 2.06, 0.291, 242, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3570, 2ku1G, 0.8266, 1.66, 0.412, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3571, 5mpbG, 0.8265, 1.82, 0.401, 237, 222, 
3572, 5le5G, 0.8263, 1.81, 0.401, 237, 222, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3573, 1yarB, 0.8263, 1.81, 0.401, 237, 222, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3574, 5lf7G, 0.8262, 1.67, 0.412, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3575, 1z7qO, 0.8262, 2.05, 0.363, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3576, 5lf1G, 0.8261, 1.85, 0.401, 237, 222, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3577, 3c92U, 0.8261, 2.71, 0.359, 249, 234, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3578, 3c92T, 0.8261, 1.67, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3579, 3c92S, 0.8261, 1.68, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3580, 3c92R, 0.8261, 1.64, 0.285, 231, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3581, 3c92Q, 0.8261, 1.87, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3582, 3c92P, 0.8261, 1.88, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3583, 3c92O, 0.8261, 1.58, 0.414, 222, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3584, 3c92G, 0.8261, 1.96, 0.350, 242, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3585, 3c92F, 0.8261, 1.53, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3586, 3c92E, 0.8261, 1.52, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3587, 3c92D, 0.8261, 2.07, 0.355, 246, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3588, 3c92C, 0.8261, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3589, 3c92B, 0.8261, 1.65, 0.285, 234, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3590, 3c92A, 0.8261, 1.68, 0.403, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3591, 1z7qA, 0.8261, 2.16, 0.330, 246, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3592, 1fntO, 0.8261, 1.89, 0.368, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3593, 4cr4G, 0.8260, 1.89, 0.368, 241, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3594, 5m32E, 0.8259, 1.53, 0.416, 221, 219, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3595, 5lf6G, 0.8259, 2.08, 0.310, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3596, 5lf4G, 0.8259, 2.03, 0.305, 243, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3597, 3jrmA, 0.8259, 1.70, 0.403, 237, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3598, 1fntA, 0.8259, 1.89, 0.368, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3599, 5vy3Y, 0.8258, 1.81, 0.297, 239, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3600, 5vy3W, 0.8258, 1.90, 0.330, 228, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3601, 5vy3U, 0.8258, 2.00, 0.311, 238, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3602, 5vy3S, 0.8258, 1.72, 0.403, 237, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3603, 5vy3Q, 0.8258, 2.06, 0.336, 243, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3604, 5vy3O, 0.8258, 1.90, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3605, 5vy3M, 0.8258, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3606, 5vy3K, 0.8258, 1.90, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3607, 5vy3I, 0.8258, 2.18, 0.300, 243, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3608, 5vy3G, 0.8258, 1.90, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3609, 5vy3E, 0.8258, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3610, 5vy3C, 0.8258, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3611, 5vy3A, 0.8258, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3612, 5vy30, 0.8258, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3613, 4zzgT, 0.8258, 1.77, 0.403, 224, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3614, 3jrmG, 0.8258, 1.77, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3615, 3jrmC, 0.8258, 1.77, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3616, 3jrmB, 0.8258, 1.77, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3617, 5t0hG, 0.8257, 1.77, 0.403, 224, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3618, 3jrmF, 0.8257, 1.77, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3619, 3jrmD, 0.8257, 1.77, 0.403, 224, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3620, 1yarA, 0.8257, 1.77, 0.403, 224, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3621, 3c91U, 0.8256, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3622, 3c91T, 0.8256, 1.77, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3623, 3c91S, 0.8256, 2.18, 0.300, 243, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3624, 3c91R, 0.8256, 2.02, 0.302, 238, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3625, 3c91Q, 0.8256, 2.22, 0.335, 245, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3626, 3c91P, 0.8256, 2.02, 0.311, 234, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3627, 3c91O, 0.8256, 1.90, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3628, 3c91G, 0.8256, 1.90, 0.368, 241, 223, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3629, 3c91F, 0.8256, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3630, 3c91E, 0.8256, 2.02, 0.302, 238, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3631, 3c91D, 0.8256, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3632, 3c91C, 0.8256, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3633, 3c91B, 0.8256, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3634, 3c91A, 0.8256, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3635, 5nifT, 0.8255, 1.55, 0.411, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3636, 3mg8S, 0.8254, 1.55, 0.411, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3637, 3jrmE, 0.8254, 1.55, 0.411, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3638, 6epeB, 0.8253, 1.55, 0.411, 221, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3639, 1yauE, 0.8253, 1.55, 0.411, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3640, 3dy3S, 0.8252, 1.55, 0.411, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3641, 3dy3E, 0.8252, 1.55, 0.411, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3642, 4zzgF, 0.8251, 1.55, 0.411, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3643, 3sdkE, 0.8251, 1.55, 0.411, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3644, 5vy4Y, 0.8250, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3645, 5vy4W, 0.8250, 1.83, 0.284, 232, 222, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3646, 5vy4U, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3647, 5vy4S, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3648, 5vy4Q, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3649, 5vy4O, 0.8250, 2.15, 0.360, 240, 228, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3650, 5vy4M, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3651, 5vy4K, 0.8250, 1.70, 0.412, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3652, 5vy4I, 0.8250, 1.56, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3653, 5vy4G, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3654, 5vy4E, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3655, 5vy4C, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3656, 5vy4AA, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3657, 5vy4A, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3658, 5vy40, 0.8250, 1.75, 0.403, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3659, 5mp9F, 0.8250, 1.75, 0.403, 227, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3660, 4hnpS, 0.8250, 1.75, 0.403, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3661, 4intE, 0.8248, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3662, 4hnpE, 0.8248, 1.75, 0.403, 227, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3663, 4fzgS, 0.8248, 1.75, 0.403, 227, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3664, 4fzgE, 0.8248, 1.75, 0.403, 227, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3665, 3bdmS, 0.8248, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3666, 3bdmE, 0.8248, 1.75, 0.403, 227, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3667, 4intS, 0.8247, 1.84, 0.284, 232, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3668, 3gpjE, 0.8247, 1.84, 0.284, 233, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3669, 5nifF, 0.8246, 1.71, 0.412, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3670, 4gk7S, 0.8246, 2.00, 0.612, 234, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3671, 4gk7E, 0.8246, 1.63, 0.414, 222, 220, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3672, 3gpjS, 0.8246, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3673, 3dy4E, 0.8246, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3674, 2zcyS, 0.8246, 1.67, 0.285, 232, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3675, 2zcyE, 0.8246, 1.85, 0.284, 233, 222, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3676, 4hrdS, 0.8245, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3677, 4fzcE, 0.8245, 1.55, 0.416, 221, 219, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3678, 3dy4S, 0.8245, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3679, 3d29S, 0.8245, 1.55, 0.416, 221, 219, PROTEASOME INHIBITION BY FELLUTAMIDE B
3680, 3d29E, 0.8245, 1.55, 0.416, 221, 219, PROTEASOME INHIBITION BY FELLUTAMIDE B
3681, 4fzcS, 0.8244, 1.55, 0.416, 221, 219, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3682, 3sdkS, 0.8244, 1.55, 0.416, 221, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3683, 3jtlG, 0.8244, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3684, 3jtlC, 0.8244, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3685, 3jtlB, 0.8244, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3686, 1z7qF, 0.8244, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3687, 4hrdE, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3688, 3jtlD, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3689, 3jtlA, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3690, 1z7qT, 0.8243, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3691, 3nzjS, 0.8242, 1.55, 0.416, 221, 219, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3692, 3nzjE, 0.8242, 1.82, 0.284, 233, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3693, 3jtlF, 0.8242, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3694, 5wvkO, 0.8241, 1.68, 0.285, 233, 221, 
3695, 4lqiS, 0.8241, 1.67, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3696, 4lqiE, 0.8241, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3697, 3un8E, 0.8241, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3698, 4eu2F, 0.8240, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3699, 3un8S, 0.8240, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3700, 3sdiE, 0.8240, 1.68, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3701, 3jtlE, 0.8240, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3702, 6bdfY, 0.8239, 1.68, 0.285, 232, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3703, 6bdfW, 0.8239, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3704, 6bdfU, 0.8239, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3705, 6bdfS, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3706, 6bdfQ, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3707, 6bdfO, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3708, 6bdfM, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3709, 6bdfK, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3710, 6bdfI, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3711, 6bdfG, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3712, 6bdfE, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3713, 6bdfC, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3714, 6bdfA, 0.8239, 1.69, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3715, 6bdf0, 0.8239, 1.68, 0.285, 233, 221, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3716, 3oeuE, 0.8239, 1.73, 0.412, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3717, 3mg6S, 0.8239, 1.73, 0.412, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3718, 5lajS, 0.8238, 1.73, 0.412, 227, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3719, 5lajE, 0.8238, 1.69, 0.285, 234, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3720, 4j70S, 0.8237, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3721, 4j70E, 0.8237, 1.74, 0.412, 227, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3722, 3mg8E, 0.8237, 1.73, 0.412, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3723, 1yarE, 0.8237, 1.69, 0.285, 234, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3724, 1ya7E, 0.8237, 1.69, 0.285, 233, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3725, 4r18S, 0.8236, 1.69, 0.285, 233, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3726, 4r18E, 0.8236, 1.74, 0.412, 227, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3727, 4jt0S, 0.8236, 2.00, 0.302, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3728, 4jt0E, 0.8236, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3729, 4jsqS, 0.8236, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3730, 4jsqE, 0.8236, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3731, 3un4E, 0.8236, 1.69, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3732, 3mg7E, 0.8236, 1.69, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3733, 3mg0S, 0.8236, 1.68, 0.285, 230, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3734, 3mg0E, 0.8236, 1.74, 0.412, 227, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3735, 5t0gL, 0.8235, 1.58, 0.416, 221, 219, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3736, 5l6cS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3737, 5l6cE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3738, 5l5zS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3739, 5l5zE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3740, 5l5uS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3741, 5l5uE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3742, 5l5tS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3743, 5l5tE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3744, 5l5sS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3745, 5l5sE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3746, 5dkjS, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3747, 5dkjE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3748, 4q1sE, 0.8235, 1.58, 0.416, 221, 219, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3749, 4jsuS, 0.8235, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3750, 4jsuE, 0.8235, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3751, 3un4S, 0.8235, 1.69, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3752, 3mg7S, 0.8235, 1.69, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3753, 1pmaO, 0.8235, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3754, 1pmaD, 0.8235, 1.69, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3755, 1fntF, 0.8235, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3756, 6epfG, 0.8234, 1.59, 0.416, 221, 219, GROUND STATE 26S PROTEASOME (GS1)
3757, 5lttS, 0.8234, 1.75, 0.412, 227, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3758, 5lttE, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3759, 5l69S, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3760, 5l69E, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3761, 5l67S, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3762, 5l67E, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3763, 5l62S, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3764, 5l62E, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3765, 5l61S, 0.8234, 1.87, 0.284, 233, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3766, 5l61E, 0.8234, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3767, 5l60S, 0.8234, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3768, 5l60E, 0.8234, 1.85, 0.317, 238, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3769, 5l5vS, 0.8234, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3770, 5l5vE, 0.8234, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3771, 5l5qS, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3772, 5l5qE, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3773, 5l5pS, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3774, 5l5pE, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3775, 5l5jS, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3776, 5l5jE, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3777, 5cz7S, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3778, 5cz7E, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3779, 4x6zF, 0.8234, 1.69, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3780, 4qw0S, 0.8234, 1.69, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3781, 4qw0E, 0.8234, 1.70, 0.285, 233, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3782, 4hrcE, 0.8234, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3783, 1fntT, 0.8234, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3784, 5l64S, 0.8233, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3785, 5l64E, 0.8233, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3786, 5l63S, 0.8233, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3787, 5l63E, 0.8233, 1.59, 0.406, 221, 219, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3788, 5l5oS, 0.8233, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3789, 5l5oE, 0.8233, 2.15, 0.288, 245, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3790, 5l5iE, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3791, 5l5hS, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3792, 5l5hE, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3793, 5cz6S, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3794, 4qvyS, 0.8233, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3795, 4qvyE, 0.8233, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3796, 4inrE, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3797, 3wxrF, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3798, 3mg6E, 0.8233, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3799, 2fakE, 0.8233, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3800, 1rypF, 0.8233, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3801, 5l6bS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3802, 5l6bE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3803, 5l68S, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3804, 5l68E, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3805, 5l66S, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3806, 5l66E, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3807, 5l65S, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3808, 5l65E, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3809, 5l5yS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3810, 5l5xS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3811, 5l5xE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3812, 5l5wS, 0.8232, 1.70, 0.285, 232, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3813, 5l5wE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3814, 5l5iS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3815, 5l5fS, 0.8232, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3816, 5l5fE, 0.8232, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3817, 5l5eS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3818, 5l5aS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3819, 5l5aE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3820, 5fgaS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3821, 5fgaE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3822, 5dkiS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3823, 5dkiE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3824, 5d0tS, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3825, 5d0tE, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3826, 5cz6E, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3827, 4x6zT, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3828, 4qzzS, 0.8232, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3829, 4qzzE, 0.8232, 1.70, 0.285, 233, 221, YCP IN COMPLEX WITH OMURALIDE
3830, 4qz6S, 0.8232, 1.70, 0.285, 232, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3831, 4qz6E, 0.8232, 1.70, 0.285, 233, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3832, 4qvvS, 0.8232, 1.71, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3833, 4qvvE, 0.8232, 1.69, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3834, 4ltcE, 0.8232, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3835, 3shjE, 0.8232, 1.70, 0.285, 231, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3836, 3nzwS, 0.8232, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3837, 3nzwE, 0.8232, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3838, 2fakS, 0.8232, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3839, 6gopS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3840, 6gopE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3841, 5wviAA, 0.8231, 1.70, 0.285, 231, 221, 
3842, 5l6aS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3843, 5l6aE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3844, 5l5yE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3845, 5l5eE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3846, 5l5dS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3847, 5l5dE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3848, 5fghS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3849, 5fghE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3850, 5fgfS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3851, 5fgfE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3852, 5fg9S, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3853, 5fg9E, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3854, 5d0xS, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3855, 5d0xE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3856, 5cgfE, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3857, 4y70S, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3858, 4y70E, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3859, 4qvlS, 0.8231, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3860, 4qvlE, 0.8231, 1.71, 0.285, 232, 221, YCP IN COMPLEX WITH BORTEZOMIB
3861, 4nnnS, 0.8231, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3862, 3shjS, 0.8231, 1.70, 0.285, 231, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3863, 3oevE, 0.8231, 1.70, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3864, 3hyeS, 0.8231, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3865, 3hyeE, 0.8231, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3866, 1pmaN, 0.8231, 1.70, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3867, 1pmaJ, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3868, 1pmaH, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3869, 1pmaF, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3870, 5mpaA, 0.8230, 1.70, 0.285, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3871, 5m2bS, 0.8230, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3872, 5m2bE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3873, 5l5rS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3874, 5l5rE, 0.8230, 2.00, 0.350, 242, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3875, 5l5bS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3876, 5l5bE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3877, 5fg7S, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3878, 5fg7E, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3879, 5czaS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3880, 5czaE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3881, 5cgfS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3882, 5bouS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3883, 5bouE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3884, 4y9zS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3885, 4y9zE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3886, 4y8uS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3887, 4y8uE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3888, 4y8rS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3889, 4y7wS, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3890, 4y7wE, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3891, 4y69S, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3892, 4y69E, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3893, 4r00S, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3894, 4r00E, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3895, 4qz5S, 0.8230, 1.70, 0.285, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3896, 4qz5E, 0.8230, 1.70, 0.285, 233, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3897, 4qz3S, 0.8230, 1.70, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3898, 4qz3E, 0.8230, 1.70, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3899, 4qvwS, 0.8230, 1.59, 0.406, 221, 219, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3900, 4qvwE, 0.8230, 1.59, 0.406, 221, 219, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3901, 4qv6S, 0.8230, 1.59, 0.406, 221, 219, YCP BETA5-A49V MUTANT
3902, 4qv6E, 0.8230, 1.59, 0.406, 221, 219, YCP BETA5-A49V MUTANT
3903, 4qv0S, 0.8230, 2.08, 0.310, 241, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3904, 4qv0E, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3905, 4quxS, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3906, 4quxE, 0.8230, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3907, 4nnnE, 0.8230, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3908, 3oeuS, 0.8230, 1.71, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3909, 3gpwS, 0.8230, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3910, 3gpwE, 0.8230, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3911, 3gptE, 0.8230, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3912, 2gplS, 0.8230, 1.71, 0.285, 231, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3913, 2gplE, 0.8230, 1.71, 0.285, 231, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3914, 5cz9S, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3915, 5cz9E, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3916, 5bxlS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3917, 5bxlE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3918, 4ya7S, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3919, 4ya7E, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3920, 4ya5S, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3921, 4ya5E, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3922, 4y9yS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3923, 4y9yE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3924, 4y8rE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3925, 4y8mS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3926, 4y8mE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3927, 4y8jS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3928, 4y8jE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3929, 4y7yS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3930, 4y7yE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3931, 4y74S, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3932, 4y74E, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3933, 4y6vS, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3934, 4y6vE, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3935, 4y6aS, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3936, 4y6aE, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3937, 4qwjS, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3938, 4qwjE, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3939, 4qvpS, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3940, 4qvpE, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3941, 4qvmS, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3942, 4qvmE, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3943, 4qv8S, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-C52F MUTANT
3944, 4qv8E, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-C52F MUTANT
3945, 4qv7S, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-A50V MUTANT
3946, 4qv7E, 0.8229, 1.71, 0.285, 233, 221, YCP BETA5-A50V MUTANT
3947, 4quyS, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3948, 4quyE, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3949, 4nnwS, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3950, 4nnwE, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3951, 4ltcS, 0.8229, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3952, 4inrS, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3953, 3nzxS, 0.8229, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3954, 3nzxE, 0.8229, 1.70, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3955, 3mg4E, 0.8229, 1.71, 0.285, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3956, 3gptS, 0.8229, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3957, 1pmaM, 0.8229, 1.71, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3958, 1pmaL, 0.8229, 1.71, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3959, 1pmaG, 0.8229, 1.71, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3960, 1pmaE, 0.8229, 1.71, 0.285, 231, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3961, 5mp9f, 0.8228, 1.71, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3962, 5laiE, 0.8228, 1.70, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3963, 5jhrE, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3964, 5fggS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3965, 5fggE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3966, 5fgeS, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3967, 5fgeE, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3968, 5fgdS, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3969, 5fgdE, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3970, 5cghS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3971, 5cghE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3972, 4ya4E, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3973, 4ya1S, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3974, 4ya1E, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3975, 4y8nS, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3976, 4y8nE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3977, 4y8iE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3978, 4y80S, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3979, 4y80E, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3980, 4rurS, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3981, 4rurE, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3982, 4r02E, 0.8228, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3983, 4qwuE, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3984, 4qwiS, 0.8228, 1.71, 0.285, 233, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3985, 4qwiE, 0.8228, 1.71, 0.285, 233, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3986, 4qv9S, 0.8228, 1.71, 0.285, 233, 221, YCP BETA5-C63F MUTANT
3987, 4qv9E, 0.8228, 1.71, 0.285, 233, 221, YCP BETA5-C63F MUTANT
3988, 3e47S, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3989, 3e47E, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3990, 1pmaI, 0.8228, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3991, 1pmaC, 0.8228, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3992, 1pmaA, 0.8228, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3993, 5laiS, 0.8227, 1.59, 0.406, 221, 219, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3994, 5jhsS, 0.8227, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3995, 5jhsE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3996, 5jhrS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3997, 5fhsS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3998, 5fhsE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3999, 5fgiS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4000, 5fgiE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4001, 5d0wS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4002, 5d0wE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4003, 5cz8S, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4004, 5cz8E, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4005, 5cggS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4006, 5cggE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4007, 5bxnS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4008, 5bxnE, 0.8227, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4009, 4z1lS, 0.8227, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4010, 4z1lE, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4011, 4ya4S, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4012, 4y8lS, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4013, 4y8lE, 0.8227, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4014, 4y8iS, 0.8227, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4015, 4qwuS, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4016, 4qwkS, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4017, 4qwkE, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4018, 4qw7S, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4019, 4qw7E, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4020, 4qw4S, 0.8227, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
4021, 4qw4E, 0.8227, 1.71, 0.285, 233, 221, YCP IN COMPLEX WITH CARFILZOMIB
4022, 4qw1E, 0.8227, 1.71, 0.285, 233, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4023, 4qvqS, 0.8227, 1.60, 0.406, 221, 219, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4024, 4qvqE, 0.8227, 1.60, 0.406, 221, 219, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4025, 4qvnE, 0.8227, 1.60, 0.406, 221, 219, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4026, 4qv1S, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT
4027, 4qv1E, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT
4028, 3jcpOA, 0.8227, 1.71, 0.285, 231, 221, 
4029, 3jcpO, 0.8227, 1.71, 0.285, 231, 221, 
4030, 1g65E, 0.8227, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4031, 5d0vS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4032, 5d0vE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4033, 5d0sS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4034, 5d0sE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4035, 5cz4S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4036, 5cz4E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4037, 4ya9S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4038, 4ya9E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4039, 4ya3S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4040, 4ya3E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4041, 4ya0S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4042, 4ya0E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4043, 4y8pS, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4044, 4y8pE, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4045, 4y78S, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4046, 4y78E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4047, 4y77E, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4048, 4r17S, 0.8226, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4049, 4r17E, 0.8226, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4050, 4r02S, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4051, 4qzwS, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4052, 4qzwE, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4053, 4qz4S, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4054, 4qz4E, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4055, 4qwrS, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4056, 4qwrE, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4057, 4qw1S, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4058, 4qvnS, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4059, 4no9S, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4060, 4no9E, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4061, 4eu2T, 0.8226, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4062, 3tddS, 0.8226, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4063, 3tddE, 0.8226, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4064, 1pmaK, 0.8226, 1.71, 0.285, 233, 221, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4065, 5cz5S, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4066, 5cz5E, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4067, 4y7xS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4068, 4y7xE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4069, 4y77S, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4070, 4y75S, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4071, 4y75E, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4072, 4y6zS, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4073, 4y6zE, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4074, 4qz7S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4075, 4qz7E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4076, 4qw6S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4077, 4qw6E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4078, 4qw5S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4079, 4qw5E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4080, 4qw3S, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4081, 4qw3E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4082, 4qv3E, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4083, 4no1S, 0.8225, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4084, 4no1E, 0.8225, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4085, 2f16E, 0.8225, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4086, 5d0zS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4087, 5d0zE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4088, 4y8qS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4089, 4y8qE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4090, 4y8oS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4091, 4y8oE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4092, 4y8kS, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4093, 4y8kE, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4094, 4y82S, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4095, 4y82E, 0.8224, 1.71, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4096, 4qwlS, 0.8224, 1.71, 0.285, 233, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4097, 4qwlE, 0.8224, 1.71, 0.285, 233, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4098, 4qv4S, 0.8224, 1.60, 0.406, 221, 219, YCP BETA5-M45T MUTANT
4099, 4qv4E, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4100, 4qv3S, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4101, 2f16S, 0.8224, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4102, 5cgiS, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4103, 5cgiE, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4104, 4y81S, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4105, 4y81E, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4106, 4qwfS, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4107, 4qwfE, 0.8223, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4108, 4no8S, 0.8223, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4109, 4no8E, 0.8223, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4110, 4hrcS, 0.8223, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4111, 1rypT, 0.8223, 1.71, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4112, 5vfoJ, 0.8222, 1.71, 0.285, 231, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4113, 5l52S, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4114, 5l52E, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4115, 4y8tS, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4116, 4y8tE, 0.8222, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4117, 4qxjS, 0.8222, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4118, 4qxjE, 0.8222, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4119, 4qlqS, 0.8222, 1.71, 0.285, 233, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4120, 4qlqE, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4121, 3wxrT, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4122, 4y8sS, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4123, 4y8sE, 0.8221, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4124, 4qzxS, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4125, 4qzxE, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4126, 4qz1S, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4127, 4qz1E, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4128, 4qz0S, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4129, 4qz0E, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4130, 4qwxS, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4131, 4qwxE, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4132, 4qwsS, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4133, 4qwsE, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4134, 4qv5S, 0.8221, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4135, 4qv5E, 0.8221, 1.72, 0.285, 233, 221, YCP BETA5-M45I MUTANT
4136, 4q1sS, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4137, 4inuE, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4138, 5l55S, 0.8220, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4139, 5l55E, 0.8220, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4140, 5a0qS, 0.8220, 1.72, 0.285, 231, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4141, 5a0qE, 0.8220, 1.72, 0.285, 231, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4142, 4qz2S, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4143, 4qz2E, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4144, 4qwgS, 0.8220, 1.72, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4145, 4qwgE, 0.8220, 1.71, 0.285, 233, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4146, 3oevS, 0.8220, 2.04, 0.338, 239, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4147, 1g0uE, 0.8220, 1.72, 0.285, 231, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4148, 4no6E, 0.8219, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4149, 3mg4S, 0.8219, 1.72, 0.285, 231, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4150, 5ln3D, 0.8218, 1.72, 0.285, 231, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4151, 4y84S, 0.8218, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4152, 4y84E, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4153, 4no6S, 0.8218, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4154, 3okjS, 0.8218, 1.72, 0.285, 231, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4155, 3okjE, 0.8218, 1.72, 0.285, 232, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4156, 5mpaF, 0.8217, 1.72, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4157, 5l54S, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4158, 5l54E, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4159, 5ahjS, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4160, 5ahjE, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4161, 4y8hS, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4162, 4y8hE, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4163, 4y8gS, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4164, 4y8gE, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4165, 4qlsS, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4166, 4qlsE, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4167, 4inuS, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4168, 3sdiS, 0.8217, 1.72, 0.285, 231, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4169, 1g65S, 0.8217, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4170, 5t0iG, 0.8216, 1.72, 0.285, 233, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4171, 4ya2S, 0.8215, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4172, 4ya2E, 0.8215, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4173, 4qluS, 0.8214, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4174, 4qluE, 0.8214, 1.31, 0.349, 215, 215, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4175, 4qltS, 0.8214, 1.31, 0.349, 215, 215, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4176, 4qltE, 0.8214, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4177, 4qbyS, 0.8214, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4178, 4qbyE, 0.8214, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4179, 4v7oT, 0.8213, 1.72, 0.285, 231, 221, 
4180, 4v7oBB, 0.8213, 1.72, 0.285, 233, 221, 
4181, 5vfqD, 0.8212, 1.72, 0.285, 230, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4182, 4v7oNA, 0.8212, 1.73, 0.285, 231, 221, 
4183, 4v7oF, 0.8212, 1.73, 0.285, 233, 221, 
4184, 4qlvS, 0.8211, 2.22, 0.322, 248, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4185, 4qlvE, 0.8211, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4186, 6epfE, 0.8210, 1.72, 0.285, 231, 221, GROUND STATE 26S PROTEASOME (GS1)
4187, 6epeC, 0.8210, 1.73, 0.285, 231, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4188, 5a5bF, 0.8207, 1.73, 0.285, 233, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4189, 4cr3F, 0.8207, 1.73, 0.285, 233, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4190, 5vfrJ, 0.8204, 1.87, 0.284, 233, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4191, 4cr4A, 0.8203, 1.73, 0.285, 231, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4192, 5wvkT, 0.8202, 1.73, 0.285, 231, 221, 
4193, 5mpbF, 0.8202, 1.73, 0.285, 231, 221, 
4194, 1jd2E, 0.8201, 1.73, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4195, 1g0uS, 0.8198, 1.72, 0.285, 231, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4196, 6epdA, 0.8188, 1.72, 0.285, 231, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4197, 5vfpD, 0.8187, 1.72, 0.285, 231, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4198, 5t0hL, 0.8187, 1.72, 0.285, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4199, 1jd2Z, 0.8187, 1.72, 0.285, 231, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4200, 5mpbA, 0.8186, 1.72, 0.285, 231, 221, 
4201, 6epeG, 0.8184, 1.72, 0.285, 233, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4202, 6epfF, 0.8183, 1.72, 0.285, 230, 221, GROUND STATE 26S PROTEASOME (GS1)
4203, 5mpcO, 0.8183, 1.73, 0.285, 233, 221, 
4204, 5fmgS, 0.8180, 2.20, 0.351, 240, 228, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4205, 5fmgE, 0.8180, 1.73, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4206, 5t0jL, 0.8179, 1.73, 0.285, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4207, 5fmgP, 0.8177, 1.73, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4208, 5fmgB, 0.8177, 1.73, 0.285, 231, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4209, 5lezU, 0.8176, 1.73, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4210, 5lexU, 0.8175, 1.73, 0.285, 231, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4211, 5lf0U, 0.8172, 1.73, 0.285, 231, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4212, 5mpbO, 0.8171, 1.73, 0.285, 231, 221, 
4213, 5lf3U, 0.8171, 1.74, 0.285, 234, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4214, 5lf7U, 0.8169, 1.74, 0.285, 234, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4215, 5leyU, 0.8168, 1.57, 0.321, 228, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4216, 5mpbT, 0.8166, 2.05, 0.338, 239, 225, 
4217, 5lf1U, 0.8166, 1.75, 0.285, 234, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4218, 5lf6U, 0.8165, 1.74, 0.285, 234, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4219, 5t0iK, 0.8162, 1.73, 0.285, 231, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4220, 6epeF, 0.8161, 1.73, 0.285, 231, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4221, 5lf4U, 0.8161, 2.16, 0.323, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4222, 5ln3A, 0.8160, 2.30, 0.335, 249, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4223, 6epcG, 0.8158, 1.88, 0.284, 233, 222, GROUND STATE 26S PROTEASOME (GS2)
4224, 5wviX, 0.8158, 1.88, 0.284, 233, 222, 
4225, 3jcoOA, 0.8150, 2.06, 0.338, 239, 225, 
4226, 3jcoO, 0.8150, 2.23, 0.304, 243, 227, 
4227, 5t0iL, 0.8149, 1.84, 0.284, 233, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4228, 5dsvC, 0.8143, 1.91, 0.284, 231, 222, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4229, 5wviY, 0.8141, 1.74, 0.285, 233, 221, 
4230, 6epcF, 0.8140, 1.75, 0.285, 230, 221, GROUND STATE 26S PROTEASOME (GS2)
4231, 5wvkAA, 0.8140, 2.20, 0.348, 246, 227, 
4232, 6epeD, 0.8135, 1.74, 0.317, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4233, 6epcE, 0.8132, 2.04, 0.338, 239, 225, GROUND STATE 26S PROTEASOME (GS2)
4234, 4g4sD, 0.8129, 1.98, 0.317, 238, 224, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4235, 5wviD, 0.8120, 1.77, 0.285, 233, 221, 
4236, 6epdG, 0.8117, 2.07, 0.307, 241, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4237, 5mpcA, 0.8115, 2.24, 0.295, 245, 227, 
4238, 5wviF, 0.8112, 1.98, 0.308, 238, 224, 
4239, 4v7oR, 0.8112, 2.06, 0.311, 241, 225, 
4240, 4v7oLA, 0.8112, 1.59, 0.332, 217, 217, 
4241, 4v7oZA, 0.8111, 1.59, 0.332, 217, 217, 
4242, 4v7oD, 0.8111, 1.93, 0.317, 238, 224, 
4243, 5mpcT, 0.8102, 1.27, 0.528, 212, 212, 
4244, 4cr2F, 0.8100, 1.27, 0.528, 212, 212, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4245, 5le5U, 0.8099, 1.99, 0.367, 235, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4246, 3ipmF, 0.8086, 2.01, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4247, 3ipmE, 0.8086, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4248, 3ipmD, 0.8086, 2.10, 0.311, 241, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4249, 3ipmC, 0.8086, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4250, 3ipmB, 0.8086, 2.00, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4251, 3ipmA, 0.8086, 2.01, 0.367, 235, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4252, 3ipmG, 0.8085, 1.91, 0.284, 233, 222, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4253, 5t0iM, 0.8074, 2.00, 0.367, 235, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4254, 5mpcF, 0.8058, 2.01, 0.367, 235, 221, 
4255, 5a5bA, 0.8051, 2.07, 0.320, 228, 225, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4256, 4cr3A, 0.8051, 2.06, 0.308, 238, 224, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4257, 5fmgQ, 0.8043, 2.01, 0.367, 235, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4258, 5fmgC, 0.8043, 2.23, 0.360, 239, 228, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4259, 4cr4F, 0.8041, 2.46, 0.284, 245, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4260, 5t0jH, 0.8039, 2.22, 0.341, 245, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4261, 6epcD, 0.8034, 1.84, 0.281, 233, 221, GROUND STATE 26S PROTEASOME (GS2)
4262, 5fmgO, 0.8030, 1.84, 0.281, 233, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4263, 5fmgA, 0.8030, 1.84, 0.281, 233, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4264, 5t0jJ, 0.8014, 2.01, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4265, 5ln3F, 0.8010, 1.82, 0.297, 234, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4266, 6epeE, 0.8002, 2.15, 0.305, 243, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4267, 5fmgT, 0.8001, 2.17, 0.307, 238, 225, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4268, 5fmgF, 0.8001, 1.97, 0.284, 233, 222, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4269, 6epdE, 0.7925, 2.14, 0.333, 246, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4270, 5a0qR, 0.7924, 2.24, 0.323, 233, 226, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4271, 5a0qD, 0.7924, 1.52, 0.379, 220, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4272, 5wviZ, 0.7920, 1.34, 1.000, 250, 250, 
4273, 5wviG, 0.7917, 2.17, 0.305, 243, 226, 
4274, 6epdF, 0.7908, 2.57, 0.281, 245, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4275, 5t0iJ, 0.7906, 2.16, 0.304, 241, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4276, 5fmgR, 0.7871, 2.27, 0.341, 245, 226, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4277, 5fmgD, 0.7871, 1.59, 0.353, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4278, 6epdD, 0.7869, 1.59, 0.353, 227, 215, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4279, 5fmgU, 0.7858, 1.59, 0.353, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4280, 5fmgG, 0.7858, 1.59, 0.353, 227, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4281, 5ts0G, 0.7790, 1.93, 0.285, 233, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4282, 5a0qU, 0.7781, 2.04, 0.284, 233, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4283, 5a0qG, 0.7781, 1.88, 0.372, 232, 218, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4284, 5trgP, 0.7775, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4285, 5trsA, 0.7757, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4286, 5thoS, 0.7751, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4287, 5trgA, 0.7744, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4288, 5trrA, 0.7738, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4289, 5thoG, 0.7738, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4290, 5tryA, 0.7737, 1.96, 0.412, 227, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4291, 5trsP, 0.7737, 2.40, 0.295, 240, 227, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4292, 5ts0A, 0.7730, 2.09, 0.284, 231, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4293, 5thoA, 0.7730, 2.36, 0.310, 243, 226, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4294, 5trrP, 0.7726, 2.36, 0.310, 243, 226, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4295, 3mi0F, 0.7726, 1.62, 0.347, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4296, 5ts0T, 0.7724, 1.62, 0.347, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4297, 5tryS, 0.7723, 2.09, 0.284, 233, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4298, 5trsC, 0.7723, 2.25, 0.596, 232, 225, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4299, 5tryQ, 0.7722, 2.55, 0.330, 246, 230, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4300, 5trsD, 0.7722, 1.84, 0.312, 219, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4301, 3mfeI, 0.7722, 1.84, 0.312, 219, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4302, 3mkaA, 0.7721, 2.28, 0.338, 239, 225, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4303, 5ts0U, 0.7720, 2.14, 0.315, 233, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4304, 5ts0Q, 0.7720, 2.57, 0.320, 233, 228, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4305, 3h6iQ, 0.7718, 1.61, 0.324, 219, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4306, 5tryF, 0.7716, 1.61, 0.324, 219, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4307, 5trgS, 0.7714, 2.61, 0.322, 233, 227, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4308, 3mkaU, 0.7714, 1.61, 0.341, 214, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4309, 5ts0B, 0.7713, 1.61, 0.341, 214, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4310, 5trrS, 0.7712, 2.11, 0.285, 233, 221, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4311, 2fhgW, 0.7712, 2.11, 0.285, 233, 221, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4312, 2fhgF, 0.7712, 2.36, 0.308, 238, 224, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4313, 5trgO, 0.7711, 2.42, 0.316, 239, 225, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4314, 2fhgU, 0.7711, 1.62, 0.388, 215, 209, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4315, 2fhgQ, 0.7711, 1.62, 0.388, 215, 209, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4316, 2fhgM, 0.7711, 2.67, 0.330, 246, 230, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4317, 2fhgI, 0.7711, 2.13, 0.231, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4318, 2fhgD, 0.7711, 2.13, 0.231, 219, 216, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4319, 2fhgB, 0.7711, 2.13, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4320, 2fhgA, 0.7711, 1.67, 0.304, 209, 207, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4321, 2fhg1, 0.7711, 1.67, 0.304, 209, 207, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4322, 5ts0E, 0.7710, 2.08, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4323, 5thoE, 0.7710, 2.12, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4324, 2fhgY, 0.7710, 2.29, 0.181, 221, 216, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4325, 2fhgS, 0.7710, 2.07, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4326, 2fhgO, 0.7710, 2.08, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4327, 2fhgK, 0.7709, 2.09, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4328, 5ts0C, 0.7708, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4329, 5ts0P, 0.7707, 2.17, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4330, 5trrT, 0.7706, 2.10, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4331, 5trrE, 0.7706, 2.10, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4332, 5trsU, 0.7705, 2.22, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4333, 5trrU, 0.7705, 2.34, 0.182, 220, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4334, 3mfeK, 0.7705, 2.12, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4335, 5trsS, 0.7704, 2.19, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4336, 3mkaF, 0.7704, 2.14, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4337, 5tryP, 0.7703, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4338, 5thoO, 0.7703, 2.13, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4339, 3mkaM, 0.7703, 2.04, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4340, 5trsE, 0.7702, 2.38, 0.181, 222, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4341, 5ts0S, 0.7701, 2.06, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4342, 5ts0D, 0.7701, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4343, 3h6iF, 0.7701, 2.22, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4344, 2fhhW, 0.7701, 2.13, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4345, 2fhhO, 0.7700, 2.15, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4346, 2fhhD, 0.7700, 2.40, 0.181, 221, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4347, 3hfaB, 0.7699, 2.03, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4348, 2fhhU, 0.7699, 2.14, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4349, 2fhhS, 0.7699, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4350, 2fhhM, 0.7699, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4351, 2fhhF, 0.7699, 2.13, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4352, 2fhhB, 0.7699, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4353, 2fhhA, 0.7699, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4354, 5ts0R, 0.7698, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4355, 5trgU, 0.7698, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4356, 2fhhY, 0.7698, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4357, 2fhhQ, 0.7698, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4358, 2fhhK, 0.7698, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4359, 2fhhI, 0.7698, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4360, 5tryU, 0.7697, 2.14, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4361, 5trgE, 0.7697, 2.14, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4362, 2fhh1, 0.7697, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4363, 5trsB, 0.7695, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4364, 5trrC, 0.7695, 2.31, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4365, 5thoU, 0.7695, 2.32, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4366, 5trsT, 0.7694, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4367, 5trrO, 0.7694, 2.16, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4368, 5tryE, 0.7693, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4369, 5thoT, 0.7692, 2.08, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4370, 5thoF, 0.7692, 2.02, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4371, 5tryD, 0.7691, 2.01, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4372, 5thoR, 0.7691, 2.02, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4373, 5thoC, 0.7691, 2.16, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4374, 5tryR, 0.7689, 2.30, 0.182, 221, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4375, 3mkaS, 0.7689, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4376, 3h6fQ, 0.7688, 2.15, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4377, 5trgT, 0.7687, 2.50, 0.181, 224, 216, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4378, 3mkaB, 0.7687, 2.09, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4379, 5trsO, 0.7686, 2.18, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4380, 5trrD, 0.7685, 2.10, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4381, 3mfeB, 0.7685, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4382, 5thoP, 0.7683, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4383, 5lzpD, 0.7683, 2.33, 0.181, 220, 215, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4384, 3h6fW, 0.7683, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4385, 5trrG, 0.7682, 1.92, 0.187, 214, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4386, 3mkaW, 0.7682, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4387, 3h6iW, 0.7682, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4388, 3mkaK, 0.7681, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4389, 3h6fF, 0.7681, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4390, 5trgQ, 0.7680, 2.34, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4391, 3h6iK, 0.7679, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4392, 5tryC, 0.7676, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4393, 5trsQ, 0.7676, 2.03, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4394, 5trsG, 0.7676, 2.34, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4395, 5thoQ, 0.7676, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4396, 2h6jB, 0.7676, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4397, 5ts0O, 0.7675, 2.33, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4398, 5tryT, 0.7675, 2.03, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4399, 3h6iA, 0.7675, 2.16, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4400, 5trgD, 0.7674, 2.34, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4401, 3mkaO, 0.7673, 2.05, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4402, 2h6jA, 0.7673, 2.09, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4403, 2h6jG, 0.7672, 2.04, 0.185, 216, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4404, 1q5qF, 0.7672, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4405, 1q5qD, 0.7672, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4406, 1q5qC, 0.7672, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4407, 1q5qB, 0.7672, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4408, 2h6jF, 0.7671, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4409, 2h6jD, 0.7671, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4410, 1q5qG, 0.7671, 2.12, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4411, 1q5qE, 0.7671, 2.12, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4412, 1q5qA, 0.7671, 2.11, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME
4413, 5tryG, 0.7670, 2.35, 0.187, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4414, 3mkaQ, 0.7670, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4415, 2h6jE, 0.7670, 2.13, 0.184, 217, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4416, 2h6jC, 0.7670, 2.37, 0.182, 220, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4417, 1q5rF, 0.7670, 2.14, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4418, 1q5rD, 0.7670, 2.06, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4419, 1q5rB, 0.7670, 2.06, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4420, 5trrB, 0.7669, 2.14, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4421, 1q5rG, 0.7669, 2.13, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4422, 1q5rE, 0.7669, 2.18, 0.184, 217, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4423, 1q5rC, 0.7669, 2.06, 0.185, 216, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4424, 1q5rA, 0.7669, 2.22, 0.184, 221, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4425, 3h6fK, 0.7667, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4426, 5trgB, 0.7666, 2.40, 0.182, 221, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4427, 5trgG, 0.7664, 2.08, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4428, 5thoD, 0.7664, 2.16, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4429, 3mkaY, 0.7663, 2.26, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4430, 3mfeS, 0.7662, 2.05, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4431, 3krdF, 0.7662, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4432, 3h6i1, 0.7661, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4433, 3h6f1, 0.7660, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4434, 3mkaD, 0.7659, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4435, 3h6iI, 0.7659, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4436, 5thoB, 0.7657, 2.07, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4437, 3h6iU, 0.7656, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4438, 3h6iM, 0.7656, 2.30, 0.183, 223, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4439, 5trgC, 0.7655, 2.29, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4440, 3mi0U, 0.7655, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4441, 5tryB, 0.7653, 2.32, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4442, 5trsR, 0.7653, 2.30, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4443, 3mi0O, 0.7652, 2.30, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4444, 5trgF, 0.7651, 2.30, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4445, 3mka1, 0.7650, 2.30, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4446, 3mi0M, 0.7649, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4447, 3h6fA, 0.7649, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4448, 5trrQ, 0.7647, 2.30, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4449, 3mi0K, 0.7647, 2.30, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4450, 5trsF, 0.7644, 2.30, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4451, 3h6fS, 0.7643, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4452, 3krdY, 0.7642, 2.30, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4453, 3mi0S, 0.7639, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4454, 3mi01, 0.7636, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4455, 3h6iO, 0.7636, 2.33, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4456, 3h6fO, 0.7635, 2.33, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4457, 3hfaA, 0.7633, 2.33, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4458, 3h6iS, 0.7633, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4459, 5trrR, 0.7632, 2.33, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4460, 5lzp2, 0.7632, 2.33, 0.182, 219, 214, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4461, 3h6fI, 0.7632, 2.33, 0.182, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4462, 5lzp4, 0.7631, 2.33, 0.182, 219, 214, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4463, 5ts0F, 0.7630, 2.01, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4464, 5lzp0, 0.7630, 2.04, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4465, 5lzp6, 0.7629, 2.09, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4466, 3krdI, 0.7629, 2.10, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4467, 5tryO, 0.7628, 2.25, 0.183, 224, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4468, 5lzpY, 0.7628, 2.04, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4469, 5lzpW, 0.7627, 2.11, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4470, 5lzp8, 0.7627, 2.03, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4471, 3hfa1, 0.7627, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4472, 3hfaS, 0.7626, 2.28, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4473, 3hfaW, 0.7625, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4474, 3mi0Y, 0.7624, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4475, 3hfaQ, 0.7623, 2.06, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4476, 3hfaM, 0.7623, 2.17, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4477, 3mi0W, 0.7622, 2.11, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4478, 3hfaU, 0.7622, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4479, 3hfaO, 0.7622, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4480, 3hfaK, 0.7622, 2.13, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4481, 3hfaI, 0.7622, 2.20, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4482, 3hfaF, 0.7622, 2.06, 0.181, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4483, 5trgR, 0.7621, 2.41, 0.183, 219, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4484, 3mfeY, 0.7621, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4485, 3h6iB, 0.7620, 2.04, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4486, 3krdS, 0.7619, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4487, 3hfaY, 0.7618, 2.24, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4488, 3h6fM, 0.7618, 2.15, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4489, 3krd1, 0.7617, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4490, 5lzpJ, 0.7616, 2.18, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4491, 5lzpH, 0.7616, 2.22, 0.185, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4492, 3mi0A, 0.7616, 2.16, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4493, 3krdW, 0.7616, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4494, 5trrF, 0.7615, 2.09, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4495, 3mi0I, 0.7615, 2.03, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4496, 3h6fD, 0.7615, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4497, 3mi0Q, 0.7611, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4498, 3h6fB, 0.7611, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4499, 3mfeA, 0.7608, 2.02, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4500, 3krdQ, 0.7605, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4501, 3krdK, 0.7605, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4502, 3h6fU, 0.7605, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4503, 3mi0D, 0.7604, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4504, 5lzpS, 0.7603, 2.11, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4505, 3hfaD, 0.7601, 2.16, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4506, 3h6iD, 0.7599, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4507, 3krdO, 0.7598, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4508, 3h6fY, 0.7589, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4509, 3mfe1, 0.7587, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4510, 3krdU, 0.7587, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4511, 3mfeO, 0.7585, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4512, 6bgoN, 0.7584, 2.14, 0.186, 216, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4513, 5lzpQ, 0.7583, 2.05, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4514, 3hf9I, 0.7582, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4515, 5lzpB, 0.7581, 2.31, 0.190, 216, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4516, 3krdA, 0.7581, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4517, 3mkaI, 0.7579, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4518, 6bgoJ, 0.7578, 2.05, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4519, 5lzpM, 0.7577, 2.06, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4520, 3krdM, 0.7573, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4521, 3mfeD, 0.7570, 2.10, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4522, 3krdB, 0.7566, 1.98, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, 3krdD, 0.7564, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4524, 6bgoK, 0.7560, 2.12, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4525, 3mfeQ, 0.7560, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4526, 6bgoO, 0.7558, 2.18, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4527, 6bgoM, 0.7558, 2.13, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4528, 6bgoL, 0.7558, 2.13, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4529, 6bgoI, 0.7558, 2.17, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4530, 6bgoH, 0.7558, 2.18, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4531, 6bgoG, 0.7558, 2.11, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4532, 6bgoF, 0.7558, 2.11, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4533, 6bgoE, 0.7558, 2.34, 0.180, 216, 211, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4534, 6bgoD, 0.7558, 2.04, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4535, 6bgoC, 0.7558, 2.22, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4536, 6bgoA, 0.7558, 2.07, 0.187, 214, 209, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4537, 6bglO, 0.7558, 2.07, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4538, 6bglN, 0.7558, 2.10, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4539, 6bglM, 0.7558, 2.19, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4540, 6bglL, 0.7558, 2.09, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4541, 6bglK, 0.7558, 2.10, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4542, 6bglJ, 0.7558, 2.18, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4543, 6bglI, 0.7558, 2.03, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4544, 6bglH, 0.7558, 2.01, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4545, 6bglG, 0.7558, 2.14, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4546, 6bglF, 0.7558, 2.04, 0.183, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4547, 6bglE, 0.7558, 2.02, 0.187, 213, 208, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4548, 6bglD, 0.7558, 2.12, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4549, 6bglC, 0.7558, 2.08, 0.187, 214, 209, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4550, 6bglA, 0.7558, 2.40, 0.184, 219, 212, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4551, 3hf9y, 0.7558, 2.11, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4552, 3h6iY, 0.7558, 1.97, 0.188, 212, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4553, 3hf9s, 0.7556, 2.13, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4554, 3mfeU, 0.7554, 2.13, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4555, 3hf9b, 0.7552, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, 3hf9f, 0.7551, 2.46, 0.184, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4557, 3hf9u, 0.7549, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, 3hf9K, 0.7548, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, 3hf9i, 0.7545, 2.06, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4560, 3hf9S, 0.7544, 2.09, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, 3hf9B, 0.7543, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4562, 3hf9k, 0.7542, 2.26, 0.186, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4563, 3mi0B, 0.7540, 2.08, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4564, 3hf9A, 0.7539, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, 3hf9U, 0.7535, 2.26, 0.186, 219, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4566, 3hf9w, 0.7534, 2.26, 0.186, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4567, 3hf9d, 0.7533, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4568, 3hf91, 0.7533, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, 3hf9Q, 0.7531, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9O, 0.7531, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf9a, 0.7529, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3hf9o, 0.7527, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4573, 3hf9Y, 0.7520, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 3hf9q, 0.7520, 2.26, 0.186, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4575, 3hf93, 0.7508, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4576, 3mfeW, 0.7486, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4577, 3hf9D, 0.7473, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4578, 3hf9m, 0.7435, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4579, 3hf9M, 0.7355, 2.26, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, 5a0qO, 0.7262, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4581, 5a0qA, 0.7262, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4582, 5a0qT, 0.7222, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4583, 5a0qF, 0.7221, 2.26, 0.186, 215, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4584, 3h4pl, 0.7102, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4585, 3h4pg, 0.7101, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4586, 3h4pa, 0.7101, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4587, 3h4pk, 0.7099, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4588, 3h4pj, 0.7096, 2.26, 0.186, 215, 210, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4589, 3h4pe, 0.7096, 1.95, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4590, 3h4pb, 0.7095, 2.10, 0.187, 213, 208, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4591, 3h4pc, 0.7094, 1.98, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4592, 3h4pn, 0.7093, 2.04, 0.188, 212, 207, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4593, 3h4pf, 0.7093, 1.97, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4594, 3h4pd, 0.7093, 1.98, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4595, 3h4pi, 0.7092, 1.97, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4596, 3h4ph, 0.7089, 1.99, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4597, 3h4pm, 0.7088, 1.97, 0.189, 211, 206, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4598, 6bdfZ, 0.7064, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4599, 6bdfX, 0.7064, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4600, 6bdfV, 0.7064, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4601, 6bdfT, 0.7064, 2.25, 0.183, 213, 208, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4602, 6bdfR, 0.7064, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4603, 6bdfP, 0.7064, 2.00, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4604, 6bdfN, 0.7064, 1.97, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4605, 6bdfL, 0.7064, 1.98, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4606, 6bdfJ, 0.7064, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4607, 6bdfH, 0.7064, 2.00, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4608, 6bdfF, 0.7064, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4609, 6bdfD, 0.7064, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4610, 6bdfB, 0.7064, 1.99, 0.189, 211, 206, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4611, 6bdf1, 0.7064, 1.96, 0.185, 210, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4612, 3j9iZ, 0.7050, 2.01, 0.189, 211, 206, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4613, 3j9iY, 0.7050, 1.97, 0.185, 210, 205, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4614, 3j9iX, 0.7050, 1.91, 0.191, 209, 204, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4615, 3j9iW, 0.7050, 2.04, 0.185, 210, 205, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4616, 3j9iV, 0.7050, 1.98, 0.187, 208, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4617, 3j9iN, 0.7050, 1.87, 0.190, 205, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4618, 3j9iM, 0.7050, 1.66, 0.365, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4619, 3j9iL, 0.7050, 1.66, 0.365, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4620, 3j9iK, 0.7050, 1.60, 0.339, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4621, 3j9iJ, 0.7050, 1.60, 0.339, 195, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4622, 3j9iI, 0.7050, 2.19, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4623, 3j9iH, 0.7050, 2.19, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4624, 3j9i2, 0.7050, 2.19, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4625, 3j9i1, 0.7050, 2.19, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4626, 2h6jN, 0.7045, 2.20, 0.254, 202, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4627, 5vy4X, 0.7044, 2.07, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4628, 5vy4R, 0.7044, 2.20, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4629, 5vy4BA, 0.7044, 2.06, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4630, 5vy41, 0.7044, 2.06, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4631, 2h6jK, 0.7044, 2.07, 0.250, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4632, 2h6jJ, 0.7044, 2.21, 0.254, 202, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4633, 5vy4Z, 0.7043, 2.06, 0.250, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4634, 5vy4V, 0.7043, 2.22, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4635, 5vy4T, 0.7043, 2.21, 0.254, 202, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4636, 5vy4P, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4637, 5vy4N, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4638, 5vy4L, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4639, 5vy4J, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4640, 5vy4H, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4641, 5vy4F, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4642, 5vy4D, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4643, 5vy4B, 0.7043, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4644, 2h6jI, 0.7041, 2.24, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4645, 2h6jL, 0.7039, 2.24, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4646, 2h6jH, 0.7038, 2.24, 0.187, 201, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4647, 5vy3Z, 0.7037, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4648, 5vy3X, 0.7037, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4649, 5vy3V, 0.7037, 2.24, 0.187, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4650, 5vy3T, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4651, 5vy3R, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4652, 5vy3P, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4653, 5vy3N, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4654, 5vy3L, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4655, 5vy3J, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4656, 5vy3H, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4657, 5vy3F, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4658, 5vy3D, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4659, 5vy3B, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4660, 5vy31, 0.7037, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4661, 1yauM, 0.7037, 2.28, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4662, 2h6jM, 0.7036, 2.28, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4663, 1yarM, 0.7031, 2.28, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4664, 1q5rN, 0.7031, 2.75, 0.185, 242, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4665, 1q5rL, 0.7031, 2.27, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4666, 1q5rM, 0.7030, 2.27, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4667, 1q5rK, 0.7030, 2.27, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4668, 1q5rJ, 0.7030, 2.27, 0.187, 203, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4669, 1q5rI, 0.7030, 2.76, 0.185, 242, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4670, 1q5rH, 0.7030, 2.78, 0.180, 242, 200, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4671, 3jrmM, 0.7029, 2.27, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4672, 1yauJ, 0.7029, 2.27, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4673, 3jrmI, 0.7028, 2.27, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4674, 1ya7M, 0.7028, 2.27, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4675, 3jrmK, 0.7027, 2.27, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4676, 3jrmJ, 0.7027, 2.27, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4677, 3jrmH, 0.7027, 2.27, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4678, 3c92M, 0.7027, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4679, 3c921, 0.7027, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4680, 3c91M, 0.7027, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4681, 3c911, 0.7027, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4682, 1yauK, 0.7027, 2.27, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4683, 1yauI, 0.7027, 2.76, 0.185, 242, 200, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4684, 1ya7K, 0.7027, 2.78, 0.185, 242, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4685, 1ya7I, 0.7027, 2.76, 0.185, 242, 200, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4686, 1pmaX, 0.7027, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4687, 1pmaT, 0.7027, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4688, 3jseM, 0.7026, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4689, 3jrmN, 0.7026, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4690, 3jrmL, 0.7026, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4691, 1pmaY, 0.7026, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4692, 3jtlJ, 0.7025, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4693, 3c92W, 0.7025, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4694, 3c92I, 0.7025, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4695, 3c91W, 0.7025, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4696, 3c91I, 0.7025, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4697, 1yauH, 0.7025, 2.30, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4698, 1yarK, 0.7025, 2.30, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4699, 1ya7H, 0.7025, 2.30, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4700, 1pmaP, 0.7025, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4701, 3jtlK, 0.7024, 2.62, 0.191, 242, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4702, 3jseK, 0.7024, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4703, 3c92X, 0.7024, 3.06, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4704, 3c92N, 0.7024, 3.06, 0.167, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4705, 3c92J, 0.7024, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4706, 3c922, 0.7024, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4707, 3c91X, 0.7024, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4708, 3c91N, 0.7024, 3.07, 0.177, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4709, 3c91J, 0.7024, 3.06, 0.167, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4710, 3c912, 0.7024, 2.37, 0.192, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4711, 1ya7J, 0.7024, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4712, 1pmaU, 0.7024, 2.38, 0.192, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4713, 1pmaQ, 0.7024, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4714, 1pma2, 0.7024, 2.38, 0.192, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4715, 3jtlL, 0.7023, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4716, 1yarI, 0.7023, 2.38, 0.192, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4717, 1pmaV, 0.7023, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4718, 3jseL, 0.7022, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4719, 3jseJ, 0.7022, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4720, 3jseI, 0.7022, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4721, 3jseH, 0.7022, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4722, 3c92Z, 0.7022, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4723, 3c92L, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4724, 3c91Z, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4725, 3c91L, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4726, 1ya7N, 0.7022, 2.30, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4727, 1pmaS, 0.7022, 2.37, 0.192, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4728, 1pma1, 0.7022, 2.38, 0.192, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4729, 3jseN, 0.7021, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4730, 3c92V, 0.7020, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4731, 3c92H, 0.7020, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4732, 3c91V, 0.7020, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4733, 3c91H, 0.7020, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4734, 1yauN, 0.7020, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4735, 1yauL, 0.7020, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4736, 1pmaZ, 0.7020, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4737, 1pmaW, 0.7020, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4738, 1pmaB, 0.7020, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4739, 3jtlM, 0.7019, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4740, 1ya7L, 0.7019, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4741, 3jtlN, 0.7018, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4742, 3jtlH, 0.7018, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4743, 1yarL, 0.7018, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4744, 1yarJ, 0.7016, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4745, 3mkaG, 0.7015, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4746, 3c92Y, 0.7015, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4747, 3c92K, 0.7015, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4748, 3c91Y, 0.7015, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4749, 3c91K, 0.7015, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4750, 1pmaR, 0.7015, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4751, 1yarH, 0.7012, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4752, 3mkaN, 0.7009, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4753, 3jtlI, 0.7009, 2.30, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4754, 1j2qN, 0.7009, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4755, 1j2qJ, 0.7009, 2.32, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4756, 1j2qI, 0.7009, 2.31, 0.187, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4757, 1j2qM, 0.7008, 2.38, 0.192, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4758, 1j2qL, 0.7008, 2.38, 0.192, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4759, 1j2qK, 0.7008, 2.38, 0.192, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4760, 1j2qH, 0.7008, 2.38, 0.192, 203, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4761, 3mkaJ, 0.7007, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4762, 3mkaL, 0.7005, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4763, 3mkaC, 0.7004, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4764, 1yarN, 0.7004, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4765, 3mkaT, 0.7002, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4766, 3mfeF, 0.6999, 2.31, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4767, 2z5cC, 0.6995, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4768, 2z5cF, 0.6994, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4769, 3mkaP, 0.6983, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4770, 3mkaV, 0.6982, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4771, 3mkaH, 0.6979, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4772, 3mkaR, 0.6977, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4773, 3mka2, 0.6976, 2.33, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4774, 3mkaE, 0.6966, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4775, 3gpjX, 0.6960, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4776, 3gpjJ, 0.6960, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4777, 3d29J, 0.6960, 2.32, 0.187, 203, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4778, 4intJ, 0.6959, 2.39, 0.192, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4779, 3sdiJ, 0.6959, 2.32, 0.187, 203, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4780, 3d29X, 0.6959, 2.39, 0.192, 203, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
4781, 1g65X, 0.6959, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4782, 3bdmX, 0.6958, 2.32, 0.187, 203, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4783, 3bdmJ, 0.6958, 2.39, 0.192, 203, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4784, 4intX, 0.6957, 3.10, 0.172, 251, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4785, 4inrX, 0.6957, 2.32, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4786, 4inrJ, 0.6957, 2.32, 0.187, 203, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4787, 3okjJ, 0.6957, 2.32, 0.187, 203, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4788, 3nzwX, 0.6957, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4789, 3nzwJ, 0.6957, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4790, 2zcyJ, 0.6957, 2.40, 0.192, 203, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4791, 4jsqX, 0.6956, 3.13, 0.172, 252, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4792, 4jsqJ, 0.6956, 2.28, 0.193, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4793, 3okjX, 0.6956, 2.32, 0.238, 202, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4794, 2zcyX, 0.6956, 2.32, 0.238, 202, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4795, 1g65J, 0.6956, 2.33, 0.238, 202, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4796, 4jsuX, 0.6954, 2.32, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4797, 4jsuJ, 0.6954, 2.32, 0.238, 202, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4798, 3nzxX, 0.6954, 2.32, 0.238, 202, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4799, 3nzxJ, 0.6954, 2.32, 0.238, 202, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4800, 5trrI, 0.6953, 3.35, 0.160, 252, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4801, 5trgK, 0.6953, 3.10, 0.172, 251, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4802, 4inuX, 0.6953, 3.11, 0.172, 250, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4803, 4inuJ, 0.6953, 2.30, 0.193, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4804, 5lzpI, 0.6952, 3.36, 0.165, 250, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4805, 3mi0L, 0.6951, 2.02, 0.198, 212, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4806, 3mg0X, 0.6951, 1.24, 0.302, 189, 182, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4807, 3mg0J, 0.6951, 1.24, 0.302, 189, 182, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4808, 3nzjX, 0.6950, 3.25, 0.162, 250, 204, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4809, 3mfeM, 0.6950, 2.88, 0.175, 249, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4810, 3un4X, 0.6949, 3.00, 0.179, 249, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4811, 3un4J, 0.6949, 2.74, 0.176, 246, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4812, 3nzjJ, 0.6949, 2.88, 0.175, 246, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4813, 3ipmK, 0.6949, 2.89, 0.175, 248, 200, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4814, 2f16X, 0.6949, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4815, 2f16J, 0.6949, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4816, 5ts0W, 0.6948, 2.06, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4817, 5trrW, 0.6948, 2.25, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4818, 5trrL, 0.6948, 2.24, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4819, 4ltcX, 0.6948, 2.06, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4820, 4ltcJ, 0.6948, 2.24, 0.187, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4821, 4hrcX, 0.6948, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4822, 3ipmM, 0.6948, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4823, 3ipmL, 0.6948, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4824, 3ipmJ, 0.6948, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4825, 3ipmI, 0.6948, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4826, 3ipmH, 0.6948, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4827, 5trsW, 0.6947, 2.06, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4828, 5trgL, 0.6947, 2.06, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4829, 4jt0J, 0.6947, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4830, 3sdiX, 0.6947, 2.25, 0.182, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4831, 3ipmN, 0.6947, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4832, 5trgY, 0.6946, 2.06, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4833, 5trgI, 0.6946, 2.05, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4834, 4q1sJ, 0.6946, 2.24, 0.187, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4835, 4jt0X, 0.6946, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4836, 4hrdJ, 0.6946, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4837, 5trrb, 0.6945, 2.06, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4838, 5lzpK, 0.6945, 2.06, 0.194, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4839, 5lzpC, 0.6945, 2.51, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4840, 5trgV, 0.6944, 2.51, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4841, 5thoL, 0.6944, 2.25, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4842, 4gk7X, 0.6944, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4843, 4gk7J, 0.6944, 2.51, 0.173, 223, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4844, 3gptX, 0.6944, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4845, 3gptJ, 0.6944, 2.24, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4846, 5trrZ, 0.6943, 2.06, 0.194, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4847, 5thoW, 0.6943, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4848, 5lzpE, 0.6943, 1.88, 0.196, 194, 189, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4849, 3wxrY, 0.6943, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4850, 3mg4J, 0.6943, 2.26, 0.182, 198, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4851, 3gpwJ, 0.6943, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4852, 3dy3X, 0.6943, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4853, 3dy3J, 0.6943, 2.25, 0.187, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4854, 2fakJ, 0.6943, 2.25, 0.187, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4855, 1g0uX, 0.6943, 2.52, 0.173, 223, 196, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4856, 5trsL, 0.6942, 2.51, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4857, 5trgX, 0.6942, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4858, 5lzpR, 0.6942, 2.27, 0.182, 198, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4859, 4fzgX, 0.6942, 2.26, 0.182, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4860, 4fzgJ, 0.6942, 2.26, 0.182, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4861, 3un8J, 0.6942, 2.39, 0.193, 203, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4862, 3hyeX, 0.6942, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4863, 3hyeJ, 0.6942, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4864, 3hf9W, 0.6942, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4865, 3gpwX, 0.6942, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4866, 2gplX, 0.6942, 2.53, 0.173, 223, 196, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4867, 2gplJ, 0.6942, 2.53, 0.173, 223, 196, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4868, 2fakX, 0.6942, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4869, 1jd2Q, 0.6942, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4870, 5trrY, 0.6941, 2.39, 0.193, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4871, 3un8X, 0.6941, 2.53, 0.173, 223, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4872, 3dy4X, 0.6941, 2.52, 0.173, 222, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4873, 3dy4J, 0.6941, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4874, 5ts0K, 0.6940, 2.26, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4875, 5trsY, 0.6940, 2.26, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4876, 5trra, 0.6940, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4877, 4hrcJ, 0.6940, 2.52, 0.173, 222, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4878, 3mg8J, 0.6940, 2.52, 0.173, 223, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4879, 1rypK, 0.6940, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4880, 5ts0I, 0.6939, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4881, 5trya, 0.6939, 2.26, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4882, 4lqiJ, 0.6939, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4883, 3mi0E, 0.6939, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4884, 3mi02, 0.6939, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4885, 3hfaV, 0.6939, 2.53, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4886, 3hfaL, 0.6939, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4887, 3hfaG, 0.6939, 2.52, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4888, 3hfaC, 0.6939, 2.28, 0.177, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4889, 1g0uJ, 0.6939, 2.08, 0.188, 198, 191, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4890, 5ts0L, 0.6938, 2.08, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4891, 5tryW, 0.6938, 2.07, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4892, 5tryb, 0.6938, 2.07, 0.188, 198, 191, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4893, 5trsI, 0.6938, 2.27, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4894, 5trga, 0.6938, 2.27, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4895, 5thoV, 0.6938, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4896, 5lzpT, 0.6938, 2.54, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4897, 4lqiX, 0.6938, 2.52, 0.173, 223, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4898, 4hrdX, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4899, 4hnpX, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4900, 4hnpJ, 0.6938, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4901, 3mi0N, 0.6938, 2.26, 0.187, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4902, 3mi0J, 0.6938, 2.26, 0.187, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4903, 3mg6J, 0.6938, 1.83, 0.197, 193, 188, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4904, 3hfaZ, 0.6938, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4905, 3hfaT, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4906, 3hfaP, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4907, 3hfaN, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4908, 3hfaE, 0.6938, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4909, 3hfa2, 0.6938, 2.52, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4910, 1rypY, 0.6938, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4911, 5thoI, 0.6937, 2.07, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4912, 5lzpG, 0.6937, 2.07, 0.188, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4913, 3tddX, 0.6937, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4914, 3tddJ, 0.6937, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4915, 3hfaX, 0.6937, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4916, 3hfaR, 0.6937, 2.26, 0.177, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4917, 3hfaJ, 0.6937, 2.08, 0.194, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4918, 3hfaH, 0.6937, 2.27, 0.187, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4919, 5trrV, 0.6936, 2.53, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4920, 5thob, 0.6936, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4921, 5lzpU, 0.6936, 2.09, 0.188, 198, 191, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4922, 4q1sX, 0.6936, 2.54, 0.173, 223, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4923, 3mi0X, 0.6936, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4924, 3e47X, 0.6936, 2.56, 0.173, 226, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4925, 3e47J, 0.6936, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4926, 1jd2J, 0.6936, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4927, 5tryZ, 0.6935, 2.57, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4928, 5lzpO, 0.6935, 2.27, 0.182, 198, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4929, 3shjX, 0.6935, 2.53, 0.173, 223, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4930, 3shjJ, 0.6935, 2.53, 0.173, 223, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4931, 3oevJ, 0.6935, 2.55, 0.173, 223, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4932, 5ts0b, 0.6934, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4933, 5trsK, 0.6934, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4934, 5trsb, 0.6934, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4935, 5trsa, 0.6934, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4936, 5thoZ, 0.6934, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4937, 5thoK, 0.6934, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4938, 3mi0T, 0.6934, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4939, 3mg4X, 0.6934, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4940, 5tryL, 0.6933, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4941, 5tryI, 0.6933, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4942, 5thoY, 0.6933, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4943, 5lzpN, 0.6933, 2.57, 0.173, 224, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4944, 5lzpA, 0.6933, 2.57, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4945, 4fzcJ, 0.6933, 2.57, 0.173, 222, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4946, 3sdkJ, 0.6933, 2.57, 0.173, 223, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4947, 3mi0G, 0.6933, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4948, 5ts0a, 0.6932, 2.57, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4949, 5trsV, 0.6932, 2.27, 0.187, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4950, 5lzpF, 0.6932, 2.61, 0.173, 222, 197, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4951, 4j70J, 0.6932, 2.54, 0.173, 222, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4952, 4fzcX, 0.6932, 2.28, 0.182, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4953, 3mi0H, 0.6932, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4954, 1q5qN, 0.6932, 2.57, 0.173, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4955, 1q5qM, 0.6932, 2.57, 0.173, 222, 196, THE RHODOCOCCUS 20S PROTEASOME
4956, 1q5qK, 0.6932, 2.57, 0.173, 222, 196, THE RHODOCOCCUS 20S PROTEASOME
4957, 1q5qH, 0.6932, 2.57, 0.173, 223, 196, THE RHODOCOCCUS 20S PROTEASOME
4958, 6bgoZ, 0.6931, 2.54, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4959, 6bgoY, 0.6931, 2.55, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4960, 6bgoX, 0.6931, 2.54, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4961, 6bgoW, 0.6931, 2.27, 0.182, 198, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4962, 6bgoV, 0.6931, 2.55, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4963, 6bgoU, 0.6931, 2.10, 0.188, 198, 191, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4964, 6bgoT, 0.6931, 2.10, 0.188, 198, 191, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4965, 6bgoS, 0.6931, 2.09, 0.194, 198, 191, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4966, 6bgoR, 0.6931, 2.54, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4967, 6bgoQ, 0.6931, 2.54, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4968, 6bgoP, 0.6931, 2.27, 0.187, 198, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4969, 6bgoc, 0.6931, 2.27, 0.187, 198, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4970, 6bgob, 0.6931, 2.10, 0.188, 198, 191, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4971, 6bgoa, 0.6931, 2.54, 0.173, 223, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4972, 6bglZ, 0.6931, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4973, 6bglY, 0.6931, 2.56, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4974, 6bglX, 0.6931, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4975, 6bglW, 0.6931, 2.54, 0.173, 222, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4976, 6bglV, 0.6931, 2.54, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4977, 6bglU, 0.6931, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4978, 6bglT, 0.6931, 2.10, 0.188, 198, 191, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4979, 6bglS, 0.6931, 2.55, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4980, 6bglR, 0.6931, 2.62, 0.173, 222, 197, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4981, 6bglQ, 0.6931, 2.53, 0.173, 223, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4982, 6bglP, 0.6931, 2.61, 0.173, 234, 197, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4983, 6bglc, 0.6931, 2.55, 0.173, 222, 196, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4984, 6bglb, 0.6931, 2.10, 0.188, 198, 191, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4985, 6bgla, 0.6931, 2.11, 0.194, 198, 191, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4986, 5ts0Z, 0.6931, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4987, 5tryK, 0.6931, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4988, 5trrK, 0.6931, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4989, 5trgW, 0.6931, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4990, 5trgH, 0.6931, 2.28, 0.182, 198, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4991, 5thoa, 0.6931, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4992, 5lzpL, 0.6931, 2.55, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4993, 3oeuJ, 0.6931, 2.49, 0.179, 224, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4994, 3mi0C, 0.6931, 2.49, 0.179, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4995, 1q5qL, 0.6931, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4996, 1q5qJ, 0.6931, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4997, 1q5qI, 0.6931, 2.55, 0.173, 222, 196, THE RHODOCOCCUS 20S PROTEASOME
4998, 5tryY, 0.6930, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4999, 5trrM, 0.6930, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
5000, 5trrH, 0.6930, 2.55, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
